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The success of neonatal intensive care in terms of morbidity and mortality is closely
linked to the success of ventilator management. Although the ventilation of sick
newborn infants has led to an increase in their survival it is clear that ventilation itself
is associated with morbidity and mortality.
Ventilation requirements depend on the mechanics of the respiratory system. When
the ventilator settings are inappropriate there is worsened gas exchange and a
potential for unnecessary lung damage. The mechanics of the respiratory system
change during the evolution of respiratory disease and therapeutic interventions such
as surfactant replacement may cause more abrupt changes that necessitate adjustment
of the ventilator settings.
Many new styles of ventilation are developing and with them techniques for
measuring respiratory function and the interactions between infants and their
ventilators. Studies suggest that these techniques may have the potential to improve
infant care but they have not been systematically evaluated. The studies described in
this thesis represent an attempt to determine the clinical value of routine
measurements of static respiratory system compliance (Crs) using the single breath
passive expiratory flow technique and their suitability for introduction into routine
practice.
Measurements of Crs were found to be reproducible and safe but because of technical
problems up to 20% of attempted measurements in unsedated ventilated infants were
unsuccessful. Junior doctors were found to perform poorly at estimating Crs by
inspection. They disagreed with one another as well as with the measurements. Many
clinical circumstances were encountered where Crs data appeared to be useful.
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Early improvements in Crs were seen following the treatment of respiratory distress
syndrome (RDS) with a natural surfactant that were not seen when an artificial
surfactant was administered. These changes may go some way towards explaining the
mechanism of action of surfactant replacement therapy in human infants with RDS
and the differences in clinical response observed between surfactant preparations. Crs
measurements demonstrated some potential as a means of selecting infants for
surfactant treatment. In a randomised controlled trial enrolling 245 infants regular
measurements of Crs as an additional guide to ventilator management did not impact
on the frequency of major adverse neonatal outcomes or reduce the duration of
ventilator or oxygen dependence.
On the basis of these studies it may be concluded that although measurements of Crs
using the single breath passive expiratory flow technique have a clear place in
research they are probably unsuitable for introduction into routine practice. The real
value of alternative methodologies should now be urgently evaluated as they are
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Chapter 1: Introduction and
Methodology
Introduction
Technological advances over the last 20-30 years coupled with rapidly increasing
medical expertise have led to huge improvements in our capacity to care for the
seriously ill newborn infant. The neonatal mortality rate per 1000 live births in
Scotland has fallen from 16 between the years 1961-70 to 4.5 in 1991 h Undoubtedly
many factors have contributed to these advances including better obstetric
management, the treatment of sepsis with antibiotics, and an improved capacity to
provide nutritional support to small infants. But perhaps the single most important
development in practice has been the evolution of artificial ventilation. This has
brought about the survival of many preterm infants who previously were felt to be
non-viable as a result of inadequate development of their lungs.
Although there has been rapid progress in the mechanical ventilation of newborn
infants in the last three decades, many of the concepts of neonatal ventilation are not
new. In 1752 the Scottish obstetrician William Smellie described a silver
endotracheal tube for the resuscitation of newborn infants and in 1776 John Hunter, a
Scottish surgeon, had constructed a ventilator with a pressure limiting valve. In 1822
a Parisian, Leroy d'Etoilles, demonstrated that overinflation of the lung may cause
pneumothorax. A monograph published in 1835 by Eduard Jorg entitled "Die
Fotuslunge im gebornen Kinde" (Foetal lung in the baby who is born) was a
description of the causes, complications and treatment of respiratory distress
syndrome. The causes included immaturity, hypothermia and asphyxia.
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The complications were right to left shunting, pneumothorax and pulmonary
interstitial emphysema and the treatment, warmth, artificial ventilation (by mouth or
instrument) and oxygen administration. He included a caution that high oxygen
administration might cause inflammation of the lung. So by 1835 it was already
becoming clear that excess inflation pressures and high concentrations of oxygen
were damaging to the lung. Alexander Graham Bell in 1889 2 described an apparatus
for ventilating newborn infants using negative extrathoracic pressures which failed to
attract much interest. Ironically in the 1990's this technique is enjoying renewed
interest3. By the 1950's interest in neonatal ventilation was widening4 and by the
1960's it was becoming accepted.
Techniques of ventilation and equipment have changed considerably in a short time.
Initial experiences were that the mortality of artificially ventilated infants was
extremely high 5'6-7 but in the beginning only the sickest infants with little chance of
survival were selected for treatment. Smythe et al5 recognised in 1963 that many
infants were dying of tetanus neonatorum because of mechanical ventilation with
inadequate inflation pressures. They made this observation on the basis of
measurements of arterial carbon dioxide tension and static respiratory system
compliance. They found by monitoring static compliance during the course of the
disease in a group of infants that problems with ventilation were explained by
changes in the respiratory system compliance and that such problems could be
overcome by adjustments in the pressures applied by the ventilator. Their new
knowledge meant that they were sometimes raising the ventilator pressures under
circumstances where they would previously have lowered them. They were able to
dramatically increase the survival rate of their infants. As infants began to be
ventilated for hyaline membrane disease the strategy for ventilation centred around
mimicking the infants' spontaneous respiratory efforts, and ventilator rates of 60 to 80
breaths per minute were used.
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In these critically ill infants with respiratory distress syndrome very high peak
inspiratory pressures were often required to achieve adequate oxygenation and many
of the treated infants died or developed bronchopulmonary dysplasia. As more
experience was gained it was found that if the respiratory rate was lowered to around
30 breaths per minute and a longer inspiratory time was used that oxygenation could
be achieved at a much lower peak airway pressure and inspired oxygen
concentration 8. The adoption of this approach was associated with an almost fivefold
increase in the number of infants surviving ventilation 9. These studies demonstrated
very early in the modem history of infant ventilation that using a ventilation strategy
appropriate to the particular underlying problem can have an important influence on
clinical outcome.
As the success of mechanical ventilation has improved, the threshold for ventilation
has become progressively lower and consequently the population characteristics of
the infants being ventilated have changed. Smaller, less mature infants are now being
ventilated 10 and some authors have suggested that a faster ventilator rate and shorter
inspiratory time may be associated with a lower frequency of air leak or other
complications n-i2. Ramsden and Reynolds stressed the important point that it is
unwise to make generalisations about the best way to ventilate an infant as the
interaction between the respiratory system and the ventilator is highly dependent on
the respiratory system mechanics at any given time 13. Since these may vary
considerably during the natural history of a particular illness 14'15.16d7 there can be no
single appropriate way to ventilate an infant. Perhaps the ideal would be to tailor the
ventilator settings to the individual infants' instantaneous lung mechanics.
Although more infants now survive than before, it is often at the cost of chronic
ventilator dependency and it may be that with further refinement of ventilation
techniques morbidity and mortality could still improve.
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The widespread introduction of antenatal steroids for mothers at risk of delivering
preterm infants to promote foetal lung maturation and the use of surfactant therapy
either as prophylaxis or rescue treatment for respiratory distress syndrome have great
potential to influence infant survival and morbidity. Both of these treatments are
undoubtedly highly effective 18,19,20 f,ut their expanding use may not reduce neonatal
unit workloads because they may the increase the number of ventilator dependent
survivors. Recent estimates suggest that the mean duration of ventilation and
hospitalisation of the smallest infants has actually been increasing 10'21. These
changes could have very important resource implications. The provision of neonatal
intensive care is extremely expensive. The average daily cost of neonatal intensive
care per patient in Birmingham (UK) in 1984 was £235 22 (approximately twice the
cost of care at lower levels of dependency). A similar estimate in Leeds (UK) in 1988
placed the cost at £467 23. The costs in 1995 must be higher still, particularly if the
cost of surfactant treatment at around £500 - £1000 per infant are added. Any new
treatment has to undergo economic as well as scientific scrutiny 24 and developments
in care which could reduce costs are viewed with enthusiasm.
Every year mechanical ventilators offer a wider range of ventilation modes, each
aimed at minimising the potential for lung damage and its consequences. There are
many ways in which inappropriate ventilator settings might prove harmful to the
infant. When excessive airway pressures are employed for a given degree of lung or
respiratory system compliance, these pressures can be transmitted to the pulmonary
and systemic circulations and have adverse effects on oxygenation, venous return and
cardiac output 25,26,27 if insufficient time is allowed for adequate expiration to occur
between ventilator breaths, the resultant intrathoracic gas trapping can cause
inadvertent positive end-expiratory pressure (PEEP) which may have similar effects
on the circulation and worsen alveolar ventilation 13,28,29,30,31,32,33,34
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Under both of these circumstances the increased airway pressures may contribute to
the already high risk of lung damage such as pneumothorax or in the longer term
bronchopulmonary dysplasia 35-36.
The lung damage attributed to ventilation is often referred to as barotrauma, implying
that it is caused by pressure. Neonatologists strive to minimise the ventilator pressures
they use in the hope of avoiding it. Recent evidence suggests that it may be volume
overdistension of the airspaces caused by pressure rather than the pressure itself that
produces the damage 37,38,39,40 Some now talk about volutrauma rather than
barotrauma41-42. Pressure-controlled ventilation is the norm in neonatal intensive care
and will probably remain so because it is easy to apply and monitor. There is a danger
that by controlling pressures the importance of thinking about volume may be
overlooked. Pneumothoraces have been associated with a high risk of death or serious
brain damage from intraventricular haemorrhage 43•44. Treatments like surfactant may
have dramatic effects on the lung mechanics45-46'47'48. Under these circumstances
prompt alterations to the ventilator settings may be required to maximise the potential
benefits of treatment. If inadequate airway pressures are employed to maintain end-
expiratory lung volume under circumstances where there is alveolar instability,
alveolar ventilation and gas exchange may be sub-optimal 49,50,51.52 an(j the course of
respiratory distress syndrome may be unnecessarily prolonged53. So ventilator
settings that are either inappropriately aggressive or gentle could delay an infant's
recovery, lengthen the duration of ventilator dependence and increase the risk of
death, chronic lung disease or serious brain damage.
Successful outcomes in neonatal mechanical ventilation will depend on the caregivers
having an appropriate knowledge of the underlying physiology and a wide experience
of the effects of different strategies for ventilation in the clinical setting.
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Clinicians judge an infant's ventilation requirements with the aid of visual
assessments of lung inflation combined with auscultation findings and blood gas
results, tailoring these to a knowledge of the natural history of the suspected
underlying condition. Clinical assessments and the accuracy of clinical diagnoses are
both subjective and may be liable to error particularly when made by less experienced
individuals. There may be subconscious bias in favour of a diagnosis if this will allow
the use of a popular therapy 54. Respiratory diagnosis often depends heavily on the
chest radiograph which can be similar in different conditions 55-56. Junior doctors'
estimates of chest inflation may not be as accurate as those of their seniors 57. Then-
seniors may not be as accurate as they would imagine. A group of experienced senior
anaesthetists manually ventilating infant test lungs with a variety of commonly used
anaesthetic circuits were unable to detect when the endotracheal tube was completely
occluded 58. The blood gas results may not always help as they can be distorted by the
ventilation strategy 27,30,59 The same gases may be obtained with different strategies
that may be more or less damaging than one another. Although in most centres,
highly experienced help is usually available, it is often less experienced junior doctors
who provide much of the basic care. These problems increase the importance of
finding other ways of supplying objective information about the clinical state to aid
the decision making process. This has led to an interest in the potential utility of lung
function measurements in this context.
It has been possible to make measurements of respiratory function on ventilated
infants since the 1960's5. Perhaps because of the increased frailty of premature
infants relative to older children or adults and limitations of equipment size, these
methods have not found their way into routine clinical use. The ready availability of
computerised methods has greatly simplified many measurement methodologies and
the calculation of results, making tests rapid, well tolerated and easy to perform. At
present they are largely confined to research centres.
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Numerous studies have demonstrated the potential utilities of various methods of
lung function testing in individual applications. Measurements of static respiratory
system compliance (Crs) made in the neonatal period have been shown to provide a
rapid estimate of early respiratory disease severity which correlates well with the risk
ofmortality 60. A recent study suggested that Crs corrected for body length performed
better as a predictor of disease severity than mean oxygen requirement in the first 12
hours of life and may be less liable to distortion by the ventilator settings 59 although
the numbers of patients involved in the study were small. Mean FiC>2 in the first 12
hours of life has been shown to be at least as good a prognostic index as either
birthweight or gestational age61. Compliance measurements have also been found to
be a better predictor of death from respiratory distress syndrome than the disease
severity suggested by the chest radiograph 62. Measurements of Crs have shown
promise as a rapid bedside method for determining biochemical lung maturity 63 and
for predicting the likely success of extubation 64. They have been less successful at
predicting the development of chronic lung disease65. Although these studies have
demonstrated that respiratory function measurements have the potential to improve
clinical management they have not enrolled large numbers of infants, making it hard
to assess whether they would truly impact on clinical outcome in some important
way. There are no published randomised trials evaluating the potential of respiratory
mechanics measurements to improve the outcome of neonatal care. The initial outlay
for measurement equipment and investment of time spent developing the expertise to
make and interpret the measurements mean that this is likely to be necessary before
lung function testing finds its way into routine neonatal management. If any
measurement of lung function is to be attractive to neonatologists as a potential
clinical tool it will have to be applicable at the cot side to the smallest, sickest infants,
be rapid, involve minimal handling of the infant, be reproducible and be easily
learned.
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Techniques for the measurement of lung volume either as functional residual capacity
(FRC) or thoracic gas volume (TGV) have provided important information about the
relationships of lung size to body size, the elastic and resistive properties of the lungs
relative to lung size and the effect of various disease processes and ventilator
strategies on lung volume 66,67,68,69,70,71,72,73,74 These have greatly enhanced our
understanding of the properties of the infant lung. Measurements of FRC or TGV are
complicated and would be difficult to apply usefully in routine care at the present
time although they may attract more interest with the increasing use of high frequency
oscillatory ventilation. Adequate volume recruitment is central to the optimum use of
this technique. This is currently assessed with frequent chest radiographs which
necessitate considerable handling of the infant. Recent studies indicate that FRC
measurements may aid optimisation of oscillatory settings 75 and that there is poor
correlation between chest radiograph appearances and FRC 76-77.
Measurements of the compliance and resistance of the respiratory system or lungs
have been the area of greatest interest in terms of clinical application. The most useful
individual measure of lung function to a clinician will depend heavily on the nature of
the clinical problems experienced with the particular patient group being cared for.
The neonatologist ventilating mainly preterm infants many of whom will have
reduced lung compliance as a result of surfactant deficiency is likely to be most
interested in measurements of compliance. Those principally concerned with the care
of mostly non-ventilated older infants, many of whom may have problems related to
airway obstruction such as bronchopulmonary dysplasia, asthma or bronchiolitis, may
be more interested in measurements of flow resistance. The studies presented in this
thesis represent an evaluation of the potential utility and shortcomings of pulmonary
function testing using the single breath technique as part of routine clinical
management in neonatal intensive care. The principal study is a randomised
controlled trial.
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I have also considered the acute effects of surfactant treatment on the lung mechanics
and the variation in these effects between a naturally derived surfactant and an
artificial one. I have included an assessment of the ability of junior doctors to make
clinical judgements of respiratory system compliance and an assessment of the inter-
and intra-observer reproducibility of the technique. Finally some of the many cases of
particular individual interest encountered during the course of these studies are
described.
Methodology
The literature now contains many studies of infant lung mechanics which between
them have used a plethora of techniques. Their results are difficult to compare directly
because differing methods measure slightly different entities. No method of
measurement is free of problems. The nature of the problems experienced depend in
part on whether the measurements are made on intubated or non intubated infants. In
intubated infants variations in airway resistance due to secretions may affect
measurement results 16. Also a large proportion of the total airway resistance is
attributable to the endotracheal tube itself 78 and this varies with the calibre and length
of the tube 79,80,81 Air leaks around the endotracheal tube can result in inaccuracies in
measurements of tidal volume. In non-intubated infants, variable laryngeal resistance
can affect expiratory flow signals82-83 and the increased respiratory dead space
attributable to face mask apparatus can alter the respiratory pattern 84-85. Difficulties
also arise when comparison between ventilator and spontaneous breaths is attempted
probably because different volume and pressure regions of the lung characteristics are
examined 86,87,88
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Measurements of dynamic compliance have contributed greatly what is known about
lung mechanics during infancy. This involves measuring the tidal volume between
two points of zero flow during tidal exchange and dividing this volume by the change
in pressure required to generate it89. The technique is applicable to both ventilated
and non-ventilated infants. A number of problems have been identified with this
technique, limiting its usefulness in ventilated preterm infants. Most studies have
measured the dynamic compliance of the lungs rather than that of the whole
respiratory system. This entails measuring changes in oesophageal pressure as a
means of estimating the transpulmonary pressure. Oesophageal pressure changes have
been demonstrated to be unreliable in small infants, particularly those with chest wall
distortion during breathing 90,91,92,93 They are increasingly unreliable when high
airway pressures are in use 94. This problem can be got over in ventilated infants by
measuring the dynamic compliance of the total respiratory system as the tidal volume
divided by the change in airway pressures measured at the endotracheal tube. Since
the chest wall compliance is very high in the newborn 95,96,97,98,99, ioo^ this would still
give an estimate which predominantly reflected the properties of the lungs. But under
dynamic conditions infants may maintain elevated intercostal muscle and
diaphragmatic tone to defend their FRC 83d0i which could decrease the chest wall
compliance, invalidating this assumption.
There are also problems of frequency dependence. Here the respiratory frequency and
inspiration and expiration times can have important effects on the dynamic
compliance results if inadequate time is allowed for all the volume changes that may
occur with a given change in pressure to take place 102,103,104 This may occur under
two circumstances. Firstly as described by Otis105. When the lung is composed of
numerous alveolar units all with the same compliance and resistance then during
ventilation they will all fill and empty at the same rate and a measurement of
compliance will reflect the sum of their individual compliances.
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If however the behaviour of the units is not homogeneous and there are many
different local compliance and resistance values as may occur with lung disease, then
some units will fill and empty faster than others. Under these circumstances as
respiratory rate increases only the fast acting units fill and empty efficiently and the
compliance may be seriously underestimated. Similarly even if the lungs are behaving
homogeneously, if they are very compliant or the airway resistance is high, then the
respiratory rate may be set so as to allow inadequate time for complete expiration.
This would lead to intrathoracic gas trapping and a fall in tidal volume for a given set
of pressures due to inadvertent PEEP, again underestimating the dynamic compliance.
When dynamic compliance is measured in ventilated infants there is usually positive
end-expiratory pressure being employed. The dynamic compliance will be affected by
the amount that the lung volume is elevated above true passive FRC by that end-
pressure. If the lungs are very non-compliant then the PEEP may prevent alveolar
collapse, keeping the lung in the optimal part of the pressure volume curve and result
in improved compliance 34,50,51 jf on the other hand the lungs are compliant then the
PEEP may result in alveolar overdistension, forcing tidal exchange to occur higher up
the pressure-volume curve in its flatter portion where dynamic compliance would be
decreased 106'107. Changes in positive end-expiratory pressure of as little as 2cmH20
can alter tidal volume by as much as 25% 49. In ventilated newborn infants changes in
PEEP may have twice the effect on tidal volume as the same change in peak
inspiratory pressure 108. Negative extrathoracic pressure has much the same effects as
PEEP 109,110
As a result of these problems dynamic compliance measurements may as much
reflect the effects of ventilatory pattern on the respiratory system as truly measure its
underlying physical characteristics.
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Whilst this may mean that individual dynamic compliance values can be hard to
interpret in relation to those of other infants, the method may still supply very useful
information in the management of individual infants by helping to determine the most
efficient style of ventilation. By selecting the ventilator settings associated with the
optimal dynamic compliance, both over- and under-inflation of the lungs could be
avoided, thereby reducing barotrauma and this might result in improved clinical
outcome ni. This hypothesis is not yet adequately proven. For the time being, the true
usefulness of dynamic compliance measurements in routine clinical management is
questionable and studies performed on ventilated infants which utilised oesophageal
pressure measurements as part of their methodology should be interpreted with
caution.
An alternative to dynamic techniques is to measure the total respiratory system
mechanics under static conditions. This removes the problems of frequency
dependence and oesophageal pressure measurements. The term static implies that the
measurements are made at points of zero flow when adequate time has been allowed
for equilibration of volume and pressure throughout the respiratory system. Static
compliance measurements were initially of limited clinical use as they were only
possible in heavily anaesthetised or paralysed subjects. This is because spontaneous
respiratory efforts must be inhibited for sufficient time to allow the airway pressure
and volume changes to become tmly static. This problem has been overcome by the
development of airway occlusion techniques which employ the Hering-Breuer
reflex 112 to inhibit respiratory activity.
The method of measurement selected for these studies was the single breath passive
expiratory flow technique which enables simultaneous estimation of the static
compliance, the resistance and the time constant of the respiratory system.
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The use of this method in human infants was first described in 1984 by LeSoeuf and
colleagues113 and it has now been employed by a large number of
authors 14>15414,115,116,117,118. Tlie method gradually evolved through experimental
work derived from the equation of motion of the respiratory system as proposed by
Rohrer.
PL = -(Pel +Pres+Pin) (i)
This equation states that any pressure applied to the respiratory system by the
respiratory muscles (Pl) will be equal and opposite to the opposing pressures
developed within the system. These opposing pressures are the sum of the pressures
arising as a result of the elastic (Pei), resistive (Pres) and inertial (Pin) properties of
the components of the system. Compliance (C) is the elastic property, resistance (R)
the resistive property, and inertance (I) the inertial property. They are defined as:
c=-3L R=I - Pln
Pel $ V
where V is the incremental volume change of the respiratory system, V is the gas
••
flow rate and V is the volume acceleration of the respiratory system. The inertial
component was left out in the following experiments that were derived from the
equation of motion of the respiratory system and formed the basis of the single breath
technique as in practice it was found to be negligible in comparison to the other forces
involved 119,120,121,122
In 1954 Comroe et al first used the properties of relaxed expiration to determine the
resistance of the respiratory system in cats and dogs 123. They achieved respiratory
muscle relaxation through anaesthesia, paralysis, hyperventilation, or the use of the
Hering-Breuer reflex.
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Expiratory volume was plotted against time during relaxed expiration, and the flow at
any given point was determined by the slope of the tangent to the volume-time graph.
The pressure driving this flow was taken from the static pressure-volume relationship
for the lung at the same expired volume as that at which the flow had been calculated
and these two values were used to determine the resistance as pressure divided by
flow. Brody 119, by mathematically manipulating the equation of motion, found that
passive expiratory flow should occur exponentially as long as the resistance due to
turbulent flow is minimal. He analysed passive expirations in dogs and humans and
found that they occurred exponentially in dogs when turbulence was minimal but not
when flows were high and that attempts at passive expiration made by adult human
subjects were not truly passive. He suggested that they were affected by inspiratory
muscle tone during expiration. Mcllroy et al124 extended the technique. Starting with
equation (1), accepting that the inertance component of the respiratory system
behaviour is negligible then:
PL = -(Pel+Pres)
or rearranging this
PL+Pel+Pres = 0 (2)
The pressure applied to the respiratory system by the respiratory muscles now equals
the opposing pressures due to the elastic recoil and frictional resistance of the lungs
and thorax. During a truly passive expiration the pressure applied by the respiratory
muscles would be zero and all the pressure overcoming resistance would be derived
from the elastic recoil.
Pres = -Pel (3)
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Since Resistance (R) and compliance (C) are defined as:
R = Pres c= v
Pel
If the resistance and compliance of the respiratory system are constant then equation
(3) can be solved as:
^=-RC (4)
V
Therefore as long as the resistance and compliance are constant, the instantaneous
ratio between the expired volume and rate of airflow during a relaxed expiration
should be constant and equal to the product of the resistance and compliance of the
system. On this basis Mcllroy et al124 reasoned that the finding of a straight line
relationship between flow and volume during expiration should imply that the subject
had managed to relax completely his/her respiratory muscles. The alternative, less
likely explanation would be that resistance and compliance had changed by exactly
equal and opposite proportions. They found that most subjects could be trained to
expire passively with a linear flow-volume relationship and that if an added resistance
were placed in the circuit the relationship remained linear. This would not be the case
if the compliance and resistance of the respiratory system were changing by equal and
opposite amounts whilst the added resistance remained constant. So they concluded
that the ratio of flow and volume was constant during a passive expiration indicating
that the relaxed respiratory system empties exponentially. They used paired
measurements made with and without an added resistance in series to calculate the
changes in the slope of the flow-volume relationship and calculated the compliance
and resistance of the respiratory system by solving equation (4) and an extension of
equation (4) incorporating the added known resistance.
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They found the method to produce reproducible results for compliance and resistance
and for the value of the added resistance in both a lung model and in human subjects.
On the basis of these findings, Bergman 125 suggested that these exponential
characteristics of passive exhalation described by Brody and Mcllroy might be
utilised to measure resistance without the need to measure gas flow. Since flow rate
(V) is change of volume per unit change of time:
-
By substituting this into equation (4) and rearranging it the following is derived:
VdV = ~RUdt (6)
If this equation is integrated an exponential equation is obtained.
V=Voe_(1/RC)t (7)
where V is the volume of gas in the thorax t seconds after the start of expiration, Vo
is the total expired volume at the end of the breath and e is the base of natural
logarithms. RC is the time constant of this equation such that after a time t of RC
seconds the volume (V) of gas remaining in the thorax is now:
V = Voe-1=Vox0.368 <8)
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Bergman reasoned that if the equations were applicable, the value of RC for a passive
expiration could be determined from the time taken for the volume of gas remaining
in the lungs to reach 0.368 of its original value using the resting end-expiratory level
as the zero reference level. By then measuring the static compliance (C) the resistance
(R) could be determined from the value of RC. He studied anaesthetised, paralysed
adults measuring static compliance as the volume exhaled passively following release
of a sustained inflation divided by the transthoracic pressure recorded during the
sustained inflation. He then determined the time constant as the time taken for the
thoracic volume to decrease to 36.8% of its end-inspiratory value and calculated the
resistance from these two values. His results showed that the ratio of volume to flow
is constant throughout the greatest part of passive expiration in paralysed subjects,
confirming the exponential nature of passive expiration. In addition the slope of the
flow-volume relationship was numerically equal to the time taken to exhale to 36.8%
of the end-inspiratory volume establishing the validity of the equations. The
resistance values calculated using the time constant were not significantly different
from those measured by the simultaneous measurement of transthoracic pressure and
gas flow, further validating the technique. The methodology still depended on
muscular paralysis or training conscious subjects in the technique and was thus not
applicable to young children or infants.
In 1976 Olinsky et al126 devised a simple method of measuring the static respiratory
system compliance that was applicable to newborn infants and did not require
paralysis or anaesthesia because respiratory muscle inactivation was achieved by
provoking a Hering-Breuer reflex. This reflex was first demonstrated in human
infants by Cross et al in 1960 127. They showed that term infants responded to lung
inflation with an apnoeic pause. This pause got longer with increasing inflation
volumes but appeared to diminish with age suggesting that it may not be present after
about 8 days of age.
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Olinsky et al also demonstrated the Hering-Breuer reflex in newborn infants128. They
went on to measure the static respiratory system compliance, utilising the Hering-
Breuer reflex, by occluding an infant's airway at different volumes above the resting
end-expiratory volume and measuring the airway pressure generated by the recoil of
the respiratory system during the resultant apnoeic pause. This pressure is assumed to
equal the alveolar pressure as long as sufficient time has elapsed for all volume and
pressure redistributions within the respiratory system to occur. By repeating this
manoeuvre at a number of different volumes a graph was plotted describing the
volume-pressure relationship within the range of tidal respiration. This relationship
was linear and the static compliance of the respiratory system was the slope of the
line calculated by regression. They also measured dynamic lung compliance in the
same infants and found that it was consistently less than static respiratory system
compliance. The difference between the two increased with increasing respiratory
frequency, suggesting that dynamic compliance measurements in normal infants were
frequency dependent. A further interesting finding was that extrapolation of the
volume-pressure graph to the volume axis gave a negative intercept suggesting that
the infants were breathing above a dynamically elevated end-expiratory lung volume
rather than the passive functional residual capacity that would be determined by the
static balance of forces between the lung and chest wall, a finding now established by
many studies 129,130,131,132,133
Mortola et al134 used the Hering-Breuer reflex to achieve respiratory muscle
relaxation in another series of infants and as well as measuring the static compliance
by the Olinsky technique plotted passive expiratory flow against volume. They
determined the time constant RC as the slope of the expiratory flow-volume
relationship and were thus able to calculate the respiratory system resistance. They
again found that the expiratory flow-volume plot was predominantly linear.
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At about the same time Zin et al135 making measurements on intubated cats measured
the static compliance, resistance and time constant of the respiratory system using a
single breath. At end inspiration the airway was occluded, inducing a Hering-Breuer
reflex. The airway pressure was measured once it had reached a plateau. The animal
was then allowed to exhale passively to atmospheric pressure during which time the
flow-volume relations of the complete expiration were plotted. Static compliance was
the expired volume divided by the plateau pressure. The slope of the flow-volume
plot was the time constant and this was used to determine the resistance. In the same
paper they reported their finding in a similar experiment that during the induced
apnoeic pause there was no measurable phrenic nerve activity either during the
pressure plateau or the subsequent relaxed expiration showing that the diaphragm was
relaxed as well as the intercostal muscles. They were able to obtain reproducible
results with and without added resistive loads indicating that compliance and
resistance were linear within the experimental range of flows and volumes.
Le Souef et al113 applied this method to newborn infants but extended it, making it
applicable both to normal infants and to those with severe respiratory illness. They
identified that one of the problems with measuring passive expiratory volumes in
newborn infants, particularly those with respiratory disease, is that they defend their
FRC by breathing in again before expiration is complete. They solved this problem by
extrapolation of the linear portion of the flow-volume plot to the axis giving the
volume that would have been expired to FRC were it not for early inspiration. By
subtraction of the actual expired volume they were able to calculate the volume by
which FRC was being dynamically elevated by the infant. They observed linear flow-
volume relationships in both spontaneously breathing and ventilated infants.
29
They also made calculations of the expiratory flow rates required to generate
turbulent gas flow for the range of endotracheal tube sizes which they used and found
that in most instances the flow rates in the study did not exceed these and that even
when they did, the departure of the flow-volume relationship from linearity was
minimal indicating that endotracheal tube turbulence was not making an important
contribution to respiratory system resistance. Their method had the advantage over
the Olinsky technique that fewer breaths needed to be sampled and that information
about the resistance and time constant was also obtained. Nevertheless static
compliance values from both methods are determined by similar means and it is not
surprising that they have been found to be similar 114,118,136,137,138 an(j it has been
suggested that where there is doubt about the validity of the results obtained with one
method it may be checked using the other 118,138 it has been suggested that the
Olinsky technique might be used in favour of the single breath technique in non-
intubated infants as laryngeal modulation of expiratory flow would not be inhibited
by the Hering-Breuer reflex 139. The increased resistance due to laryngeal braking
could lead to overestimation of compliance results through extrapolation of the flow-
volume relationship to a falsely elevated expired volume with the single breath
technique . Although this suggestion is not supported by the findings of studies where
constant external resistive loads were added and compliance results remained
reliable 124,135,137 q-s results were found to be overestimated by the single breath
technique when the difference between the actual expired volume and the volume
intercept of the linear portion of the flow-volume trace was large 118,138 Variable
expiratory resistance would invalidate single breath measurements by making the
flow-volume relationship non-linear. Obviously, any laryngeal braking would make
resistance measurements unreliable.
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From the above discussion it is clear that the validity of results obtained using the
single breath technique depends on the accuracy of a number of assumptions under
the circumstances where a measurement is made. If these conditions are not fulfilled
then the results may be inaccurate or potentially misleading.
(A) The respiratory system is behaving as a single compartment model with a single
compliance and resistance
(B) All the respiratory muscles are relaxed during the airway occlusion and the
subsequent relaxed expiration.
(C) The respiratory system inertance is negligible under the measurement
conditions.
(D) All pressures and flows within the system have truly equilibrated at the
point that the occlusion pressure is measured.
Single compartment model
It may be reasonable to assume that the respiratory system behaves as a single
compartment in health as suggested by the above data but this is not always the case
when there is lung disease. Variations in resistance or compliance during the
respiratory cycle would make the flow-volume relationship non-linear as would the
existence of inhomogeneities within the lung resulting in a mixture of compartments
with differing time constants 140-141 This would make it impossible to assign a single
value to the time constant, resistance, and compliance. This is often seen to be the
case in infants with chronic lung disease where the flow-volume relationship is found
to be curvilinear and limits the number of infants with chronic lung disease that can
be successfully measured with the single breath technique.
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As a result of this there has been interest shown in using more complex mathematical
models to describe and interpret the respiratory system behaviour under these
conditions 140,141,142 These may be valid but their complexity has limited their
popularity and clinical application so far. This is one circumstance where the Olinsky
technique would be more useful for measuring the compliance as it does not depend
on a linear flow-volume relationship. As this thesis examines the utility of single
breath measurements alone, in some instances where there was alinearity of the flow-
volume trace respiratory function data was not obtainable.
Respiratory muscle relaxation
It is assumed that the respiratory muscles of human infants are relaxed by the Hering-
Breuer reflex during the airway occlusion and the subsequent passive expiration.
Animal studies have demonstrated that both the intercostal muscles and the
diaphragm are inhibited by the Hering-Breuer reflex 135,143,144 jt has been shown by
many studies that human infants (including preterm infants) have a readily elicitable
Hering-Breuer reflex 127,128 {hat persists beyond the neonatal period 145,146,147 Qf
particular relevance to the use of lung mechanics measurements in ventilated neonates
are the observations that the reflex is easier to elicit in preterm infants than term
infants 148,149 an(j in those with reduced lung compliance 150 and its intensity is not
reduced by sedation 146. Conversely Gerhardt et al found it to be weaker in premature
infants in a small series15 k Absolute exclusion of muscular activity during the reflex
would require this to be measured simultaneously which has not been studied directly
in humans and is an area where further research would help to validate the technique
fully. There are however human studies which strongly support the assumption. Using
the multiple occlusion technique, Fletcher et al152 measured Crs before and after
pharmacological muscular paralysis and noted no change in the results when
measurements were made at similar tidal volumes to those prior to paralysis.
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Shulman et al153 noted no change in the expiratory time constant measured using the
single breath technique before and after pharmacological paralysis. When
measurements are made, muscle relaxation is assumed if there is a satisfactory
pressure plateau following airway occlusion and a linear flow-volume relationship.
Both of these could still be seen if there were a constant level of muscular activity
throughout these phases. The likelihood of respiratory muscle activity distorting the
measurement can be reduced by calculating the result of any study from at least
several satisfactory breaths as any muscular activity would be very unlikely to remain
constant under these circumstances. The effect of any muscular activity would be
minimised by taking the average of all the satisfactory breaths. Since changes in
muscle activity would change the chest wall compliance, the respiratory system
compliance and the time constant, inaccuracies can be further limited if only those
studies in which the variation between breaths is minimal are accepted. The flow-
volume trace can often be affected by muscular activity in its terminal portion as
infants may inspire before end-expiration or actively expire once the Hering-Breuer
reflex has worn off 113,138,154 so js advisable to avoid using the most terminal parts
of the flow-volume trace for calculation. Obviously these problems do not occur
when the technique is applied to paralysed infants.
Inertance
As described above, inertance has been measured by a number of authors and the
assumption that it is negligible under the conditions of conventional mechanical
ventilation in infants would seem reasonable in most circumstances. Under truly static




The assumption that all changes in flow and pressure have reached equilibrium is
crucial to the term static compliance. Equilibration may be said to have occurred once
there is a clearly defined pressure plateau in the airway pressure trace following
airway occlusion. If the occlusion is released before equilibration has taken place
compliance may be over- or underestimated. Since equilibration depends on the time
taken for flow and pressure changes to occur within the lungs, the time taken for
equilibration will depend at least in part on the compliance and resistance. Infants
with very stiff lungs and low airway resistance should reach equilibration more
quickly than those with relatively normal compliance and high airway resistance. It
has been shown that the results of single breath measurements made on infants with
bronchiolitis vary with the length of time that the airway is occluded until occlusion
times of > 275 milliseconds (ms) are used117 but in that study occlusion was
automated and pressure traces were not examined for a satisfactory plateau. It is
important to distinguish between airway occlusion time and pressure plateau duration
as different authors refer to one or the other. Small infants with RDS may have
reached equilibrium after a plateau duration of < 100 ms 155. There is no established
standard. Different authors have used occlusion times/pressure plateau durations
varying from 50 ms to 500 ms 136,154,156,157 interrupter technique is a variation of
the multiple occlusion technique whereby, using an automated system, multiple
airway occlusions are performed during expiration and the airway pressures measured
during these occlusions are plotted against the expiratory volume to generate a
pressure-volume relationship 138,142,158 jn these studies occlusion times of 50-80 ms
were used and, whilst the automation of this technique may make it simple to apply,
until a lot more data is available to validate results obtained using such short
equilibration times, they should be interpreted with caution. Other authors have used
this technique with longer occlusion times but the infants concerned were either
heavily sedated or paralysed 159.
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As well as defining the duration of the airway pressure plateau some authors have
defined the plateau mathematically 118,138,154,160 jn terms of the acceptable deviation
from the mean plateau pressure over a given time. These criteria can be applied if data
is analysed by computer. Using a long plateau time can also be problematic as the
Hering-Breuer reflex may wear off during expiration allowing active inspiration or
expiration to distort the flow-volume trace. The ideal time is likely to vary between
infants.
As with all methods, when the single breath technique is used there must be careful
quality control to ensure the validity of the results. It must be recognised that no one
value for compliance will truly describe the mechanical properties of the lungs. The
static relationship of pressure and volume of the respiratory system is sigmoid in
shape rather than linear 161,162 Relatively high pressures are required to produce a
given change in volume as a collapsed lung begins to inflate. There then follows a
relatively linear portion through which the compliance is better. At higher lung
volumes the relationship flattens again as greater pressures are required to generate a
given change in volume. Tidal ventilation usually takes place in the linear portion of
the curve where compliance is relatively constant 161,162 5^ measurements made at
different lung volumes or pressures may produce varying results in the same
lungs 87<88 so results should be expressed in relation to the pressures or volumes at
which they were made. For reliable comparison, successive studies made in the same
infant should be made at similar pressures or volumes152'163. In normal clinical
management ventilator settings are adjusted according to the apparent needs of the
individual patient so it would be impracticable for all studies to be conducted at the
same ventilator settings. In most cases tidal volume remains within a relatively
narrow range as ventilation is adjusted in response to changes in lung function and
comparison of successive studies is feasible.
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Respiratory system compliance results can vary with posture and this should be
standardised if studies are to be compared 164,165,166,167,168,169 jn intubated infants the
accumulation of secretions in the endotracheal tube can cause large inaccuracies in
measurements of resistance 16, so endotracheal suction shortly before lung mechanics
measurements is advisable. Airway suctioning may lead to a temporary loss of lung
recruitment, causing a temporary fall in lung compliance as a consequence so studies
should not be performed too soon afterwards. Likewise prolonged or large inflations
may temporarily recruit lung volume allowing compliance to be overestimated 152.
Studies should therefore be performed in the context of a similar lung volume history.
Any air leak from the system can lead to inaccuracies in measurements. In practice
these tend to occur when pressure is maximal during airway occlusion. Significant
leak would prevent the establishment of a pressure plateau. This is another important
reason for checking for the presence of an acceptable plateau. In practice air leaks can
usually be overcome by gentle fingertip pressure over the trachea but some studies are
invalidated when this is not successful155.
Expression of data in relation to infant size
For lung function data to be useful to the clinician it must be presented in a form
which allows some comparison of an individual result to what it might be expected to
be were the lung function normal. A crucial aspect of this about which there is no
consensus is the expression of results of compliance or resistance measurements in
relation to the size of the infant concerned. Neonatologists tend to correct compliance
measurements for body weight, Physiologists for FRC and Paediatricians and
Respiratory Physicians for height (or length). None is consistently ideal. The solution
to the problem will depend on the reason that lung function is being measured and the
age group of the population being studied.
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In normal individuals throughout life, the compliance of the lung is directly
proportional its size or volume and the relationship passes very close to the
origin 66,67,70,71,73,170,171 This has led many to believe that compliance values should
be corrected to FRC and expressed as specific compliance. There are a number of
problems with this approach. Obviously to correct compliance measurements to FRC
in clinical practice would require that both were measured. Compliance and FRC are
inextricably linked. Reduced FRC implies there are fewer recruited alveoli available
for expansion by applied airway pressure. Reduced compliance increases the
tendency for alveoli to collapse at end expiration which reduces FRC. In clinical
practice one is usually dealing with the abnormal rather than the normal. Many
newborn infants with respiratory disease particularly those with surfactant deficiency
will have reduced FRC as a component of the problem 74-172,173 p^iy as a result of
this but also because of increased surface tension throughout their respiratory cycle
these infants will have reduced compliance. Expressing their compliance results
corrected to FRC would underestimate their compliance abnormality and decrease the
clinical usefulness of compliance data. A clearer example of this would be a
ventilated infant who is intubated with an endotracheal tube which passes into the
right main bronchus forming a snug fit. If compliance and FRC were now measured
the infant would have a compliance that was roughly 50% of normal but the specific
compliance would be approximately normal. The infant would require a substantial
increase in ventilator settings reflecting the reduced compliance until the problem was
remedied.
Many newborn infants maintain their FRC substantially above the position
determined by the balance of the passive forces in the respiratory system by a number
of mechanisms such as post-inspiratory activity of the diaphragm and intercostal
muscles, laryngeal braking of expiration, and early inspiration before expiration is
complete 82'126d29,130,131,132,174
37
These factors may vary considerably with sleep state 101,130,133 although this has not
been a universal finding 175,176 LUng volume changes over the first hours of life with
the absorption of the foetal lung fluid and varies in early life according to the mode of
delivery177 and so measurement of FRC may reflect other dynamic factors as well as
the properties of the lungs. This is particularly important in the case of ventilated
infants in whom there is almost always positive end expiratory pressure (PEEP) being
applied as part of the management strategy. As discussed above, PEEP will elevate
FRC by an amount determined by the level of PEEP and the static compliance. Indeed
this is the basis of the weighted spirometer method for measuring static
compliance 171>178. Small changes in PEEP can cause large changes in FRC
25,34,106,179 FRC measurements are also frequency dependent28-180. Improvements in
compliance would increase the amount that the lung volume was being elevated
above passive FRC by PEEP and would therefore be masked if they were expressed
as specific compliance. Measurements of FRC are technically difficult, particularly in
ventilated preterm infants and would be difficult to make serially as a routine index of
lung function. All of these factors limit the value of expressing compliance corrected
to measured FRC in ventilated infants with lung disease and it has been suggested
that measurements may be better corrected to some index of predicted FRC 181.
Predictions of FRC may be based on body length or body weight. In preterm infants
both of these are oversimplifications because the rates of growth of different tissues
of the body are non-uniform 66,69,70 At different stages of development, the ratio of
lung volume to body weight or body length varies. Most authors have found that lung
volume is linearly related to body weight. However when one is plotted against the
other the intercept is on the volume axis. This means that larger infants have a lower
lung volume per unit body weight than smaller infants 66,68,69,70,182,183 Consequently,
correction of compliance values to body weight would tend to overestimate slightly
the disease severity of heavier infants and underestimate that of lighter infants.
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Weight is relatively easy to measure accurately but can vary by more than 10% in an
individual infant over the first few days of life and the degree of adiposity can vary
significantly in relation to nutrition in late gestation. The relationship of FRC to body
length has been found to be linear by some authors 66,71,72,171 an(j curvilinear by
others 69,170 xhe intercept of the relationship of FRC and body length is on the length
axis. This means that correction of compliance values to body length would tend to
overestimate the disease severity of smaller infants and underestimate the disease
severity of larger infants. Length is more difficult to measure accurately but does not
vary significantly in the short term. These observations about the relationship of FRC
to body size are supported by compliance studies. Crs in neonates has been found to
be linearly related to weight with an intercept on the Crs axis H4,156,184,185 an(} both
linearly 114,126,171,185 ancj cuvilinearly 69,157,170,184,186 related to length with an
intercept on the length axis.
The optimum method of correcting lung function tests for size in the clinical setting is
that which yields the most useful information. The most important cause of
respiratory problems in neonatal intensive care is surfactant deficiency which is more
likely to occur the smaller or less mature the infant. The risk of death from respiratory
disease in the neonatal population increases with decreasing birth weight. On this
basis, it might be expected that an index of disease severity with a degree of bias
toward smaller infants might be found to be more clinically useful than one with a
bias toward larger infants. Few authors have directly compared the usefulness of
different methods of correcting lung function data for infant size. Tarnow-Mordi et al
found correction of compliance measurements to body length to be a better predictor
of death from respiratory distress syndrome than correction to body weight59. Wilkie
et al found that compliance corrected to length was a better predictor of biochemical
lung immaturity than compliance corrected to weight63.
39
On this basis the compliance measurements made in the studies described in this
thesis were corrected to body length. These observations may not apply outside the
neonatal period when prognosis is less critically dependent on infant size and in any
clinical study careful consideration should be given to this issue.
Reference values
Many authors have reported respiratory system compliance data obtained from
normal infants. Most of the data series are small. There is no consistency in the way
the results are expressed. Some authors have provided regression equations describing
the relationship between compliance and various indices of body size for their study
populations whereas others have given the mean and standard deviation for the whole
study population assuming that all the infants in the age range studied have a similar
ratio of compliance to whatever index of body size it is corrected to. Different series
considered infants of different degrees of maturity and size and also of differing
postnatal ages. This makes the data difficult to summarise. From the discussion above
about correction of results for body size it is obvious that expressing the results per
unit body size is a simplification but using regression equations to compare individual
results to normal would be cumbersome in routine clinical use. Therefore where
possible the reference data described below is expressed as the population mean per
unit of body size. This approach is reasonable as long as the range of infant sizes
considered is not too wide. Where regression equations were supplied rather than
individual data points they have been used to calculate the expected compliance per
unit body size of a 1kg and a 3.5kg infant or a 35cm and a 50 cm infant.
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Since the study population considered in this thesis consists exclusively of ventilated
neonates, most of whom are preterm, the studies selected as representing normal data
are all those found in the literature measuring static respiratory system compliance by
the single breath technique or any method reasonably comparable to it in infants, term
or preterm measured less than one month beyond their expected date of delivery
(EDD). Normal values for term and preterm infants breathing spontaneously who
were free of respiratory problems are summarised in table 1.1 Values for infants
requiring ventilation for respiratory distress syndrome are summarised in table 1.2.
The study by Olinsky et al126 was included in table 1.1 as, even though some of the
infants must have been a little older than one month past their estimated date of
delivery, the range of body weights and lengths of the infants studied was similar to
those of the other studies. The study by Thomson et al184 was included in table 1.1
after excluding the results from the older infants. Measurements of dynamic
compliance are not considered because of the important differences between dynamic
and static measurements already discussed.
Whilst normal data may give some basis for comparison they are not likely to be very
informative when lung function tests are used to aid the management of ventilated
infants. Normal infants have a considerable respiratory reserve which has to be
exhausted before they will need to be ventilated. Similarly the lung function of
ventilated infants does not have to return to normal before extubation will be
successful. Extubation is usually successful with respiratory system compliance
values that are approximately 50% of normal 64 and this level of "functional
































































































































































































































































































































































































































































































































































































The apparatus used for all the lung mechanics measurements detailed in this thesis
was constructed by the Medical Physics Department of Ninewells Hospital and
Medical school, Dundee, under the guidance of Dr Rosalie Wilkie based on her
experience working in Toronto with Dr A.C. Bryan. It is the same apparatus as that
used in several previous studies in Canada and Scotland59'63.
Breath sampling is done manually using a two-way airway occlusion device which is
inserted into the ventilator circuit (fig. 1.1). This device is constructed of nylon and
has wide bore channels to minimise resistance. The device can be thoroughly cleaned
with alcohol between measurements. The dead space (measured by water
displacement) added to the ventilator circuit by the occlusion device is 4mls. There is
a rotatable slide-valve within the device which enables different channels to be
opened or closed. The resistance of the occlusion device and pneumotachograph in
series is essentially that of the pneumotachograph. With the device inserted into the
ventilator circuit the infant is ventilated normally and the pneumotachograph is
excluded from the circuit (fig. 1.1a). The device has a side port for sampling proximal
airway pressure which is measured using a Furness Controls differential pressure
transducer (0 - 10 kPa). Expiratory flow is measured with a Fleisch O
pneumotachograph linear to 300 ml/s connected to a Validyne MP45 (± 2cmH20)
differential pressure transducer. Pressure and flow data are sampled at a frequency of
250 Hz and processed and stored on an on-line IBM compatible personal computer.
Data is analysed using software developed at the Children's Hospital, Toronto by
Professor A.C. Bryan, Dr M.H. Bryan and Dr P.N. LeSouef.
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Figure 1.1: Airway occlusion device
(a) Occlusion device inserted into ventilator circuit. Pneumotachograph is
excluded from the circuit.
Pneumotachograph Ventilator
J I I L
▼
Infant
(b) Airway is occluded at peak inflation, trapping a breath in the infant's
lungs. Proximal airway pressure is sampled.
Proximal airway pressure
Infant







The program is called Rawfoot © and was written solely for this purpose. To sample
a breath, the slide valve is manually rotated through 90° at the peak inflation pressure
during a ventilator inflation. This occludes the infant's airway, trapping the ventilator
breath in the lungs (fig. 1.1b) and usually induces a Hering-Breuer reflex. The
occlusion is momentarily maintained to allow time for the proximal airway pressure
to equilibrate with the alveolar pressure and during this time the proximal airway
pressure is sampled continuously through a side port in the occlusion device. The
slide valve is then rotated a further 90° this time excluding the ventilator from the
circuit and allowing passive exhalation to occur to atmospheric pressure through the
pneumotachograph (fig. 1.1c). The slide valve is then rotated back through 180° to its
original position so that the procedure may be repeated. The whole breath sampling
procedure takes no more than a few seconds and results in no significant disturbance
to the infant. After the breath is sampled it can be viewed on screen to determine its
suitability for analysis and during this time the infant is ventilated normally before the
next breath is sampled. A number of satisfactory breaths are collected and their results
averaged. The entire measurement procedure usually takes five to ten minutes.
During breath sampling the computer displays the data first in the form of a
pressure-flow plot (fig. 1.2) and then as a flow-volume plot (fig. 1.3). The
pressure-flow plot displays first the proximal airway pressure measured during
sampling and then the passive expiratory flow, both against time. In fig. 1.2a the
proximal airway pressure trace initially represents the positive end expiratory pressure
set on the ventilator. There is then a sharp rise in pressure with a ventilator breath.
The airway is occluded and there follows a pressure plateau. The occlusion is then
released allowing proximal airway pressure to fall rapidly to zero and at this point the
recording switches to passive expiratory flow as measured by the pneumotachograph.
This starts at zero, rising rapidly to a peak and then falls back to zero.
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(b) Positioning of cursor.
time (s)
Proximal airway pressure during ventilation.
Recording stops when ventilation is interrupted to
sample passive expiratory flow.
Passive expiratory flow from peak inflation to
atmospheric pressure.
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Shortly afterwards the slide valve is rotated back to its starting position and the
airway pressure trace resumes. The pressure plateau is inspected to determine that it is
satisfactory. Its duration can be compared with that of the following ventilator breath.
If the plateau is accepted and further breath analysis is desired, the airway pressure
just prior to release of the occlusion is selected by positioning a cursor (fig. 1.2b).
This is the pressure that will be used to calculate the compliance when the
flow-volume trace is analysed. Once the cursor is positioned and entered the
computer displays the flow-volume trace (fig. 1.3a) for inspection. The actual expired
volume and maximal expiratory flow are given. If the breath appears satisfactory in
terms of linearity, morphology and expired volume, the linear portion can then be
selected for analysis by positioning two cursors (fig. 1.3b). The computer analyses all
the data points between these two cursor points using linear regression and plots a
straight line of best fit (fig. 1.3c). The line is extrapolated to the volume axis to give
the expired volume at zero flow and this is divided by the occlusion pressure
determined earlier to give the respiratory system compliance. The slope of this line is
the time constant and dividing this by the compliance gives the respiratory system
resistance.
The software includes a calibration run which enables the pneumotachograph to be
calibrated to known flows and pressures and the accuracy of volume estimations can
be checked with a syringe. Calibration was performed weekly throughout the studies,
previous experience with this apparatus indicating that drift over this length of time
was minimal. The pneumotachograph was calibrated using air. The ideal would be to
calibrate the apparatus before each study with the same gas mixture as that being
breathed by the infant, as different gas mixtures have different viscosities and will
cause slightly different pressure drops across a pneumotachograph at identical flow
rates. The very large number of studies to be done made this impracticable.
48



















0 Volume (ml) H-0
49
Oxygen is more viscous than air so at the same flow rates 100% oxygen would cause
a pressure drop across a pneumotachograph approximately 9-10% greater than that
caused by air 192,193 Thjs wouid cause a 9% overestimation of expiratory flow and
therefore compliance in infants breathing 100% oxygen compared to those breathing
air. As the respiratory function of these infants improved and their inspired oxygen
concentration was reduced, their improvements in compliance would be slightly
underestimated as a result. The pressure transducer was calibrated using a water
manometer.
To maximise comparability we applied the same data acceptance criteria in all the
studies described later in this thesis.
1. Only ventilator generated breaths were analysed (only intubated infants were
studied).
2. All infants were studied lying supine whilst breathing quietly and not displaying
gross body movement.
3. Studies were performed soon after endotracheal suction.
4. Results calculated from a minimum of three, preferably four or more technically
satisfactory breaths with a coefficient of variation between breaths < 15%.
5. Clearly defined pressure plateau following airway occlusion lasting approximately
200ms.
6. Actual expired volume to atmospheric pressure 5 - lOml/kg body weight.
7. Linear portion of the flow/volume trace approximately 2/3 or more of the
expiration from peak expiratory flow to zero flow.
8. Correlation coefficient of the straight line fit to the linear portion of the
flow-volume trace r > 0.996.
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In practice it is relatively easy to fulfil these criteria in the majority of cases. They
were applied as absolute criteria except for the actual expired volume which was
occasionally above or below 5-10 ml/kg. These studies were accepted as half of the
compliance data collected was blind to the clinicians caring for these infants and
ventilator adjustment would have been required to alter the expired volume range.
Summary
This thesis represents an evaluation of the potential of routine measurements of static
respiratory system compliance made using the single breath passive-expiratory flow
technique to improve the care of ventilated newborn infants. The measurement
technique has been validated in newborn infants and used in many studies. Because it
is dependent on the respiratory system behaving as a single homogeneous
compartment and the measurement conditions being carefully controlled there may be
circumstances where reliable data is unobtainable. Although there are a number of
techniques available for measuring respiratory function in ventilated infants, no
technique is without problems and no technique has been demonstrated in a
randomised study to improve the outcome of neonatal ventilation.





Whenever an infant is mechanically ventilated an informal clinical appraisal of the
respiratory system compliance is made by the individual deciding on the ventilator
settings. They estimate the chest inflation and therefore the tidal volume that is being
delivered by the ventilator settings in use. Other clinical observations such as the
chest radiographic findings and the oxygen requirements may influence their decision
and there is often blood gas data outlining the infant's response to the current
ventilator settings. All this information is combined with the knowledge and
experience of the care-giver and the most appropriate ventilator settings are decided
on. But the accuracy of clinical judgements is likely to vary with the experience of the
observer making them. Aufricht et al 57d94 suggested that senior experienced
clinicians can make reliable visual judgements of static respiratory system compliance
based on assessment of tidal volume in two papers examining the abilities of doctors
to estimate compliance. This is the only published work on the topic in infants. Closer
scrutiny of their data 57 suggests that they may not have been as accurate as they
believed themselves to be. The mean (sd) difference between the estimated and
measured compliance was given as -7 (24)% and it was concluded that the estimates
agreed with the measurements to within 24%. The compliance values were not
corrected for patient size.
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This may have contributed to the relatively high correlation coefficient of r=0.81 as
the range of values was wider than it would have been after correction for size, and
the wider the numerical range of any two variables that are compared the better the
correlation coefficient will be 195. The authors felt that an error of ± 24% was
acceptable given the wide range of compliance values from severe abnormality to
complete normality, but since they used the mean difference ± one standard deviation
to calculate this potential error, fifteen out of their forty-five observations lay outside
these limits (as would be expected). This demonstrates the inadequacy of using one
standard deviation as a measure of agreement between methods.
Bland and Altman 195 suggested that a more reliable way of comparing different
methods of measurement would be to express the 95% limits of agreement. These are
the limits within which 95% of differences between two methods of measuring the
same parameter would be expected to lie and are expressed by the mean difference ±
2 standard deviations. For Aufrichts' study57 they would be -55 to + 41%. Examined
in this way the agreement between the estimates and measurements does not appear
as close and since it is often junior doctors that are managing the ventilation of infants
this observation may be important. It was suggested in the paper, but data was not
supplied, that junior doctor's estimates were not as accurate. Spears showed that even
senior anaesthetists manually ventilating infant test lungs using the anaesthetic
circuits that they commonly used on infants of similar size were unable to detect
when the endotracheal tube was repeatedly occluded58. Chest radiographs may give
valuable clinical information but it can be difficult to determine the diagnosis from
them alone particularly in neonates 55-56 and, as a measure of disease severity,
assessment of chest radiographs performed less well than compliance results at
predicting death from respiratory distress syndrome62. Blood gas analysis is an
essential clinical tool in managing ventilated patients but it is a measure of the effect
of the current ventilator settings rather than a measure of what they ideally might be.
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As discussed already, it is possible to cause the blood gas tensions significantly to
worsen, particularly the oxygenation, by over- or under-ventilation. The clinicians
who conduct most of the care of ventilated infants are usually in training and will
almost always have access to expert help but may not refer to it. Despite considerable
improvements in the outcomes of ventilated newborn infants there continue to be a
significant number of infants who die of respiratory failure during the acute stages of
their lung disease or who develop other serious problems such as pneumothorax or
bronchopulmonary dysplasia. Any objective information about lung function that
might help tailor the ventilation strategy to the individual's needs might be expected
to prove beneficial given the subjective nature of the other information available. On
the other hand if junior doctors can reliably judge respiratory mechanics then the
additional handling associated with making the measurement however minimal would
be hard to justify outside the research setting. This study was designed to determine
whether the different grades of junior doctors involved in the ventilator care of infants
in a regional intensive care unit were able reliably to judge respiratory system
compliance clinically.
Patients and methods
This study was made on 46 newborn infants mechanically ventilated from the early
hours of life and enrolled in a randomised controlled trial of compliance
measurements. Infants were eligible for inclusion in the study if the Senior House
Officer, Registrar and Research Fellow involved in the care of the infant were
available to make estimates of compliance at the same time and no preceding
compliance measurements had been made.
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Compliance Estimates
As soon as possible after ventilation was commenced the three observers made
estimates of the static respiratory system compliance using 2 methods: (a) optical
compliance (Crs0p), and (b) analogue compliance (Crsan)- Optical compliance is
derived from assessment of tidal volume 57'189. The tidal volume delivered by the
ventilator is estimated from the degree of chest inflation visible. The observer decides
whether the chest inflation is less than normal and barely visible, approximately
normal, or greater than normal and distinctly visible (normal being that which would
be observed in a healthy newborn infant breathing spontaneously). A tidal volume of
5, 7.5 or 10 mis per kg body weight is assigned accordingly. These values are then
multiplied by the body weight of the infant to give the total estimated tidal volume
which is then divided by the pressures set on the ventilator (peak inspiratory pressure
minus positive end-expiratory pressure) to give the optical compliance. One limitation
of this method is that it only allows for 3 possible values of optical compliance for
each set of ventilator settings which could limit its accuracy. In view of this we
assessed the potential of estimates made using a linear analogue scale to perform
more reliably. Junior doctors were asked to mark a cross on a linear analogue scale
corresponding to what they thought the Crs would be. They were given a line 21cm
long which on a linear scale described possible Crs values corrected to body length
ranging from 0.4 to 2.5 ml/cmH20/m (fig 2.1) They were told that this described the
range of values from worst possible to normal. There were two pre-existing marks on
the scale at 0.6 ml/cmH20/m and 1.8 ml/cmH20/m to assist them in their estimates.
The observers were told that a Crs of 0.6 ml/cmH20/m corresponded to very stiff
lungs and a high incidence of morbidity and mortality as demonstrated in a previous
study using the same apparatus 59 and that the lowest Crs value recorded from more
than 100 ventilated newborn infants during the previous year was 0.5ml/cmH2O/m.
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The junior staff were told that a Crs of >1.8 ml/cmH20/m was indicative of
minimally stiff lungs as infants with compliance values greater than or equal to this
had been found to have normal lung phospholipid profiles in another study with the
same apparatus 63 and in our experience these infants had not responded well to
surfactant replacement therapy 196. The observers were told that the compliance of 2.5
ml/cmH20/m at the upper extreme of the scale corresponded to normality. There are
no substantial reference data for the normal values of compliance using this method in
ventilated infants since normal infants are not usually ventilated. In our experience up
to the beginning of this study infants recovering from lung disease were usually well
enough to be extubated and were often breathing air by the time their compliance had
reached 2.5 ml/cmH20/m. The median (quartile) static respiratory system compliance
measured within the 24 hours before extubation of 144 infants successfully extubated
(not re-intubated within 24 hours) during the randomised trial described in this thesis
was 2.6 (2-3.2) ml/cmH20/m. Normal non-intubated infants have static compliance
values of around 5-7.8 ml/cmH20/m or 1.1-1.5 ml/cmH20/kg 83,114,126,178,187 ancj jn
our experience infants ventilated for reasons other than lung disease can have
compliance values of 5 ml/cmH20/m or more. "Normal" in the context of this study
therefore represented functional normality as defined by a respiratory system
compliance value not usually associated with the need for mechanical ventilation for a
pulmonary cause. For the purposes of comparison all measured and optical
compliance values that were greater than 2.5ml/cmH20/m were called 2.5. The
estimates using both methods were made simultaneously and each observer was blind
to the estimates of the other observers. The senior house officer and registrar were
often in possession of other data at the time of their estimates such as blood gas data
or x-ray findings and at least one of them would have hand-ventilated the infant in the







































Immediately following the estimates the Crs was measured by the research fellow
who was blind to the estimates made by the senior house officer and registrar at the
time of measurement. The measurements were made using the single breath passive
expiratory flow technique, applying the same data quality control standards and using
the same apparatus described in chapter 1.
Statistical methods
The 95% limits of agreement between the estimates and the measurements were
calculated for each grade of junior doctor and for each method of Crs estimation.
These were expressed as percentages of the measured Crs. To give a comparison
between this and the previous studies, the agreement was also assessed by the
correlation coefficients calculated by linear regression. The agreement between the
two methods of estimation was also determined using the same methods.
Results
From the start of this study until the randomised trial finished, 72 infants were
available for enrolment. Satisfactory data was collected from 46 infants (64%). On 8
(11%) occasions the junior doctors were not available and on 18 (25%) occasions the
compliance measurement was not successful. The baseline characteristics of the 46
studied infants are described in table 2.1 and the results comparing the estimations
and measurements of Crs are outlined in tables 2.2-2.8. Figures 2.2 and 2.3 show the
differences between each measurement and the corresponding estimates plotted
against the measurements. The estimates of all 3 observers are combined in each plot
as the patterns were similar between observers.
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Table 2.1: Patient characteristics. Data are median (range)
n 46
Gestational age (weeks) 31 (25-41)
Birthweight (kg) 1.496 (0.553 - 4.050)
Length (cm) 40 (29 - 57)
Crs (ml/cmH20) 0.519 (0.174-3.744)
Crs (ml/cmH20/m) 1.3 (0.5-7.8)
Crs (ml/cmH20/kg) 0.368 (0.175- 1.138)
Table 2.2: Agreement between optical or analogue estimates and measured Crs
(corrected to length). Limits of agreement are % of the measured Crs.
Correlation coefficient 95% limits of agreement
Observer Crs,op Crsan CrsGp Crsan
SHO r=0.616 r-0.631 -87%, +63% -72%, +69%
Registrar r=0.631 r=0.434 -86%,+61% -121%,+89%
Research r=0.673 r=0.680 -93%, +63% -94%, +67%
Fellow
59
Table 2.3: Agreement between optical or analogue estimates and measured Crs
(corrected to weight). Limits of agreement are % of the measured Crs.
Correlation coefficient 95% limits of agreement
Observer Crs0p Crsan ^rsop ^rsan
SHO r=0.339 r=0.646 -87%, +63% -72%, +69%
Registrar r=0.421 r=0.404 -86%,+61% -121%,+89%
Research r=0.525 r=0.623 -93%, +63% -94%, +67%
Fellow
Table 2.4: Agreement between optical or analogue estimates and measured Crs (not
corrected for body size). Limits of agreement are % of the measured Crs.
Correlation coefficient 95% limits of agreement
Observer Crs0p Crsan Crs0p Crsan
SHO r-0.787 r=0.785 -87%, +63% -72%, +69%
Registrar r=0.796 r=0.710 -86%,+61% -121%,+89%
Research r=0.827 r=0.835 -93%, +63% -94%, +67%
Fellow
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Table 2.5: Agreement between optical estimates and measured Crs (corrected to
body length). All estimated and measured values > than 2.5ml/cmH20/m
included as their actual values rather than limited to 2.5 ml/cmH20/m.
Limits of agreement are % of the measured compliance.
Correlation coefficient 95% limits of agreement
Observer Crs,op Crsop
SHO r=0.632 -90%, +74%




Table 2.6: Agreement between estimates of optical and analogue compliance for
each grade of observer (corrected to length). Limits of agreement are
percentages of the optical compliance.
Observer Correlation coefficient 95% limits of agreement
SHO r=0.463 -80%, +70%














Table 2.8: Population distribution of values for measured static respiratory system
compliance and analogue estimates by grade of observer.
Variable Coefficient of variation
Measured Crs 42%
SHO Analogue estimate 30%
Registrar analogue estimate 27.1%
Research Fellow analogue estimate 28.9%
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For all three grades of observer the agreement between estimates and measurements
of Crs corrected to body length was poor whether assessed by the correlation
coefficient or by the 95% limits of agreement (table 2.2). There was little difference
between the grades of observer. As would be expected there was no difference in the
95% limits of agreement whether the results were expressed uncorrected for body
size, or corrected to length or weight (tables 2.2, 2.3 and 2.4). The mode of correction
for size did however have a dramatic effect on the correlation coefficients (tables 2.2,
2.3 and 2.4). The correlation coefficient (r) for the relationship between the optical
compliance estimates and the measured compliance for the Senior House Officers
was 0.339 when the values were corrected to body weight, 0.616 when corrected to
length and 0.787 when uncorrected for body size. Of the 46 infants, 5 (11%) had
measured Crs > 2.5 ml/cmH20/m. The values were 2.8, 3.3, 3.5, 5.4, and 7.8. The
data for all 46 infants were re-analysed with those infants whose measured or optical
compliance was greater than 2.5 ml/cmH20/m analysed according to their actual
values rather than assigned a value of 2.5 ml/cmH20/m (table 2.5). In all cases the
95% limits of agreement got slightly wider, indicating worse agreement, whereas by
contrast the correlation coefficients improved (tables 2.2 and 2.5). When the optical
and analogue estimates were compared to one another rather than to the measured
compliance they too showed poor agreement both in terms of the correlation
coefficients and the limits of agreement (table 2.6). Despite this, neither method of
estimating the measured compliance was superior. They agreed poorly both with
each other and with the measured compliance. When estimating the optical
compliance (table 2.7), all three grades of junior doctor usually selected the middle
tidal volume option of 7.5 mls/kg (105/138=76% of occasions). A similar observation
could be made about the analogue compliance estimates as these were more closely
distributed around their mean than the measured compliance values (table 2.8).
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Figure 2.2: Difference between measured and analogue
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Figure 2.3: Difference between measured and optical
Crs plotted against measured Crs.
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Diagonal dotted lines represent ± 50% of the measured Crs.
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Figures 2.2 and 2.3 demonstrate that for both methods of estimation this meant that
the observers tended to overestimate the Crs of the infants with the lowest Crs and to
underestimate the Crs of the infants with higher Crs. The observers differed by more
than one category of estimated tidal volume on two occasions. The differences
between the estimates and the measurements was calculated by subtracting the
estimated value from the measured value in all cases. The estimates using both
methods were on average slightly higher than the measurement for all three grades of
observer as demonstrated by the negative weighting of the limits of agreement (tables
2.2, 2.3 ,2.4).
Discussion
This study clearly demonstrates that junior doctors' estimates of Crs are unreliable.
Neither method of estimating Crs performed within acceptable limits of accuracy to
represent a realistic alternative to direct measurement. The limitations of using linear
regression to assess the agreement between two methods of measuring the same
parameter are demonstrated by the large variations in the correlation coefficient. It
might have been concluded if only uncorrected estimates were considered that the
estimates showed acceptable agreement with the measurements as the correlation
coefficients ranged from r=0.710 to r=0.835 but the limits of agreement were all
wide. As has been discussed, correction of Crs measurements for size is important if
they are to represent disease severity. Narrowing the range over which Crs
measurements were considered in order to accommodate the analogue scale led to a
slight overestimation of the accuracy of the optical estimates but despite this they still
performed poorly.
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It is possible that this also led to a marked overestimation of the accuracy of the
analogue estimates and that they would have been much worse than the optical
estimates if considered over a wider range but since they too were unreliable in the
narrower range this is immaterial. It is interesting and disappointing that the two
methods of estimating Crs agreed so poorly with one another when they were
developed to assess the same parameter.
The junior doctors mostly chose the intermediate tidal volume when estimating the
optical Crs. This was also the finding of Aufricht et al57. They attributed the poorer
performance of the junior doctors when compared to a senior neonatologist partly to
this apparent preference for selecting the middle value. It is a weakness of the method
of assessing optical Crs that it starts with an assumption that the ventilator settings are
appropriate by limiting the tidal volume options to a range of 5-10mls/kg. Normal
non-ventilated infants have mean tidal volumes ranging from 7-9 ml/kg 139 so
5-10ml/kg is probably within an acceptable "normal" range for ventilated infants and
does not really describe chest inflation that is either less than normal and barely
visible, or greater than normal and distinctly visible. As such optical Crs estimation
cannot be expected to detect inappropriate ventilator settings which might be one
important clinical role for Crs measurement59. The observers differed by more than
one tidal volume category on 2 out of 46 occasions. Considering that this required one
observer to think that the tidal volume was less than desirable and barely visible
whilst another simultaneously thought that it was greater than desirable and distinctly
visible it should give us pause. Both the optical and analogue estimates were made
during tidal ventilation. It could therefore be argued that they are more a reflection of
dynamic than static respiratory system compliance. If this were so they might be
expected to be lower on average than the static respiratory system compliance values
yet they proved to be higher.
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The measured Crs may not be the appropriate gold standard. The more important
question is what gives the best indicator of disease severity and is therefore most
relevant and potentially useful in clinical practice. There is already much evidence
that Crs measurements may provide clinically useful information. In 1982 Crs
measurements were found reliably to measure respiratory disease severity and predict
clinical outcome 60. Ten years on these findings have been confirmed 59 although the
Crs values associated with a high risk of death are now appreciably lower presumably
as a result of improvements in care. Tarnow-Mordi et al 59 also showed that Crs
measurements may be a more reliable measure of disease severity than oxygen
requirements in ventilated infants. Crs can predict biochemical lung maturity 63 and
may also measure the response to surfactant15 and later the risk of developing
bronchopulmonary dysplasia 197. They have been used to measure the response to
bronchodilators 198,199,200 They may also identify infants suitable for extubation 64.
None of these studies demonstrate that the use of Crs measurements in routine clinical
care can improve outcome in an important way. This will be necessary if lung
function testing is to become widely popular. It should be remembered that in this
study 25% of Crs measurements were unsuccessful which may limit their usefulness.
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There seems little doubt from the breadth of the available data that making routine
measurements of respiratory mechanics as an adjunct to clinical management would
be a feasible aim. Studies identify many specific areas of clinical management where
additional information about respiratory function might prove useful. Nevertheless
the commercially available technology required to make respiratory function
measurements is expensive. The measurements themselves have limitations and their
rigorous interpretation requires expert knowledge. There are many circumstances
where the data obtained may be uninterpretable or misleading. More information is
required about the reliability of the techniques. The introduction of many new
modalities of ventilation has made the process of ventilation extremely complicated
for the junior doctors that care for preterm infants and further information overload
may be counterproductive. The question remains therefore whether in a more global
sense the adoption of respiratory function testing into practice will result in some
measurable improvement in clinical outcomes or resource utilisation. There are no
published studies that address this question directly. We therefore performed a
randomised controlled trial of conventional clinical management (control group)
versus clinical management supplemented by routine information on Crs
(experimental group) in two Scottish neonatal units
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We wished to determine whether the experimental group would have
(a) fewer adverse clinical events. Defined for this study as death before
discharge, or receiving mechanical ventilation at 15 days, or breathing
supplementary oxygen at 36 weeks post conception, or pneumothorax,
or pulmonary interstitial emphysema (PIE), or pulmonary haemorrhage,
or abnormal cerebral ultrasound scan (USS) appearances at 6 weeks
postnatal age.
(b) improved lung function, assessed by greater mean Crs after the first 48
hours of life.
(c) fewer days of respiratory support by endotracheal tube.
(d) fewer days in 40% oxygen.
(e) fewer days in supplementary oxygen.
(f) fewer doses of surfactant.
Patients and methods
All neonates receiving mechanical ventilation by endotracheal tube in the neonatal
intensive care units of the Simpson Memorial Maternity Pavilion in Edinburgh and
Ninewells Hospital and Medical School in Dundee between August 1991 and June
1993 were considered for inclusion in the study. Infants were not enrolled if it was
felt by the responsible clinician that their inevitable death was imminent or if a life
threatening congenital abnormality was apparent in the immediate neonatal period.
Written parental consent was obtained in all cases.
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Infants were randomised by the opening of a sealed, numbered envelope.
Randomisation was stratified by treatment centre. All aspects of the clinical
management of the control group was conducted according to the normal practice in
each centre. In addition, Crs was measured by the clinical research fellow in each
infant, using the single breath technique as soon as possible after endotracheal
intubation, at least daily for the first seven days of ventilation and twice weekly
thereafter until extubation. Additional measurements were made immediately before
and 3 and 12 hours after each dose of surfactant. The results of these Crs
measurements were not made available to clinical staff. The experimental group were
managed in the same way as the control group except that the results of each Crs
measurement were routinely entered on the blood gas recording sheet where they
would be frequently seen by the clinical staff adjusting the ventilator. The
measurements were corrected to body length to give units of ml/cmH20/m.
Guidelines to assist the clinical staff in the interpretation of Crs were entered on the
clinical record alongside the Crs data (table 3.1). They were based on two previous
studies using the same apparatus in the nurseries of Ninewells Hospital in Dundee and
Mount Sinai Hospital in Toronto, Canada 59>63.
Table 3.1: Clinical guidelines based on Crs data.
Crs < 0.6 ml/cmH20/m indicates very
stiff lungs.
Crs 0.6 - 1.2 ml/cmH20/m indicates
moderately stiff lungs.
Crs 1.2 - 1.8 ml/cmH20/m indicates
mild to moderate lung stiffness.
Crs >1.8 ml/cmH20/m indicates
minimal or no lung stiffness.
Not advisable to reduce ventilator
support.
Weaning may be justified if clinically
improving.
Try weaning. Aim for I:E < 1:2,
PIP < 21, PEEP < 4.
Try weaning. Aim for I:E < 1:2,
PIP < 21, PEEP < 4.
71
Because they were "unblinded" as to Crs data, the research fellows were not part of
the clinical team managing the infants. They were available to explain the Crs data
but did not make management decisions. It was calculated that a sample size of 104
infants in each group would yield >80% power to show a reduction from 40% to
20% in the combined rate of adverse clinical events at the 5% level of significance
using a 2 tailed test. This sample would also provide >80% power to demonstrate a
reduction in median duration of respiratory support by endotracheal tube from 7 to 4
days. Differences in proportions of categorical data were compared using the test.
Differences in continuous data were compared using the Mann-Whitney U test.
Results
Two hundred and forty-five eligible infants were enrolled into the study. Their
characteristics at study entry are shown in table 3.2. The two groups did not differ
significantly in birthweight, gestational age, length, initial Crs, frequency of antenatal
steroid exposure or Apgar scores. The experimental group contained by chance a
significantly greater proportion of males than the control group.
Problems with data collection
Because of difficulties resulting from air leaks around the endotracheal tube, non¬
linear expired flow-volume plots and failure to induce relaxation the Crs
measurements were often unsuccessful. The initial measurement at study entry was
successful in 102 of 123 infants (83%) in the experimental group and 94 of 122
controls (77%) giving an overall success rate of 80%. In 25 (10%) infants, no
successful measurements at all were made (11 infants in the experimental group and
14 in the control group). The infants with no successful Crs data tended to have been
ventilated for less time than those with successful data collection. The median (range)
duration of ventilation of the infants with no successful measurements was 2 (1-13)
days compared to 5 (1-114) days for the study population as a whole.
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Table 3.2: Population characteristics at study entry. Data are median (range) or
number (%).
Control Group Experimental Group
n 122 123
Birth weight (g) 1423 (580 - 5250) 1426 (452 - 4400) p = 0.69
Birth length (cm) 40 (30 - 57) 40 (29 - 55) p = 0.65
Gestation (weeks) 31 (23 -42) 30 (25 - 42) p = 0.94
Gender (M/F) 62/60 (51%:49%) 79/44 (64%:36%) p = 0.046
Antenatal steroids 37 (30%) 44 (36%) p = 0.44
Initial Crs 1.5 (0.5-7.9) 1.4 (0.5 - 5.6) p = 0.34
Inborn 106 (87%) 110(89%) p = 0.675
Delivery mode
Vaginal 63 (52%) 56 (46%)
C/S in labour 22 (18%) 26 (21%)
C/S no labour 37 (30%) 41 (33%) p = 0.623
Singleton 99 (81%) 99 (80%) p = 0.975
Apgar at 1 minute 5 (0 - 9) ONi©in p = 0.25
Apgar at 5 minutes 8 (0 - 9) 8 (1 - 9) p = 0.59
Primary outcomes
Adverse clinical events: The numbers of infants in each group with each adverse
clinical event are given in table 3.3. There were no significant differences between the
two groups for any individual adverse event or in the total number of infants in each
group with any averse event.
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Table 3.3: Frequencies of adverse events. Data are number (%)
Control Group Experimental group
n 122 123
Death 16 (13%) 19 (15%) p = 0.735
Ventilator dependent day 15 27 (22%) 24 (20%) p = 0.728
02 dependent at 36 weeks 24 (20%) 23 (19%) p = 0.975
Pneumothorax 11 (9%) 9 (7%) p = 0.800
PIE 12 (10%) 10 (8%) p = 0.808
Pulmonary haemorrhage 10 (8%) 7 (6%) p = 0.603
Abnormal USS at 6 weeks 14(11%) 18 (15%) p = 0.586
Any adverse event 54 (44%) 54 (44%) p = 0.943
Lung function at 48 hrs: Forty-two infants were extubated on the first day after
study entry (21 infants in each group). A further 39 infants were extubated on their
second day in the study (24 infants in the experimental group and 15 controls). Crs
results were obtained on day two in 108 infants (62 infants in the experimental group
and 46 controls). There was no significant difference in the distribution of the Crs
values of the two groups. The experimental group had a median (quartile) Crs of
1.3 (0.8-2.2) ml/cmH20/m. The corresponding values for the controls were 1.3 (0.9-
1.9) ml/cmH20/m (p = 0.92).
Duration of ventilation: Infants in the experimental group required respiratory
support by endotracheal tube for a median (quartile) 4 (2-9) days compared to 5 (2-
12) days for the controls (p = 0.20). Excluding the 19 infants in the experimental
group and the 16 control infants that were still intubated at the time of their deaths,
the median (quartile) ages in days at final extubation were 4 (2-10) for the
experimental group and 5 (2-21) for the controls (p = 0.048).
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Oxygen supplementation: Data on oxygen supplementation are presented in table
3.4. There were no significant differences between the two groups in duration of
requirement for greater than 40% oxygen or in duration of requirement for any
supplemental oxygen.
Table 3.4: Duration of oxygen supplementation. Data are median (quartile).
Control group Experimental group
n 122 123
Days in > 40% oxygen 2 (1-8) 3 (1-5) p = 0.87
Days in oxygen 6(2-34) 6 (3-36) p = 0.71
Surfactant treatment: During the study period infants were considered eligible for
surfactant treatment if they were less than 72 hours old, had no major congenital
malformation, had a clinical and radiological diagnosis of respiratory distress
syndrome and an arterial/alveolar oxygen tension (a/A) ratio < 0.22 . The same
criteria and the same surfactants were used in both centres. The decision whether or
not to give surfactant was not based on the Crs data. At the time that this study began
on 5/8/91 both centres were already participants in the Curosurf IV multicentre
study201. Curosurf IV finished at the beginning of 1992 and the last Curosurf was
given on 15-1-92 in Edinburgh and on 26-2-92 in Dundee. The Curosurf IV study was
a comparison of 2 different dose regimens for Curosurf. Infants were randomised to
receive either a high dose regimen (initial dose 200mg/kg followed by up to four
further doses of lOOmg/kg at 12 hour intervals thereafter if clinically indicated) or a
low dose regimen (initial dose lOOmg/kg with up to two further doses of lOOmg/kg at
12 hourly intervals thereafter if clinically indicated). From the end of the Curosurf IV
study onwards, infants in both centres received Exosurf 5ml/kg according to the
above criteria, with up to two repeat doses at 12 hour intervals if clinically indicated.
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Following the publication of the OSIRIS study 202 in 1992 the number of repeat doses
of Exosurf permitted was reduced to one. The details of surfactant administration to
the two groups are detailed in table 3.5. There were no significant differences in the
number of infants in each group that received surfactant, the surfactant regimens used
or the total number of surfactant doses administered to each group.
Table 3.5: Surfactant administration. Data are number (%).
Control Group Experimental Group
n 122 123
Received surfactant 62 (51%) 60 (49%) p = 0.848
High dose Curosurf 9 8
Low dose Curosurf 17 15
Exosurf 36 37 p = 0.920
Total doses 121 115
Other outcomes
Remaining outcome data are detailed in table 3.6. There were no significant
differences between the two groups in the frequencies of development of chronic lung
disease (CLD), defined as requiring supplemental oxygen and having an abnormal
chest x-ray at 28 days of age, or persistent ductus arteriosus (PDA) requiring clinical
intervention. Similar numbers of infants in the two groups were treated with steroids
and intralipid. There were no differences in the patterns of cranial ultrasound
abnormalities during the first week of life. The median duration of hospitalisation was
identical for the two groups.
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Table 3.6 study outcomes. Data are median (quartile) or number (%).
Control Group Experimental Group
n 122 123
CLD 31 26 p = 0.522
Steroids for CLD 23 20 p = 0.715
Significant PDA 29 19 p = 0.139
Given intralipid 47 48 p = 0.96
Abnormal USS week 1 35 34 p = 0.968
Subependymal bleed 9 11 p = 0.830
Intraventricular bleed 15 13 p = 0.823
Periventricular bleed 10 5 p = 0.279
Days in hospital 40 (21 - 67) 40 (21-65) p = 0.97
Sum days in hospital 6311 6167
Sum days intubated 1429 1186
Secondary analysis - survivors only
Secondary analysis was performed according to whether or not infants survived to
determine the quality of outcomes in the survivors and to examine the possibility that
the primary analysis was skewed by the survival in the experimental group of infants
who might otherwise have died. Nineteen infants in the experimental group and 16 in
the control group died. The characteristics of the surviving infants are shown in table
3.7. Again the two groups did not differ significantly in birthweight, gestational age,
length, initial Crs, frequency of antenatal steroid exposure or Apgar scores. The
experimental group still contained a significantly greater proportion of males than the
control group.
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Table 3.7: Characteristics of survivors. Data are median (range) or number (%).
Control group Experimental group
n 106 104
Birth weight (g) 1525 (640 - 4200) 1531 (592 - 4400) p = 0.85
Birth length (cm) 41 (32 - 57) 41 (30 - 55) p = 0.95
Gestation (weeks) 31 (25-42) 31 (25-42) p = 1.0
M:F 52:54 (49%:51%) 67:37 (64%:36%) p = 0.035
Antenatal steroids 22 (21%) 30 (29%) p = 0.231
Initial Crs 1.5 (0.5-7.9) 1.5 (0.6 - 5.6) p = 0.78
Inborn 94 (89%) 96 (92%) p = 0.509
Delivery mode
Vaginal 52 (49%) 47 (45%)
C/S in labour 20 (19%) 25 (24%)
C/S no labour 34 (32%) 32 (31%) p = 0.654
Singleton 86 (81%) 83 (80%) p = 0.946
Apgar at 1 minute 5 (0 - 9) 5 (0 - 9) p = 0.45
Apgar at 5 minutes 8 (0 - 9) 8 (1 - 9) p = 0.85
Adverse clinical events: The numbers of infants in each group with each adverse
clinical event are given in table 3.8. Again there were no significant differences
between the two groups for any individual adverse event or in the total number of
infants in each group with any adverse event.
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Table 3.8: Frequencies of adverse events. Data are number (%).
Control Group Experimental group
n 106 104
Vent, dependent on day 15 25 (24%) 18 (17%) p = 0.339
O2 dependent at 36 weeks 24 (23%) 19 (18%) p = 0.539
Pneumothorax 8 (8%) 5 (5%) p = 0.591
PIE 7 (7%) 3 (3%) p = 0.331
Pulmonary haemorrhage 5 (5%) 1 (1%) p = 0.214
Abnormal USS at 6 weeks 11 (10%) 15 (14%) p = 0.496
Any adverse event 39 (37%) 36 (35%) p = 0.853
Duration of ventilation: Surviving infants in the experimental group required
respiratory support by endotracheal tube for a median (quartile) 3 (2-8) days
compared to 5 (2-13) days for the controls (p = 0.03). The total duration of ventilation
was 775 days for the infants in the experimental group and 1269 days for the controls.
The median (quartile) ages in days at final extubation were 4 (2-10) for the
experimental group and 5 (2-21) for the controls (p = 0.048).
Oxygen supplementation: Data on oxygen supplementation are presented in table
3.9. There were no significant differences between surviving infants in the two groups
in duration of requirement for greater than 40% oxygen or in duration of requirement
for any supplemental oxygen.
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Table 3.9: Duration of oxygen supplementation in survivors. Data are median
(quartile).
Control group Experimental group
n 106 104
Days in > 40% oxygen 2(1-8) 2 (1 - 4) p = 0.54
Days in oxygen 6 (3 - 43) 6 (2 - 35) p = 0.33
Surfactant treatment: Details of the surfactant treatment received by surviving
infants are shown in table 3.10. There were no significant differences in the number
of infants in each group that received surfactant, the surfactant regimens used or the
total number of surfactant doses administered to each group.
Table 3.10: Surfactant administration. Data are number (%).
Control Group Experimental Group
n 106 104
Received surfactant 53 (50%) 44 (42%) p = 0.327
High dose Curosurf 8 6
Low dose Curosurf 14 12
Exosurf 31 26 p = 0.979
Total doses 100 87
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Other outcomes
Remaining outcome data are detailed in table 3.11. There were no significant
differences between the two groups in the frequencies of development of chronic lung
disease (defined as requiring supplemental oxygen and having an abnormal chest x-
ray at 28 days of age), or persistent ductus arteriosus (requiring clinical intervention).
Similar numbers of infants in the two groups were treated with steroids and intralipid.
There were no differences in the patterns of cranial ultrasound abnormalities during
the first week of life. The median duration of hospitalisation was almost identical for
the two groups.
Table 3.11 Other study outcomes. Data are median (quartile) or number (%).
Control Group Experimental Group
n 106 104
CLD 29 23 p = 0.471
Steroids for CLD 22 17 p = 0.520
Significant PDA 27 16 p = 0.101
Given intralipid 42 35 p = 0.451
Abnormal USS week 1 25 23 p = 0.929
Subependymal bleed 8 10
Intraventricular bleed 10 8
Periventricular bleed 6 1
Other USS abnormality 1 4 p = 0.125
Days in hospital 47 (25 - 75) 46 (24 - 68) p = 0.79
Sum days in hospital 6101 5702
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Secondary analysis - non survivors
The characteristics of the infants that died are detailed in table 3.12. Again there were
no significant differences between the groups in birth weight, gestational age, gender
distribution or Crs at study entry. The experimental group contained a larger number
of infants that had been delivered by elective Caesarian section.
Table 3.12: Patient characteristics (non-survivors). Data are median (range) or
number (%).
Control group Experimental group
n 16 19
Birth weight (g) 838 (580 - 5250) 967 (452- 1326) p = 0.71
Birth length (cm) 35 (30 - 55) 34 (29 - 41) p = 0.73
Gestation (weeks) 26 (23 - 39) 27(25-31) p = 0.15
M:F 10:6 (63%:37%) 12:7 (63%:37%) p = 0.756
Antenatal steroids 4 (25%) 3 (16%) p = 0.799
Initial Crs 1.1 (0.6-5.8) 1.0(0.5-1.8) p = 0.22
Inborn 12 (75%) 14 (74%) p = 0.765
Delivery mode
Vaginal 11 (69%) 8 (42%)
C/S in labour 2 (13%) 1 (5%)
C/S no labour 3 (18%) 10 (53%) p = 0.005
Singleton 13(81%) 16(84%) p = 0.827
Apgar at 1 minute 2(0-9) 5(1-9) p = 0.10
Apgar at 5 minutes 7(2-9) 8(1-9) p = 0.36
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Adverse clinical events: The numbers of infants in each group with each adverse
clinical event are given in table 3.13. Again there were no significant differences
between the two groups for any individual adverse outcome.
Table 3.13: Frequencies of adverse events. Data are number (%).
Control Group Experimental group
n 16 19
Vent, dependent on day 15 2 (13%) 6 (32%) p = 0.18
02 dependent at 36 weeks 0 (0%) 4 (21%) p = 0.157
Pneumothorax 3 (19%) 4(21%) p = 0.799
PIE 5 (31%) 7 (37%) p = 0.992
Pulmonary haemorrhage 5 (31%) 6 (32%) p = 0.730
Abnormal USS at 6 weeks 3 (19%) 4 (21%) p = 0.799
Duration of ventilation: Non-surviving infants in the experimental group received
respiratory support by endotracheal tube for a median (quartile) 8 (3-27) days
compared to 3 (1-12) days for the controls (p = 0.10). The total duration of ventilation
was 411 days for the infants in the experimental group and 160 days for the controls.
Oxygen supplementation: Data on oxygen supplementation are presented in table
3.14. There were no significant differences between non-surviving infants in the two
groups in duration of requirement for greater than 40% oxygen or in duration of
requirement for any supplemental oxygen.
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Table 3.14: Duration of oxygen supplementation. Data are median (quartile).
Control group Experimental group
n 16 19
Days in > 40% oxygen 3 (1 - 12)
Days in oxygen 3 (1 - 9) 7(3 - 27)
5(2 - 13) p = 0.26
p = 0.09
Other outcomes - non survivors
Remaining outcome data are detailed in table 3.15. There were no significant
differences between the two groups in the frequencies of development of chronic lung
disease (defined as requiring supplemental oxygen and having an abnormal chest
x-ray at 28 days of age), or persistent ductus arteriosus (requiring clinical
intervention). Similar numbers of infants in the two groups were treated with steroids
and intralipid. There were no differences in the patterns of cranial ultrasound
abnormalities during the first week of life. The median duration of hospitalisation was
almost identical for the two groups.
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Table 3.15: Other outcomes (non-survivors). Data are median (quartile) or
number (%).
Control Group Experimental Group
n 16 19
CLD 2 (13%) 3 (16%) p = 0.835
Steroids for CLD 1 (6%) 3 (16%) p = 0.726
Significant PDA 3 (19%) 2(11%) p = 0.835
Given intralipid 5(31%) 13 (68%) p = 0.064
Abnormal USS week 1 10 (63%e 11 (58%) p = 0.945
Subependymal bleed 1 (6%) 1 (5%)
Intraventricular bleed 5 (31%) 5 (26%)
Periventricular bleed 4 (25%) 4 (21%)
Other abnormality 0 (0%) 1 (5%) p = 0.812
Days survived 6 (2-20) 7 (2-29) p = 0.39
Sum days survived 210 465
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Discussion
In this study the introduction of measurements of static respiratory system compliance
into clinical practice had no significant effect on any of the primary outcome
measures. This disappointing estimate of the potential "real life" impact of respiratory
function testing on the outcomes of a population should lead to caution in the rapidity
with which it is being incorporated into routine care.
There are many possible reasons that no clinical benefit was demonstrated in this
study. The obvious possibility is that there is no benefit. Many experiences during the
study were against this conclusion in that in individual circumstances the data was
often extremely helpful. There are already studies demonstrating specific areas of
utility for the technology. Static Crs measurements correlate with gas exchange 191,203
and reflect the course of lung disease 14. They may help select infants for surfactant
treatment63 and predict the likelihood of successful extubation 64. Improvements in
Crs are seen after surfactant treatment that are not apparent when dynamic
measurements are used 15,160,204 qs predicts death from respiratory failure at least as
well as other more traditional measures of disease severity 59,60 The 0ther
information obtained using the single breath technique may also be useful.
Measurements of respiratory system resistance (Rrs) can demonstrate endotracheal
tube obstruction with secretions 16. They can also demonstrate response to
bronchodilators in infants with chronic lung disease 198,199 The time constant could
be used to ensure that the ventilator settings do not result in inadvertent PEEP 13.
Perhaps the potential benefit from the data is smaller than was hoped at the outset and
a much larger sample size would be needed to demonstrate it clearly. Smaller
improvements in outcome would still be important in a global sense but the cost of
the technology would make it unattractive to clinicians making difficult resource
decisions if it were unlikely to make a palpable difference to their own practice.
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In the era of antenatal steroids and replacement surfactant only a small proportion of
infants present serious problems with ventilation and it may be that by considering all
ventilated infants the power of the study was blunted by the number of infants who
were destined to have good outcomes in any case. Again a much larger sample size
would be required to gather enough data for meaningful sub-group analysis.
The measurements were made daily and sometimes more frequently but perhaps this
was not often enough. Without dedicated staff trained in the technique it would be
impracticable for any sizeable neonatal unit to make more frequent measurements
using the single breath technique because of the time involved and expertise required.
The large number of studies that were unsuccessful is likely to have diminished the
power of the study. This problem is unavoidable with the single breath technique but
may be overcome with on-line techniques. Monitoring techniques that constantly
display real time data on-line are becoming available205. It may be that these will
solve that problem but they need to be critically evaluated because they will increase
the respiratory dead space of the infant, often by several millilitres, and unless there is
a reasonable leak around the endotracheal tube this will result in a need for more
ventilation to achieve the same carbon dioxide exchange 84>85. Because they make
measurements under dynamic conditions they may be subject to all of the problems
associated with this approach such as frequency dependence and distortion of the
results by the effects of positive end-expiratory pressure. Kelly et al were unable to
detect improvements in dynamic compliance and by inference tidal volume in a
population of infants treated with Survanta despite large improvements in static
compliance measured simultaneously using the single breath technique that were
coupled with obvious clinical improvements 15.
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Although the measurement results were written on the blood gas sheets along with an
explanation of their significance the study did not stipulate that the medical staff
caring for the infants acted on the basis of the study recommendations. At the time of
the study these monitoring techniques were new to the majority of the staff and there
was significant uncertainty about the reliability of the information. It may be that if
the study was repeated now that the technique is accepted and understood that a
different result would be obtained. We chose to present the data in the form of
respiratory system compliance. This is an abstract concept that does not immediately
mean anything quantifiable. It is possible that it would have been more meaningful to
present tidal volume and expiration time data and to have asked the clinicians to set
the ventilators so as to avoid excessive inflation volumes or inadequate expiration
times.
If compliance measurement is a truly effective intervention it might be expected to
result in the survival of some infants who would otherwise have died or prolonged the
survival of some infants that eventually died. This might have blunted the power of
the study. This sort of observation has been made with surfactant treatment and
antenatal steroids 24. There was by chance significant excess of males in the
experimental group than in the control group. Males are known to have worse
outcomes than females for a given birthweight or gestational age because of their
increased severity of RDS 206. This could have been avoided by stratifying
randomisation by gender as well as by centre. When a secondary subgroup analysis of
the results was performed according to whether or not infants survived there was a
significant difference between the two groups in the duration of ventilation of
surviving infants with infants in the control group requiring a median (quartile) of 5
(2-13) days ventilation compared to 3 (2-8) days for surviving infants in the
experimental group (p = 0.03). The total duration of ventilation in survivors in the
experimental group was roughly 40% less than that of controls.
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This was not a pre-specified outcome and should be regarded as a hypothesis rather
than a definitive finding. Any potential advantage in survivors would be offset by the
longer survival that was observed in the infants that eventually died that were in the
experimental group.
There are no other published trials of this nature for direct comparison. Rosen et al111
performed a retrospective comparison of their outcomes during two consecutive time
periods during the second of which they instituted regular pulmonary function testing
into routine care. They found a lower incidence of pneumothoraces and
intraventricular haemorrhages in the second group. The pulmonary function testing
was performed frequently by three senior neonatologists and repeated whenever the
ventilator settings were adjusted. It may be that the increased frequency of
measurement enabled a greater effect or that the increased frequency of assessment by
a senior neonatologist alone would have been effective. It may also be that the
expertise of the clinicians had improved by the second time period. This study was
performed in the pre-surfactant era when outcomes may have been more dependent
on ventilator management than now.
The way that health care is currently structured in the UK means that the majority of
the routine neonatal ventilation is managed by Senior House Officers and Registrars
with relatively little experience that change post every six months. They are
supervised by senior Neonatologists who educate them whilst in post but there is
probably a limit to the amount of information about sophisticated ventilation
techniques and detailed respiratory physiology that they can be expected to learn and
use effectively in such a short time. Emphasis should be therefore be placed on simple
effective concepts. Information overload is likely to be counterproductive.
Improvements in outcomes are likely to require changes in the structure of care which
place the patients more constantly in the hands of more experienced personnel.
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In the meantime new technology such as this is only likely to be palpably effective if
it combines useful information with an effective, simple information display that
encourages its use. We have been unable to demonstrate that this is the case for the
single breath technique for measuring static respiratory system compliance. Further
research is urgently required to evaluate other techniques before they become
irreversibly incorporated into practice.
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Before any technique for measuring a physiological variable is introduced into
clinical practice with the potential to alter clinical decisions there should be a clear
understanding of the accuracy and reproducbility of the data generated. There are no
clearly agreed standards of accuracy or reproducibility for respiratory system
mechanics measurements in ventilated newborn infants nor are there agreed methods
for assessing it139. Different authors have used a variety of methods to determine this
within their studies. In practical terms the acceptable reliability standards of a method
depend on the circumstances of its use. If any accidental difference between two
successive measurements performed in close succession were large enough to be
confused with a clinically relevant change that might influence management then this
would be important. Having stipulated the data acceptance criteria described in the
opening chapter we studied various aspects of the reliability of the methodology.
Intra-observer reliability
Patients and methods
To assess the intra-observer reliability of the technique, paired Crs measurements
were made 5 minutes apart in a group of ventilated infants treated with surfactant for
respiratory distress syndrome. Three hours after exogenous surfactant was given
endotracheal suction was performed.
91
Five minutes later a series of breaths were sampled. The apparatus was then removed
from the ventilator circuit for 5 minutes and then re-inserted for a further
measurement series. The results of the 2 studies were then analysed and compared.
To obtain 25 successful paired Crs measurements 32 infants were studied. Paired
results were not obtained in 7 infants. In 4 of these 7 infants both attempts at
measurement were unsuccessful because of inability to induce satisfactory respiratory
muscle relaxation in active infants. In 1 infant 1 of the 2 measurements was
unsuccessful because of the same reason. In 1 infant 1 of the 2 studies was
unsuccessful because of insufficient linearity of the flow-volume relationship and in 1
infant both studies were unsuccessful because of an air leak around the endotracheal
tube that could not be eliminated. The characteristics of the infants with successful
measurements are detailed in table 4.1.
Results
The results of the paired Crs measurements are shown in table 4.2 and displayed
graphically in figures 4.1 and 4.2. There was no systematic difference between the
pairs in either direction. The absolute size of the potential error did not vary with the
mean compliance so the percentage error was a little larger the lower the underlying
compliance. 95% of all paired measurements would be expected to be within 0.2
ml/cmH20/m of one another or within 15% of one another (mean
difference ± 2 sd)195.
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Table 4.1: Characteristics of the infants in the intra-observer reliability study.
Infant no. Gestation (weeks) Birth weight (g) Length (cm)
1 30 976 37
2 30 1340 41
3 31 1837 43
4 29 1618 43
5 34 2330 46
6 35 2660 49
7 31 1793 42
8 32 2070 40
9 29 1396 39
10 29 990 37
11 29 1785 42
12 30 1508 43
13 27 1010 35
14 28 825 34
15 27 900 35
16 25 945 35
17 29 1390 37
18 29 1380 41
19 31 1710 43
20 35 2500 48
21 28 958 35
22 27 755 34
23 31 1595 41
24 29 1430 40
25 26 1020 38
Mean (range) 30 (25-35) 1469 (755-2660) 40 (34-49)
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Table 4.2: Paired Crs results (ml/cmH20/m).
Infant no Crs 1 Crs 2 Mean Difference % Difference
1 1.0 0.9 0.95 0.1 10.5
2 2.0 2.0 2.0 0 0
3 1.1 1.1 1.1 0 0
4 1.4 1.4 1.4 0 0
5 1.2 1.2 1.2 0 0
6 0.8 0.8 0.8 0 0
7 1.7 1.6 1.65 0.1 6.1
8 1.6 1.6 1.6 0 0
9 1.7 1.7 1.7 0 0
10 1.1 1.2 1.15 -0.1 -8.7
11 1.2 1.1 1.15 0.1 8.7
12 1.3 1.1 1.2 0.2 16.7
13 0.9 0.9 0.9 0 0
14 1.0 1.0 1.0 0 0
15 0.9 1.0 0.95 -0.1 -10.5
16 1.2 1.3 1.25 -0.1 -8
17 1.3 1.3 1.3 0 0
18 1.1 1.2 1.15 -0.1 -8.7
19 2.2 2.0 2.1 0.2 9.5
20 1.7 1.7 1.7 0 0
21 0.8 0.9 0.85 -0.1 -11.8
22 1.0 1.0 1.0 0 0
23 1.7 1.6 1.65 0.1 6.1
24 1.2 1.1 1.15 0.1 8.7
25 2.0 2.0 2.0 0 0
Mean (sd) 1.3 (0.4) 1.3 (0.4) 1.3 (0.4) 0.016 (0.085) 0.74 (7)%
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Figure 4.1: Difference between paired measurements of
Crs plotted against the mean of the two
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Figure 4.2: Difference between paired measurements of
Crs as % of their mean plotted against the
mean of the two measurements. Dotted lined
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The Crs results for all of the studies described in this thesis were calculated using the
same criteria as described in chapter 1. When analysing the data from a single
measuring session on a single patient the observer selects the satisfactory breaths and
then manually selects the linear portion of the flow-volume trace that will be used to
determine the time constant for each breath. The final result is calculated as the
average of the results of all the satisfactory breaths. Although breath acceptance
criteria were defined it was possible that two observers independently reviewing the
same dataset might accept or discard different breaths. If they also selected different
portions of the flow-volume plots for analysis then they might obtain quite different
results despite analysing the same dataset. To determine the possible magnitude of
this problem as it related to our study, 10 infants from each centre that were enrolled
in the randomised controlled trial of Crs measurements were selected by the
generation of random numbers. The stored data from the first 5 studies performed on
each infant (or all the studies performed on that infant if there were fewer than 5)
were retrieved and re-analysed by the observer from the other centre, blind to the
results obtained from the initial analysis.
The characteristics of the infants whose data were assessed are detailed in table 4.3.
Their range of birthweights and body lengths spanned the whole study population
although the mean values for these parameters were higher than those for the study as
a whole. Between them there were 71 studies for which satisfactory data were
obtained.
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Table 4.3: Patient characteristics for inter-observer reliability study.
Study Number Length (cm) Weight (kg) No. of Studies
N2 46 2.40 4
N7 50 3.03 4
N12 33 0.74 4
N15 37 1.30 5
N26 48 2.46 4
N34 42 1.62 5
N35 43 2.26 2
N40 49 3.00 4
N42 45 2.02 1
N44 36 1.02 4
S18 43 1.62 2
S19 44 2.35 1
S32 47 2.81 4
S46 37 1.03 5
S49 41 1.60 2
S50 34 0.80 5
S57 44 1.74 4
S89 47 2.09 4
S92 45 2.22 2
S124 41 1.44 5
Mean (range) 43 (33-50) 1.88 (0.74- 3.03) Total 71
Results
There was no systematic bias in either direction between the 2 investigators. The
mean (sd) difference between the results obtained by each observer was
0 (0.12 ml/cmH20/m) or 0 (7.4%). The range of differences was -0.3 to
+ 0.6 ml/cmH20/m (-15% - +32%). Statistically, 95% of differences between the 2
observers would be expected to lie between ± 0.25 ml/cmH20/m or between + 15%
(mean ± 2 sd). The full results are displayed in figs 4.3 and 4.4.
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Fig. 4.3:Difference between paired values plotted
against mean of paired values. Dotted lines
represent ± 2 sd of the mean difference.
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Figure 4.4: Difference between paired values expressed
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Figure 4.3 demonstrates that there was no change in the absolute size of the potential
error associated with different observers analysing the same data in relation to the size
of the underlying value for Crs. This means that the percentage potential error is
larger the lower the underlying Crs as seen in figure 4.4.
Within study coefficient of variation
One of the data acceptance criteria in these studies was that the coefficient of
variation of the results of individual breaths within a study should be less than 15%.
This was imposed as a means of preventing the acceptance of potentially misleading
data where respiratory muscle activity or non-linearity of the flow volume trace might
influence the results. This would obviously be expected to result in an average
coefficient of variation for each study that appeared favourable.
The mean (sd) within-study coefficient of variation between breaths for the last 227
sequentially performed successful studies within the randomised controlled trial of
Crs measurements was 6.12 (3.54) % with a range of 0.43% to 14.67%.
Discussion
The data on intra- and inter-observer reliability indicate that the single breath
technique as applied in these studies is acceptably reproducible. The data can only be
assumed to apply to the population of infants studied under the conditions employed
and for the rules for data screening applied. If less stringent rules were applied the
variation in results would be expected to be wider.
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As well as variations attributable to the methodology itself there are other sources of
potential variation that need to be controlled between measurements Changes in
infant position or ventilator settings are known to alter respiratory function test
results 87,88,164,165,166,167,168 f^e duration of the airway occlusion may also be
important117. As discussed earlier the pressure-volume history of the lungs prior to
the measurement may be important.
Infants recovering from RDS were selected for the comparison as they were generally
still receiving fast enough ventilation to make them easy enough to study twice in
quick succession. They therefore represent a population of infants in whom the
reproducibility is likely to be better than average. Infants on low rate ventilation often
become active towards the end of a study making a repeat study unlikely to be
successful. This problem could have been overcome by sedating the infants but this
was felt to be unjustifiable simply for the purpose of this study. The second study
could have been performed several hours later or several repeat studies could have
been performed over a period of hours but this would have introduced the possibility
that some of the variation between the studies was due to true changes in the lung
mechanics. Stable infants without lung disease could have been studied to overcome
this problem but they would not have been relevant to the application of the technique
in these studies as the study population consisted exclusively of ventilated infants.
The Crs results in all of the studies were expressed rounded to 1 decimal place after
correction to body length as it was felt that changes smaller than this were clinically
irrelevant. This could in small samples lead to under- or over-estimation of the
repeatability of the measurement but should not have made a systematic difference in
any one direction over the study as a whole. The potential errors between observers
and measurements over time are small in relation to the range of Crs measurements
between the severely stiff lungs of RDS and normal lungs.
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Ideally the studies would have included an assessment of the variation between 2
measurements made in rapid succession in the same infants by different observers.
Given the small number of infants in either centre that were enrolled in the study at
any given time this was not feasible because of the travelling between centres that
would have been involved but this would be an important area for further study.
There are no published data examining this aspect of reproducibility of the single
breath technique.
Obviously the data on the within study coefficient of variation are only as good as
the 15% limit set on data acceptability and would be wider if these limits were
relaxed. They are comparable to other similar data on the subject. Baraldi et al160
found a median (range) coefficient of variation of 8.5 (2-17)% in 20 ventilated infants
with RDS using the single breath technique. They did not report failure to obtain
satisfactory data on any of their study infants at any time point in their study. Guslits
et al136 found a mean (range) within study coefficient of variation of 8.4 (1.9 -
14.3)% in 10 ventilated infants. Morley et al190 using a sustained inflation method for
measuring Crs found a within subject coefficient of variation of 22% for 6
measurements over 6 hours in 20 infants with RDS and attributed the variability to
the long time period of their study. The infants had received surfactant and true
changes in the lung mechanics might be expected over this time course. Thomson et
al137 found a between study coefficient of variation of 14% for Crs measured in 11
ventilated infants using the multiple occlusion technique. Fletcher et al152 found the
mean (range) change in Crs value on repeated measurement to be -1.3% (-4.9 -
+4.7)% in 4 paralysed infants measured using the multiple occlusion technique under
constant volume conditions but that increasing the tidal volume could lead to
dramatic differences in the results obtained.
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Mallol et al116 found a within test coefficient of variation of 8.7 (4.3 - 16.4)% and a
between test coefficient of variation of 11.9 (5-24.1)% when they studied
spontaneously breathing infants recovering from bronchiolitis. Marchal et al207
studied reproducibility of Crs measurements in 5 spontaneously breathing infants and
found a mean (sd) within study coefficient of variation of 7.2 (3%) and a correlation
coefficient of r=0.97 between paired measurements made 15-30 minutes apart in the
same subjects. Haouzi et al114 found a mean (sd) within subject coefficient of
variation of 9.6 (5.3)% in spontaneously breathing infants. Popow et al208 found a
mean (sd) coefficient of variation of 3.9 (3)% using an occlusion technique in 10
spontaneously breathing infants.
The reproducibility of the single breath techniques as employed in the studies appears
to compare reasonably to that observed by other authors using the same or similar
techniques. Other authors have compared the reliability of static to dynamic
compliance measurements and have generally found static measurements to be more
reproducible90-94'208'209 particularly when the dynamic measurement methodology
incorporates the measurement of oesophageal pressure. The importance of controlling
data quality for static techniques results in a significant number of episodes where
measurements are attempted but are not successful. It may be that more relaxed
criteria could be applied depending on the application intended for the results
allowing greater success rate but further study would be required to ascertain whether
it is safe to do so.
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Comparison of Curosurf and Exosurf
Introduction
Exogenous replacement surfactant has now become established as a routine treatment
for infants with respiratory distress syndrome. In contrast to most treatments currently
in use its introduction followed numerous well designed randomised controlled trials
which have established its effectiveness beyond reasonable doubt, whether given
prophylactically to infants at risk of RDS or as a rescue treatment for those with
established disease. These have been well reviewed 19,20,210,211_ There are many
different preparations, some artificial and some derived from animal lungs and there
are potentially important biochemical differences between these preparations which
might be expected to affect the way that they cause the lungs to behave following
their instillation.
In the neonatal units of the Simpson Memorial Maternity Pavilion and Ninewells
Hospital during the study period two surfactants were in use. Between July 1991
when the study began and December 1991 all infants treated with surfactant in both
units received Curosurf. They were enrolled in Curosurf IV which was a randomised
trial comparing the effectiveness of two dose regimens201 that was already in
progress at the time that these studies commenced.
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The Curosurf trial ended at the end of December 1991 and from January 1992 until
the end of the study period in June 1993 infants in both centres received Exosurf
Neonatal which was at that time the only readily available licensed product in the
United Kingdom. Curosurf is a preparation of polar lipids isolated from minced pigs
lungs. It contains approximately 99% lipids, mainly phospholipids, and 1% low
molecular weight hydrophobic apoproteins SP-B and SP-C212. Exosurf is a wholly
synthetic surfactant which contains 13.5 mg/ml of dipalmitoyl phosphatidyl choline,
1.5 mg/ml hexadecanol, 1 mg/ml tyloxapol in 0.1N sodium chloride and no surfactant
apoproteins 46.
In order for pulmonary surfactant to lower surface tension effectively its principal
component dipalmitoylphosphatidylcholine (DPPC) must be able rapidly to form a
surface film over the air-water interface in the airspaces of the lung. In the absence of
the surfactant apoproteins, DPPC does this very poorly 213. These apoproteins (SP-B
and SP-C) are responsible for improving its characteristics in this respect. Surfactants
derived from animal lungs such as Curosurf contain these apoproteins whereas
artificial surfactants do not. The hexadecanol and tyloxapol in Exosurf are added to
mimic the effects of the apoproteins. Measured in vitro the surface properties of the
two surfactants are different, with Curosurf reducing surface tension more
effectively 46,213,214,215,216 Since RDS is caused by increased surface tension in the
lung resulting from surfactant deficiency217, it might be expected that the
replacement surfactant with the greater ability to reduce surface tension would
produce a more pronounced physiological effect. This is the case in animal models of
RDS. Randomised studies have shown that naturally derived surfactants produce a
larger, more rapid improvement in lung mechanics and oxygenation than artificial
ones46-213'215'216'218-219'220. The position is less clear in human infants.
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The early clinical response to exogenous surfactant therapy is variable, but there is
usually a rapid improvement in oxygenation and a reduction in requirements for
ventilatory support. At the time of our studies human infants had not been
demonstrated to show consistent early changes in lung compliance after exogenous
surfactant 86,172,188,189,190,221,222,223,224,225,226 although one study examining the
effects of canine surfactant on lungs excised from human infants that had died from
respiratory distress syndrome showed that it produced immediate improvements in
the lung pressure-volume characteristics 227. This inconsistency between the animal
and human data was puzzling. It may have been a reflection of the methodologies
used for measuring the lung mechanics and in the earlier studies the lack of activity of
the surfactant preparations used or the administration technique.
We planned in our original protocol to study the changes in Crs, ventilation
requirements and oxygenation seen following surfactant treatment in a randomised
comparison of Curosurf and the artificial surfactant ALEC (artificial lung expanding
compound). Unfortunately the Curosurf IV study ended before we had randomised
any infants to ALEC, and Curosurf ceased to be available to us. We therefore started
using Exosurf and continued to evaluate the acute effects of treatment as we had been
doing. This chapter details the findings of our investigations. Although the results
seen after the two surfactants are presented for comparison it must be stressed that




All infants treated with surfactant in either centre that had been enrolled in the
randomised controlled trial of Crs measurements were eligible for inclusion in this
study. Infants were treated with surfactant if between 2 and 72 hours of age they
required mechanical ventilation for clinical and radiological respiratory distress
syndrome (RDS) and had an arterial/alveolar (a/A) oxygen tension ratio < 0.22.
Oxygenation, ventilator support requirements and static respiratory system
compliance (Crs) were assessed in each infant shortly before and 3 and 12 hours after
the first dose of surfactant. All the infants were ventilated with Sechrist iv 100b
pressure limited, time cycled, continuous flow ventilators. The investigators were not
responsible for the clinical care of the infants. The study was accepted by the ethical
committees of both hospitals. Written consent was obtained from one or both parents
prior to the inclusion of their infant in the study.
Infants given Curosurf were randomly assigned to receive either 1.25 or 2.5 ml /kg
body weight (lOOmg or 200mg/kg) as directed by the Curosurf IV randomisation
centre. Half was delivered into each lung by positioning the infant on one side before
instilling the surfactant intratracheally and continuing mechanical ventilation in that
position for one minute. The procedure was then repeated on the opposite side.
Infants given Exosurf received 5 ml/kg administered over approximately 20-30
minutes into a side arm of the proximal endotracheal tube. The infants remained
supine and mechanical ventilation continued throughout. The Exosurf was given more
slowly with the aim of minimising the risk of poor toleration of the larger volume in
terms of decreased oxygenation and heart rate which was being experienced by others
giving Exosurfmore rapidly at the time 228.
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Respiratory System Compliance measurements
Static respiratory system compliance (Crs) was measured using the computerised
single breath passive expiratory flow technique as already described. Changes in Crs
over the study period were expressed as percentage changes in relation to their
corresponding pre-treatment value. Before analysis of the results, the infants were
subdivided according to whether their static Crs before treatment was consistent with
surfactant deficiency (<1.8 ml/cmt^O/m) or surfactant maturity (>1.8 ml/cm
H^O/m). This was based on two previous studies. D'Costa et al 229 measured
lecithin/sphingomyelin (L/S) ratios using high performance liquid chromatography
(HPLC) on directly sampled tracheal secretions from 115 newborn infants taken
within 3 hours of birth. They found that this assay could predict respiratory distress
syndrome requiring ventilation with 100% sensitivity and 91% specificity. Wilkie et
al63 applied this assay using identical equipment in two populations of ventilated
newborn infants in whom they also measured Crs. They found that a static Crs of <
1.8 ml/cmH20/m predicted an immature tracheal aspirate L/S ratio with 93%
sensitivity, 94% specificity, 96% positive predictive value and 89% negative
predictive value. On this basis we wished to examine whether or not the degree of
lung maturity apparent from the pre-treatment Crs as opposed to the clinical and
radiological findings (which suggested RDS in all cases) influenced the response to
surfactant treatment.
Oxygenation
Arterial oxygen tension (Pa02) was measured intermittently by arterial puncture or
sampling from arterial lines. Oxygenation was expressed as the fractional inspired
oxygen concentration (Fi02) required at the time of study to maintain the infants'
arterial or transcutaneous P02 between 6 and 10.3 kPa or oxygen saturation between
90 and 94% by pulse oximetry. These limits were those in current use in the two
nurseries as the desired range for ventilated newborn infants.
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Ventilator support requirements
In order to adjust for variations in ventilator settings between infants, we used the
ventilator efficiency index (VEI) devised by Notter et al 230 as an estimate of
ventilation requirements. This index estimates alveolar ventilation in relation to
ventilator input and can be calculated by the equation:
VEI = 3800
p x f x PaCCK
where p is the inspiratory pressure minus the expiratory pressure of the ventilator, f is
the ventilator rate in cycles per minute and PaCC>2 is the arterial partial pressure of
CO2 in millimetres of mercury. VEI increases as ventilation becomes easier. As
ventilation requirements become minimal VEI increases rapidly. Therefore all VEI
values of >1 were defined as 1 in the group comparisons 231.
Data collection and statistical analysis
The results were analysed using SPSS-PC and Minitab. Variables were compared 3
and 12 hours after surfactant treatment to their corresponding pre-treatment value in
paired group analyses using the Wilcoxon matched pairs signed ranks test.
Comparisons of the distributions of variables between the two surfactants were made
using the Mann-Whitney U test. A probability was accepted as statistically significant
if p<0.05.
Results
During the study period 111 infants were treated with surfactant in the two centres
and 88 of these infants were enrolled in this study (table 5.1). They did not differ
from the whole population of 111 infants in terms of their basic characteristics. Pairs
of Crs measurements were made successfully in 73 of these 88 infants (83%).
110
The reasons for failure to obtain Crs data in the others were (i) inability to obtain
adequate pressure plateaux following airway occlusion (either because of air leaks
around the endotracheal tube or failure to induce a Hering-Breuer reflex in active
infants) or (ii) alinearity of the flow-volume relationship. Of the 15 enrolled infants
without successful Crs measurements 9 received Curosurf and 6 Exosurf. There was
no statistically significant difference in birth weight, gestational age or oxygen
requirement before treatment between them and the babies measured successfully.
Their changes in oxygen requirements and VEI after treatment were similar to those
seen in the infants measured successfully that were treated with the corresponding
surfactant.
Table 5.1: Infants eligible for study, enrolled and successfully measured. Gender,












































Of the 73 enrolled infants with valid Crs data, there were no differences in the
distributions of birth weight, gestational age, oxygen requirement before treatment,
Crs before treatment, and postnatal age at treatment between the infants treated with
Curosurf and those treated with Exosurf (table 5.2). The infants with initial Crs
suggesting surfactant deficiency (<1.8 ml/cmH20/m) who received Exosurf had
slightly greater ventilation requirements (lower VEI) before treatment than those
treated with Curosurf. There were 15 infants whose Crs values before treatment were
not consistent with surfactant deficiency (>1.8 ml/cmH20/m). They were
significantly heavier, easier to ventilate, older at time of treatment and of later
gestation than those whose initial Crs was consistent with surfactant deficiency.
The changes in Crs, oxygen requirements and VEI seen after treatment are shown in
figures 5.1 and 5.2. Of the 58 infants with initial Crs < 1.8 mls/cmH20/m (fig 5.1) 32
received Curosurf. They showed a median improvement in Crs of 17.9 % (p=0.002) 3
hours after treatment increasing to 39.3 % (p=0.0001) at 12 hours. These changes
were accompanied by significant improvements in oxygenation and VEI at both 3 and
12 hours. The 26 infants who received Exosurf showed no statistically significant
changes in Crs at 3 or 12 hours with median changes of -6.2% (p = 0.24) at 3 hours
and +5% (p = 0.28) at 12 hours. Their oxygen requirements were significantly lower
at 3 hours than before treatment but their ventilation requirements were not improved
until 12 hours. The median reduction in oxygen requirement was greater after
Curosurf as compared to Exosurf both at 3 hours (change in Fi02 -0.32 compared to













































































































































































If the Crs results of these infants are expressed in absolute terms rather than as
percentage changes from the baseline Crs, the same pattern is observed with median
pre-treatment Crs for the Curosurf treated infants of 1.1 ml/cmH20/m and median
change at 3 hours of + 0.2 ml/cmH20/m (p=0.0037), and median pre-treatment Crs
for the Exosurf treated infants of 1.1 ml/cmH20/m and median change at 3 hours of
-0.1 ml/cmH20/m (p=0.156). At each time point in figure 5.1 the medians and 95%
confidence intervals for each of the three variables were calculated from the same
infants except that there was one missing data point for the YEI in an infant treated
with Exosurf.
It was not our prestated intention to analyse the changes in the time constant (x) or
resistance of the respiratory system as part of this study. Nevertheless when the
computerised single breath technique is used these are automatically derived. They
are presented in table 5.3. There was a slight lengthening of x after Curosurf (+
0.0125 s at 3 hours and + 0.0215 s at 12 hours). This was not surprising given the
increase in compliance seen in these infants. This would cause an increase in the time
taken for 95% complete expiration (3x) of 0.0375 s at 3 hours and 0.0645 s at 12
hours. The median time constant 12 hours after treatment with Curosurf was 0.083
seconds. Therefore unless the infant was receiving a high rate of ventilation, a change
in the time constant of this magnitude would be unlikely to have important
consequences such as inadvertent PEEP in the majority of cases. The slight
shortening of the time constant after Exosurf, jointly attributable to a small fall in
both compliance and resistance would result in a median decrease in the time taken
for 95% complete expiration of 0.042 seconds which would be unlikely to be
clinically important unless an infant was not receiving positive end expiratory
pressure as part of the ventilation strategy. Both neonatal units in the study routinely
use PEEP in all ventilated neonates.
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Fig 5.1: Changes following surfactant administration in
infants with initial Crs <1.8 ml/cmH20/m.
Graphs show medians with 95% confidence intervals.



















































Symbols denote significant difference from value before treatment. * p < 0.05,






































































There were 15 infants with initial Crs suggesting a mature lung phospholipid profile
(> 1.8 ml/cmH20/m). Their results are presented in figure 5.2. All 8 treated with
Exosurf and 5 out of 7 treated with Curosurf showed a fall in Crs after treatment. The
infants treated with Curosurf showed an overall reduction in their oxygen
requirements whilst those treated with Exosurf did not. There was no consistent
pattern to their changes in VEI. After either surfactant there was a slight shortening of
x in association with the fall in Crs. The infants treated with Curosurf showed a slight
increase in respiratory system resistance whilst those treated with Exosurf showed a
slight decrease. The numbers of observations were small so they have not been
subjected to statistical analysis.
Discussion
In this study infants with a clinical and radiological diagnosis of RDS and an a/A ratio
<0.22 demonstrated rapid improvements in Crs, oxygenation and ventilation
requirements after porcine surfactant if their initial Crs was consistent with surfactant
deficiency. A similar group of infants showed no improvement in Crs, a smaller
improvement in oxygenation and a slower reduction in ventilation requirements over
the same time after treatment with a synthetic surfactant. These two groups were not
randomly assigned so this comparison should be interpreted with caution. However,
the results are consistent with those of randomised studies using animal models of
RDS as described above. They are also consistent with the individual studies of
changes in static Crs following naturally derived 15d60 an(j synthetic surfactants
191,232,233 jn human infants that have been published since the current studies were
started. Two recent comparisons of Survanta and Exosurf in human infants 234,235
showed similar differences in acute response patterns between the two surfactants in
terms of oxygenation and ventilation to those in our study although they did not
measure Crs. Improved pressure-volume characteristics may therefore be an
important factor in the rapid clinical improvements seen after natural surfactant.
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Fig. 5. 2: Changes following surfactant administration in
infants with initial Crs > 1.8 ml / cm H20 / m.
(Lines represent individual infants).
Curosurf n = 7 Exosurf n = 8
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At the time of our studies, published in vivo studies had not shown rapid
improvements in lung mechanics that would explain the immediate improvements in
gas exchange seen in human infants after treatment with replacement
surfactant 86,172,188,189,190,191,221,222,223,224,225,226_ Some of these studies were made
on infants treated with synthetic surfactant 188,189,190,191,223 which may have slower
effects on lung mechanics and oxygenation than natural surfactant as we and others
have found191-232'233. Seven studies had considered infants treated with natural
surfactants 86,172,221,222,224,225,226 Only one of these had measured changes in static
Crs using the single breath technique 226. There were no improvements documented.
It is hard to find a reason why their results differ from ours and the other two recently
published studies using the single breath technique to measure the response to natural
surfactant except that their infants were quite sick in terms of FiC>2 and mean airway
pressure requirements and this has been associated with a blunted response to
treatment225. The other six studies had measured changes in dynamic compliance
after treatment 86,172,221,222,224,225 The infants showed rapid improvements in
oxygenation but no concurrent improvements in dynamic compliance during
ventilation.
The improvements in oxygenation have been attributed to documented changes in
functional residual capacity (FRC) 158,172,224,236,237 These observations and
conclusions may partly reflect the limitations inherent in measuring dynamic
compliance and FRC. Positive end expiratory pressure (PEEP) is usually applied to
non-compliant lungs to prevent alveolar collapse at end expiration thereby
maintaining FRC. But strictly speaking FRC is the volume of the lungs at end
expiration as determined by the balance of the retractile forces of the lungs and the
outward recoil of the chest. If the FRC is measured whilst PEEP is being applied then
a portion of the volume determined will be attributable to the PEEP rather than to the
propeities of the lungs and thorax.
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If the lung compliance improves, the same PEEP will maintain a higher end
expiratory volume than before. This might be sufficient to cause the lung to operate
higher up the pressure-volume curve in its flatter portion. Under these circumstances
there might be no measurable improvement or even a fall in dynamic compliance but
a large improvement in end expiratory lung volume and consequently in
oxygenation 34'106,107,235,238 single breath technique for measuring static
compliance avoids this problem by measuring expired volume from peak inflation to
zero (atmospheric) pressure. This has recently been clearly demonstrated by Kelly et
al15 who measured both static and dynamic compliance in a population of infants
treated with a naturally derived surfactant and demonstrated significant early
improvements in static compliance and oxygenation without improvements in
dynamic compliance. The tidal volume did not appreciably change after surfactant
treatment but the volume expired to atmospheric pressure increased dramatically
indicating that the PEEP was maintaining a higher end expiratory lung volume than
before and thereby pushing the lungs up the pressure-volume curve. This
improvement in lung compliance at low lung volume was not detectable by the
dynamic compliance measurements but was picked up by the single breath technique.
The additional volume exhaled to atmospheric pressure on release of the PEEP would
have been measurable as an increase in FRC. Gommers et al204 published a study
performed in animals with similar findings of improved compliance at low lung
volumes which was less obvious at higher lung volumes. Bartholomew et al108
recently demonstrated in a population of ventilated newborn infants, many of whom
had RDS, that a given change in PEEP had twice the effect on tidal volume as the
same change in peak inspiratory pressure, again indicating better compliance at low
lung volumes. That is not to say that true FRC does not increase after surfactant
treatment. It would have to increase to allow an appreciable increase in compliance
because compliance is proportional to the number of alveoli that are inflated.
Overdistension of already recruited airspaces would probably reduce compliance.
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If the lungs were operating on the flatter portion of the pressure-volume curve
because of excessive peak inflation pressure this would lead to underestimation of
changes in both dynamic and static compliance. Indeed Kelly et al15 reported
improvements in both static and dynamic compliance when peak inflation pressure
was reduced after surfactant treatment. Davis et al 86 found early improvements in
dynamic compliance after a administration of a naturally derived surfactant when
measurements were made on the infants' spontaneous breaths but not on mechanical
ventilator breaths perhaps because there was less overdistension. The infants in our
study were unlikely to have been ventilated with excessive peak inflation pressures as
their expired volume extrapolated to zero flow and atmospheric pressure was usually
5-10ml/kg or less. Although the static Crs of these infants improved after surfactant
treatment and oxygen requirements often decreased substantially the infants still
required to be ventilated, often vigorously, and their respiratory compliance did not
reach the levels seen in infants without lung disease. Surfactant therefore alleviated
but did not cure their respiratory distress syndrome 15.
The observation that in 15/73 (21%) of the infants static Crs before surfactant
treatment was consistent with biochemically mature lungs and that in 13/15 of them
static Crs fell after treatment raises important questions. Should they have received
surfactant? Did it do them more harm than good? The results of the OSIRIS
Collaborative Group 202 suggested that early treatment of infants at risk of RDS
resulted in a lower overall morbidity than later selective rescue treatment of infants
with established RDS despite the treatment of a significant proportion of infants who
would not have developed RDS. This would tend to encourage less discriminate use
of surfactant to maximise any potential benefits. It remains possible that methods
capable at an early stage of selecting out infants unlikely to benefit from surfactant
treatment would further improve overall outcome 239. Furthermore, if as many as 21%
of infants could be selected out this would result in a considerable cost saving.
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Enthusiasm for such an effective treatment may lead to the ventilation and treatment
of more infants than would be necessary54. There is evidence that the constituents of
naturally derived and synthetic surfactants may be capable of damaging the cell
membranes of type II pneumatocytes resulting in cell lysis 240. Surfactant treatment is
associated with an increased risk of pulmonary haemorrhage. Recent work in which
disease severity was measured by the CRIB score241 suggests that surfactant
treatment may be associated with increased mortality when given to infants with the
mildest disease (Tarnow-Mordi, personal communication). These 15 infants in our
study may have had other respiratory problems than RDS which can be difficult to
discriminate on an early chest radiograph. If so, the apparently poorer lung mechanics
and gas exchange of the 8 "mature" infants after Exosurf may have reflected the
adverse effects of the greater volume of fluid instilled into their lungs. The 7 "mature"
infants treated with Curosurf still showed a reduction in their oxygen requirements
which might reflect more rapid clearance of the smaller volume of administered fluid
and continuing improvement in their underlying condition. Animal evidence has
suggested that increasing the surfactant dose volume may adversely affect outcome
once it is higher than 16% of FRC242. Five ml/kg is approximately 25% of a normal
human FRC. Whilst our results seem logical in that significant quantitative or
functional surfactant deficiency would be unlikely in the absence of stiff lungs, the
numbers of observations are small and further studies comparing clinical outcomes
would be necessary before it could be recommended that surfactant be given or
withheld on the basis of a single lung function test.
On the basis of two previous studies 59-63 using the same apparatus which suggested
that correction of Crs to body length gave more useful information than correction to
body weight we corrected our Crs measurements to length. The lack of improvement
in Crs after surfactant treatment in 13/15 infants classified as mature (static Crs
< 1.8ml/cmH20/m) seems consistent with the behaviour of mature lungs.
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Had we instead corrected the measurements for body weight using a predefined cut¬
off for lung maturity of Crs > 0.54 ml/cmH20/kg as in a previous study 63, only 5
infants would have been identified as having mature lungs rather than 15 (figure 5.3).
Furthermore, 6 of the 8 infants treated with Exosurf whose lung mechanics and
oxygenation did not improve would have been identified as immature, which seems
inconsistent with their lack of response to surfactant. This finding further supports the
suggestion that correction of static Crs for weight in this age group may give less
useful information than correction for length.
The rapidity of action of a surfactant may not confer additional benefits. In the
Curosurf IV trial201, infants receiving an initial dose of 200mg/kg body weight of
surfactant showed faster improvements in oxygenation and ventilation requirements
than those receiving lOOmg/kg but there was no significant difference in clinical
outcome between the two groups. Minimal handling and avoidance of stress is part of
the basic approach to the care of these fragile infants. It could be argued that a
surfactant that produced very rapid changes in oxygenation and lung mechanics may
place the infant under more stress than one which worked gradually.
In the final analysis the rapidity of action, effect on the lung mechanics or stress of
administration of a replacement surfactant are of secondary importance in comparison
to the effects on important clinical outcomes such as death, pneumothorax,
bronchopulmonary dysplasia, intraventricular haemorrhage and long term
neurological deficit. There are no good data to suggest that any preparation is superior
to the others in this respect at present. A recent study randomising 600 infants to
Exosurf or Survanta 234 showed no statistically significant difference between the
two. The power of the study was calculated to be sufficient to detect an absolute
difference in the combined incidence of death and bronchopulmonary dysplasia of


























































A difference of this magnitude would be extremely important at a national or
international level. The 95% confidence intervals for the risk ratios of adverse
outcomes between the two surfactants in the study were very close to showing a
significant difference and suggested the possibility of a statistical error. The high cost
of treatment, the widely different formulations and the differences in acute response
to treatment justify much larger studies to determine which surfactant(s) are most
effective.
Rapid or slow instillation of Exosurf
Introduction
During the period of these studies evidence from animal models of RDS began to be
presented at international meetings that suggested that the mode of surfactant
instillation could affect the eventual distribution of the preparation in the lungs and
the clinical response to treatment. Ueda et al found that bolus instillation of Survanta
(bovine surfactant) into ventilated preterm lambs resulted in a relatively uniform
distribution whereas instillation as an infusion over 30 minutes resulted in a much
more uneven pattern with 30% of lung pieces receiving almost no surfactant. Segerer
et al showed that when Curosurf was instilled rapidly into the lungs of preterm rabbits
it was evenly distributed and the response to treatment was good whereas following a
slow infusion the distribution was uneven and the clinical response was poor. Both of
these studies have since been published 243'244.We had been giving Exosurf as a 30
minute infusion to avoid problems with bradycardia, hypoxia and surfactant reflux
that were being experienced by others. Our experience as described above was that
over the 12 hours following treatment there was only a small improvement in
oxygenation in most cases.
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The manufacturers of Exosurf recommended an instillation time of around four
minutes as tolerated by the infant and on the basis of our observations, the
manufacturers' recommendations and the data of Segerer and Ueda we switched to a
more rapid instillation method to see if this would lead to an improved clinical
response. From December 1992 onwards all the infants treated with Exosurf in the
Simpson Memorial Maternity Pavilion received it as a rapid infusion over 2-5
minutes as tolerated. Their oxygenation and Crs data are presented here for
comparison to the infants that had received their Exosurf as a half hour infusion
earlier in the study. No Crs measurements were being made in Ninewells Hospital
during this period as the investigator in that centre had departed.
Patients and Methods
The indications for surfactant treatment were unchanged from the earlier time period.
Exosurf was administered as a rapid infusion into the endotracheal tube connector
with the infant lying supine and the head in the midline. The aim was to administer it
over 2-3 minutes but administration was slowed if the infant became hypoxic or
bradycardic or if surfactant was refluxing back up the endotracheal tube. Occasionally
the procedure took 4 to 5 minutes. A second dose of Exosurf was administered twelve
hours later to those infants that remained ventilator dependent with a significant
requirement for supplemental oxygen. Oxygenation and Crs were assessed in each
infant shortly before and 3 and 12 hours after the first dose of surfactant. Ventilation
management policies were unchanged between the 2 time periods. Oxygenation was
again expressed as the fractional inspired oxygen (Fi02) required at the time of study
to maintain arterial oxygen tension between 6 and 10.3 kPa as in the earlier period of
the study. Crs was measured using the single breath technique applying the same data
quality criteria as before. The same statistical methods were used.
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Results
Satisfactory data were collected on a further 28 infants treated with Exosurf. Their
characteristics are detailed in table 5.4. They were again divided according to their
pre-treatment Crs. The 24 infants with initial Crs <1.8 ml/cmH20/m were were not
significantly different from the infants in the earlier part of the study in birth weight,
gestational age, Crs or FiC>2 before treatment. There were 4 infants with initial Crs
before treatment that suggested biochemical lung maturity (Crs > 1.8ml/cmH20/m).
Table 5.4: Pre-treatment patient characteristics. Data are median (range).
Initial Crs Initial Crs All infants























The changes in Crs and oxygen requirements seen after treatment are shown in figs
5.4 and 5.5. The 24 infants with initial Crs suggestive of surfactant deficiency (Crs
<1.8 ml/cmH20/m) showed no significant change in Crs either 3 or 12 hours after
treatment (fig 5.4). The median (95% confidence intervals) changes were 0% (-14,
+6) at 3 hours and +3% (-11, +40) at 12 hours. The corresponding changes in oxygen
requirements were -0.22 (-0.1, -0.35) at 3 hours and -0.3 (-0.24, -0.4) at 12 hours. The
changes in oxygenation were greater than when Exosurf was administered slowly
(median change -0.11 at 3 hours and -0.13 at 12 hours) and the difference between the
two methods was highly significant (p=0.028 at 3 hours, p=0.004 at 12 hours).
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All four of the infants that had initial Crs suggesting biochemical lung maturity before
treatment (Crs >1.8 ml/cmH20/m) showed a fall in Crs 3 hours after treatment with
improvement by 12 hours but unlike their predecessors that had received their
Exosurf over 30 minutes they showed improved oxygenation over the study period
(fig 5.5).
Discussion
As was found with infusion over half an hour, administration of Exosurf over 2-5
minutes to infants with a clinical and radiological diagnosis of RDS and a Crs in
support of the clinical diagnosis resulted in no significant improvement in Crs over
the twelve hours following treatment. There is no evidence from any human in vivo
study that the immediate clinical response to Exosurf is attributable to early
improvements in the lung mechanics. Recently it has been suggested that Exosurf
may exert its acute effects by reducing pulmonary artery pressure 245-246 with the
effects on the lung mechanics arriving later. This may involve cellular repackaging of
the surfactant lipids as exogenous surfactant is rapidly taken up by the lung tissue
after instillation 247.248. Halliday et al249 were unable to identify early changes in
pulmonary blood flow 4 hours after Curosurf despite large improvements in
oxygenation.
There was a significant improvement in oxygenation in this group of infants and this
was substantially larger than that seen with slow infusion. The infants with initial Crs
suggesting mature lungs showed a fall in Crs after treatment as had been noted with
slow surfactant infusion.
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Figure 5.4: Percentage change in Crs and change in Fi02
after rapid infusion of Exosurf to infants with Crs <1.8




























Fig 5.5: Percentage change in Crs and change in Fi02 after
administration of a rapid infusion of Exosurf to infants with







Although their Crs fell their oxygenation improved during the study period,
suggesting either that they had benefitted from their surfactant or at least that unlike
their predecessors who received their surfactant slowly they had not apparently been
harmed by it.
The difference in surfactant response observed with the two administration methods
provides indirect support for the finding from animal models that the method of
surfactant instillation has important effects on the distribution of the surfactant within
the lungs 243,244 The findings need not necessarily be confined to Exosurf. The
animal studies that raised the issue used Curosurf and Survanta. The treatment
allocation in these infants was not randomised and this study supports the hypothesis
that surfactant distribution in humans follows the patterns that are seen in animal
models but does not prove it. This may be an important area for further prospective
study. There is no consensus as to how surfactant should be administered. Many give
it rapidly, sometimes manually ventilating the infant for a short period. Others give it
as a slow infusion. It may be that the advantages of improved surfactant distribution
gained by rapid instillation are outweighed by the harm of the additional stress of the
procedure. When Exosurf is given rapidly, oxygen desaturation during administration
is seen in up to 40% of infants and bradycardia is also frequently observed 234. It is
increasingly recognised that surfactant instillation is stressful to the infant. This is true
of natural surfactant as well as artificial surfactant. Saliba et al250 found surges in
cerebral blood flow velocity and rises in carbon dioxide tension after rapid
administration of Exosurf that were not seen following slow infusion over 15 minutes.
Cowan et al251 showed large fluctuations in cerebral blood flow velocity after rapid
instillation of Curosurf. Studies performed in Edinburgh have demonstrated large
swings in blood pressure and carbon dioxide tension during both natural and artificial
surfactant administration 252. Acute changes in blood pressure have been implicated
in the pathogenesis of intraventricular haemorrhage.
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Despite its undoubted efficacy in reducing the mortality of respiratory distress
syndrome, surfactant treatment has failed to impact consistently upon the frequency
of intraventricular haemorrhage. Given that there is diversity of clinical practice
around this issue and there are scientific reasons to suppose that either a slow
adminstration or a rapid administration policy may be preferable, consideration
should be given to randomised controlled trials to determine the optimum policy of
surfactant administration.
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Chapter 6: Case Histories
Introduction
Although there is still considerable adverse outcome associated with mechanical
ventilation very many infants are relatively straightforward to manage and do not
develop serious problems. This may mean that for of any study to detect improved
clinical outcome resulting from an intervention a very large population sample will be
required to avoid a statistical error and that potentially large individual patient
benefits may be obscured if smaller samples are studied. When the randomised
controlled trial of compliance measurements was planned it was calculated that a
sample size of 208 infants would have > 80% power to detect a fall in the incidence
of combined adverse outcomes from 40% to 20%. The eventual outcome was that
there was no difference between the two groups in the number of infants with one or
more adverse events. Despite this, respiratory function data often appeared to make a
dramatic difference to patient management resulting in changes of ventilation strategy
that were associated with marked clinical improvements. Some of these cases are
described.
Inadvertent positive end expiratory
pressure
During mechanical ventilation, when lung inflation occurs before the preceding
deflation is complete, gas is trapped in the lungs 32. This gas trapping raises the lung
volume and exerts a positive pressure within the airspaces which is not apparent
clinically. The phenomenon is called inadvertent positive end expiratory pressure
(inadvertent PEEP) 30>3i
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Respiratory dead space increases, impairing gas exchange and tidal volume decreases
because the effective difference between inspiratory and expiratory pressures is
reduced 28-49'106. Cardiac output may be impaired by the increase in intrathoracic
pressure 25,26,29 The result of unnecessarily high ventilator pressures may be
increased adverse clinical outcome such as air leak syndromes, bronchopulmonary
dysplasia or even death 35'36.
As described in chapter 1, passive expiratory flow occurs exponentially and the time
required for expiration is determined by the expiratory time constant 124,125 This is
the mathematical product of the compliance and resistance of the respiratory system.
According to the equation:
V = (Chapter 1)
During passive expiration, after a time (t) equal to 1 time constant (RC), the volume
V of gas remaining in the respiratory system of the total inspiratory volume Vo is:
V
V = Voe 1 or = e 1 = 37% (approx)
Vo
After one time constant, expiration is 63% complete. After five time constants
expiration is 99% complete. After three time constants expiration is 95% complete
and clinically important gas trapping is unlikely 13-32. Increases in compliance or
resistance will lengthen the time constant and therefore prolong the time required for
efficient expiration. Long expiration times are especially likely to be required where
compliance is not severely impaired but airway resistance is high as may be the case
in bronchopulmonary dysplasia.
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Inadvertent PEEP is frequently observed in ventilated infants 30,104,253 jt can 5e
measured directly in paralysed or hypocapnic patients by occluding the airway
exactly at end expiration and measuring the tracheal pressure after sufficient time has
elapsed for equilibration 29'30. This is technically difficult and not practicable in the
clinical setting. Alternatively, the presence of inadvertent PEEP can be inferred if the
expiration time set on the ventilator is less than 3 time constants. These observations
are valid when the respiratory system is behaving as a single compartment with a
single time constant. When there is lung disease this may not be the case. Under these
circumstances inadvertent PEEP may be inferred if the expiration time set on the
ventilator is less than the time spent in expiration when ventilation is interrupted. One
study measuring inadvertent PEEP directly 30 found that it was present to at least
some degree on 19 of 29 occasions when it was looked for in 10 ventilated infants.
There was a small improvement in gas exchange when the ventilation was adjusted to
provide a longer expiration time despite lower mean airway pressure being used but
inadvertent PEEP did not appear to be making the infants critically ill. Despite the
theoretical dangers of inadvertent PEEP there are no reports of infants being seriously
harmed by it. In contrast, when adults with chronic obstructive airways disease were
ventilated in such a way that resulted in inadvertent PEEP, they often became
critically ill29. Inadvertent PEEP can be difficult to diagnose clinically. In the
following infants it was life threatening. Lung function testing led to its recognition
and a change of ventilation led to a dramatic clinical improvement.
Case 1
A male infant was delivered vaginally at 25 weeks gestation with birth-weight 890g.
He required assisted ventilation initially but did not develop respiratory distress
syndrome (RDS) and was extubated on day 4. He collapsed on day 7 and was
ventilated and treated with antibiotics for presumed infection, and indomethacin for a
patent ductus arteriosus. Following this he remained ventilator dependent.
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On day 26 he was on a ventilator rate of 30 breaths per minute (BPM). A chest
radiograph showed bilateral hazy opacification and he was given a further course of
antibiotics. His condition worsened and by day 32, because of respiratory acidosis his
ventilator settings had increased to 50 BPM, with Fi02 60%. The arterial blood gas
tensions showed pH 7.23, pC02 6.94 kPa and he was started on dexamethasone. Over
the next 3 days he deteriorated. His oxygen requirements increased to 90% and the
ventilator rate increased to 60 BPM with pressures 24/5 cmH20 and inspiration time
0.45 seconds (s). The infant was critically ill and frequently hypoxic. He was
reintubated without improvement. The static compliance (Crs), resistance (Rrs) and
time constant (X) of the respiratory system were measured using the single breath
technique as described earlier. Figure 6.1 shows the expiratory flow-volume curve.
Crs was 3.2 ml/cmH20/m (1.0 ml/cmH20/kg) indicating only mild lung stiffness. X
was 0.26 s giving a time for 95% exhalation of 0.78 s (3X). The ventilator settings
allowed 0.55 s expiratory time. The expired volume to atmosphere was 18.5 ml/kg
body weight (normal is 7-9 ml/kg 139) j^is indicated severe gas trapping and
inadvertent PEEP within the lungs. The ventilator rate was reduced to 40 BPM and
the pressures to 16/4 cmH20 with the inspiration time left constant at 0.45 seconds.
The infant's oxygen requirements fell immediately to 50% with no increase in arterial
pCC>2 and over the next 18 hours continued to fall to 25%. He was successfully
extubated into head-box oxygen 3 days later and discharged home breathing air on
day 151.
Case 2
A male infant with birth-weight 1089g was delivered by Caesarean section at 27
weeks gestation because of maternal antepartum haemorrhage. He required assisted
ventilation from birth and developed moderate RDS receiving 3 doses of Curosurf
(porcine surfactant). He was extubated to nasal CPAP on day 10. From days 12-16 he
was re-ventilated with a suspected infection and then extubated.
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The slope of the straight line extrapolated to the axes in case 1 is equal to the time
constant of the respiratory system.
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He remained stable in supplemental oxygen until day 30 when his condition
deteriorated markedly with recurrent episodes of apnoea and bradycardia and
increasing oxygen requirements. The chest radiograph showed generalised patchy
consolidation. He was ventilated and his condition stabilised with ventilator settings
of 20 BPM, pressures 22/4 cmH20, 30% 02- The following day he became
increasingly difficult to ventilate. There were frequent serious desaturations that could
only be overcome by vigorous manual ventilation and it was difficult to achieve chest
inflation without occluding the pressure relief valve of the bag. A variety of ventilator
approaches were attempted utilising both fast and slow rates and none were able to
prevent him deteriorating and requiring manual ventilation. His arterial blood gas
tensions showed pH 6.9, pC02 18.4 kPa, pC>2 7.9 kPa, base excess -8.2. He was
reintubated to exclude blockage of the endotracheal tube without improvement. Later
that day it was only possible to maintain his gas exchange by manual ventilation with
100% O2 and he was continuously ventilated by hand for over an hour. Measurement
of his lung function was attempted. Because his flow-volume trace was very irregular
(fig. 6.1), Crs, Rrs and T could not be calculated but his expiratory flow-time tracing
(fig 6.2) showed that he required an extremely long expiration time (>1.5 seconds)
and when complete expiration occurred the expired volume was 23 ml/kg indicating
marked over-inflation. The continuous traces of respiratory rate and transcutaneous
pC02 displayed on his cot-side monitor suggested that higher respiratory rates were
associated with higher pC02- The infant was paralysed with pancuronium and the
ventilator set at a rate of 20 BPM, pressures 25/4, inspiration time 0.6 seconds. The
clinical condition stabilised, PaCC>2 fell to 3.12 kPa, and FiC>2 settled at 50%. It was
now easy to see the prolonged expiratory phase and there was obvious wheeze
audible on auscultation that had not been detectable earlier. The presumed cause of
this deterioration was infection but aetiology was not proven. He remained dependent
on low rate ventilation with low FiC>2 and was successfully extubated on day 53. He
was discharged home on day 148 requiring O2 via nasal cannulae.
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Figure 6.2: Airway pressure and expiratory flow v's
time. Cases 2 and 3, with tracing from an infant











(c) Infant in recovery phase of RDS
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Proximal airway pressure during ventilation.
Recording stops when ventilation is interrupted
to sample passive expiratory flow.




A male infant was delivered vaginally at 27 weeks gestation with birth weight 750g.
He was intubated for resuscitation but had no initial lung disease and was extubated
into air on day 1. On day 5 his respiratory function deteriorated and he was re-
ventilated. Chest radiograph showed slightly increased lung markings and hazy
opacification bilaterally. He was treated with antibiotics and was easy to ventilate on
low rate, pressures and Fi02. Over the next few days he continued to deteriorate and
by day 10 his chest radiograph showed a bilateral honeycomb appearance. His oxygen
requirements had increased to 50% and his ventilator settings were 25 BPM,
pressures 22/4 cmH20. The oxygen and ventilation requirements continued to
increase and on day 14 dexamethasone was started. There was no significant
improvement seen and from days 14 to 19 he required > 90% oxygen almost
continuously. By this time his ventilator settings had increased gradually to 55 BPM,
pressures 24/4 cmH20, inspiration time 0.5 seconds, 100% O2. Re-intubation had
excluded endotracheal tube blockage as an explanation for his deterioration. Blood
gas analysis showed p02 7.3, pH 7.39, pCC>2 5.04. There was no clinical
improvement with nebulised ipratropium bromide. Because of his respiratory efforts,
measurement of lung function was impossible until he was paralysed with
pancuronium. It was then demonstrated that the expiration time was markedly
prolonged (fig 6.2). The volume expired to atmospheric pressure was 17.5 ml/kg
indicating that gas trapping would be expected with the ventilator settings prior to
paralysis. The infant was ventilated at a rate of 25 BPM with pressures 24/4 cmH20,
inspiration time 0.6 seconds and expiration time 1.8 seconds. His oxygen
requirements fell rapidly and were 30% five hours later with a minimal increase in
pC02- Pancuronium was discontinued after 3 days and the infant was extubated on
day 37. He had continuing problems with bronchopulmonary dysplasia until
discharge home on day 275 at which time he had been breathing air for one month.
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Case 4
A male infant weighing 737g was delivered at 26 weeks gestation by emergency
Caesarean section for maternal pregnancy induced hypertension. He required
ventilation from birth and developed RDS receiving 3 doses of Curosurf. His
respiratory function improved but he remained ventilator dependent on low rate,
pressures and Fi02- On day 9 he became pyrexial and was handling less well. His
ventilation and oxygen requirements were increasing. A blood culture grew coagulase
negative staphylococci. Chest radiograph showed bilateral patchy opacification. The
infant was treated with vancomycin. The ventilation requirements carried on
increasing and by day 17 he was on pressures 22/4 cmH20, rate 60 BPM, inspiration
time 0.4 s and in 90% O2. Repeat chest radiograph showed a bilateral honeycomb
pattern. Lung function testing showed that the lungs were not stiff. Crs was
2.5 ml/cmH20/m (1.0 ml/cm H20/kg). The time constant was 0.3 s suggesting that
inadvertent PEEP may be a problem on the ventilator settings being used. The infant
was in the study group whose Crs could not be revealed. Five hours later the infant
was in 98% 02 on the same ventilator settings. Arterial blood gases showed pH 7.16,
PaC02 9.22 kPa, Pa02 7.6 kPa. The pressures were increased to 25/4 cmH20
without improvement. Pancuronium was given with no significant immediate change
in condition and 3 hours later the Fi02 was still 90%. The PaC02 had fallen to 4.39
so the ventilator rate was reduced to 50 and then 40 BPM. The FiC>2 fell to 75% and
then 40% with the successive reductions in rate and PaC02 fell to 3.69 kPa. The
infant had a long and difficult course from this point onward including the
development and treatment of necrotising enterocolitis (NEC). He was still ventilated
on day 44 when his 2 weeks of antibiotics and parenteral nutrition for NEC were
completed. He co-ordinated poorly with the ventilator and it was proving difficult to
wean him off it so he was started on dexamethasone. Shortly after this he was
extubated onto nasal CPAP but this failed to stabilise him and he was reintubated and
ventilated at a low rate.
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Because of poor co-ordination with the ventilator he was placed on patient triggered
ventilation (PTV) on day 55 using an SLE 2000 ventilator in assist-control mode with
pressures 20/4 cmH20 and inspiration time 0.44 s. His Fi02 during the 12 hours prior
to commencing PTV was mostly 24-40%. The infant triggered at a rate of around 60-
65 BPM for the next 2 days and did not appear to be auto-cycling. Soon after the
commencement of PTV the Fi02 rose to 65% and remained steady around this value.
Lung function measured during this time showed Crs 3.4 ml/cmH20/m
(0.9 ml/cmH20/kg) indicating that the lungs were not stiff. The time constant was
0.24 s. This suggested that the infant required 0.72 s to efficiently exhale. The
average expiration time allowed by the ventilator at a trigger rate of 65 BPM was
0.52 s. The expired volume to atmospheric pressure was 16.2 ml/kg. The lung
function measurements were made at three time points over the space of an hour. On
each occasion that the measurements were made the transcutaneous p02 increased
dramatically as ventilation was interrupted and the trapped gas was released (fig 6.3).
These findings suggested that the infant was self-administering inadvertent PEEP
through the trigger ventilator and that this had caused the oxygen requirements to
increase. The blood gases at this time showed pH 7.38, PaC02 6.06, Pa02 6.6. The
following day the infant self-extubated from the same settings and never required re-
ventilation. He was discharged home on day 167 breathing air, with low flow 02














The airway obstruction common in bronchopulmonary dysplasia makes inadvertent
PEEP especially likely to occur. Perhaps it should have been anticipated in these
cases. However their problems evolved gradually and the ventilator rates had been
slowly increased in response to respiratory acidosis which developed at lower rates.
The infants were examined frequently by experienced clinicians. Chest hyperinflation
was not apparent clinically or radiologically. Chest movement with the ventilator
gave the impression that the lungs were stiff and expiration did not appear prolonged.
Gas trapping can force tidal volume exchange to occur further up the lung pressure-
volume curve in its flatter portion where compliance is reduced and resistance may
also be lower32. This would tend to make the early part of expiration more rapid.
Under these circumstances expiration during the time allowed by the ventilator
settings may not appear prolonged and this may only become apparent if ventilation is
interrupted. The infant's own respiratory efforts may also confuse the issue. In case 2,
low rates were tried without improvement and it was only when they were imposed
by the addition of pancuronium that success was achieved. It is tempting to assume
that the problems were simply due to the infant's reluctance to co-operate with the
ventilator. However, in case 4 the oxygen requirements did not fall after paralysis but
fell dramatically after the ventilator rate was reduced and later inadvertent peep was
observed when the infant was apparently comfortable and breathing quietly on PTV.
Our experiences suggest that unrecognised inadvertent PEEP may be a widespread
and serious problem. Although the techniques exist, we did not measure the actual
amount of inadvertent PEEP directly as this would be technically difficult in such sick
infants on such rapid respiratory rates. The actual level is not particularly important
once it is recognised that it is causing impaired gas exchange as the time constant,
expiration time or expired volume to atmospheric pressure will give sufficient
information to allow the ventilator to be adjusted appropriately.
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Diagnosis of RDS
Surfactant replacement is established as a proven, effective treatment for RDS on the
basis of a large number of well designed randomised controlled trials. There are
however a significant number of infants who either show a poor response to
surfactant or whose condition is apparently worsened following surfactant
administration. Various explanations have been put forward for this
phenomenon 254,225 Now that there is such an effective treatment for RDS it is to be
expected that the diagnosis may be made more frequently than before 54. Under these
circumstances more infants who are not surfactant deficient may receive treatment.
Case 5
A female infant was delivered vaginally at 34 weeks gestation with birth weight
1980g. Her mother had had ruptured membranes and chronic liquor leakage with
consequent oligohydramnios since 20 weeks gestation. She had received many
courses of dexamethasone prior to delivery. The infant was in good condition and was
not considered to need resuscitation before transfer to the neonatal unit. She was
noted to have marked bilateral talipes equinovarus, flexion contractures of the elbows
and knees and squashed looking facies. On arrival in the neonatal unit she was
cyanosed and was given facial O2. She required intubation and ventilation and it was
difficult to inflate her lungs without occluding the pressure relief valve on the
resuscitation bag. To achieve adequate ventilation she required ventilator pressures of
40/5 cmH20, inspiration time 0.8 s and her ventilator rate was set at 35 BPM. Chest
radiograph suggested small poorly inflated lungs and the clinical impression was one
of pulmonary hypoplasia. It was possible to reduce her pressures after a few hours to
32/6 cmH20 maintaining the inspiration time at 0.8 s. A repeat chest radiograph
showed some interstitial emphysema and the chest appeared a little bell shaped.
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After 6 hours of ventilation the FiC>2 was still 60% and the chest inflation still
appeared poor so in view of the infant's prematurity it was decided to give her
surfactant. Her ventilator settings at this point were 32/6 cmH20, inspiration time
0.8 s, rate 35 BPM. Her lung function was measured and it was immediately obvious
that although the chest movements with the ventilator were poor, when ventilation
was interrupted and the infant allowed to exhale to atmospheric pressure the chest
movement was large. The exhaled volume to atmospheric pressure was 15 ml/kg and
the flow-volume curve appeared very overdistended. The ventilator pressures were
reduced until the exhaled volume was in the range 5-10 ml/kg and satisfactory flow-
volume curves for compliance measurements were obtained. The compliance was
2.3 ml/cmH20/m (0.5 ml/cmH20/kg) indicating that although the compliance was
reduced it was not markedly so. The ventilator settings were pressures 17/3 cmH20,
inspiration time 0.5 s, rate 40 BPM. The infants 02 requirements rapidly fell to 30%
and there was no increase in PaC02- Surfactant was no longer considered to be
clinically indicated. The infant was extubated on day 3. The initial impression of
pulmonary hypoplasia was revised to dry lung syndrome 255>256.
Case 6
A male infant was delivered at 31 weeks gestation by Caesarean section for maternal
pregnancy induced hypertension with birth weight 1245g. He was ventilated from
birth and a chest radiograph was consistent with RDS. At 5 hours of age the ventilator
settings were 30 BPM, inspiration time 0.5 s and pressures 23/4 cmH20. The FiC>2
had been 60% since birth and the blood gases on these ventilator settings were
pH 7.42, Pa02 5.4 kPa, PaCC>2 4.66 kPa. It was decided to treat the infant with
surfactant. Crs before treatment was 2.7 ml/cmH20/m (0.86 ml/cmH20/kg)
indicating that the lungs were not stiff. This value is well above the level previously
associated with surfactant deficiency 63. The infant was in the study group whose
compliance data were not revealed.
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Exosurf was given and the infant's respiratory function steadily deteriorated. Three
hours after treatment the Crs had fallen to 1.6 ml/cmH20/m (0.53 ml/cmH20/kg).
The FiC>2 had increased to 90% on the same ventilator settings. Twelve hours after
treatment the Crs was 1.3 ml/cmH20/m (0.42 ml/cmH20/kg), and the infant was
requiring 98%02- He had been started on pancuronium, the ventilator rate had been
increased to 60 BPM and the pressures to 26/4 cmH20. A further dose of Exosurf
was given. Three hours later the Crs was 0.7 ml/cmH20/m (0.22ml/cmH2O/kg) the
FiC>2 was 85% and the ventilator settings unchanged. Twelve hours later the Crs was
0.6 ml/cmH20/m (0.2ml/cmH2O/kg), a value previously associated with a high risk
of death 59. No further surfactant was given. From this point onwards the respiratory
function gradually improved and ventilation was able gradually to be weaned. By day
6 the Crs had increased to 1.8 ml/cmH20/m (0.58ml/cmH2O/kg) and the infant was
ventilated on low rate and pressures and was breathing air. He was successfully
extubated the following day but went on to develop bronchopulmonary dysplasia and
was oxygen dependent until his expected date of delivery.
Discussion
These situations arose when the clinical impression was that the lungs were much
stiffer than the Crs suggested. This clinical impression was probably influenced by
the history in case 5 and the birth weight and gestation in case 6. The infant described
in case 5 would reasonably have been felt to have pulmonary hypoplasia and or
surfactant deficiency in the absence of lung function measurements, but the clinical
course once the ventilator was adjusted was not typical of either. Considered alone
and without the lung function data the clinical course seen in case 6 might seem
typical of severe RDS. However this infant was one of the 19 infants described in
chapter 4 with pre-surfactant Crs suggestive of biochemically mature lungs.
Seventeen of these infants showed a fall in Crs after surfactant treatment.
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Six of the 8 infants in this group that were treated with a slow infusion of Exosurf
showed increased oxygen requirements after treatment whilst the infants with low
compliance before Exosurf showed reduced oxygen requirements after treatment. The
median Crs measured in the 24 hours before successful extubation of 100 infants in
the randomised trial was 2.6 ml/cmH20/m. This infant was easily to ventilate before
treatment and became critically ill after successive doses of surfactant and his Crs
before treatment was 2.7 ml/cmH20/m (0.86 ml/cmH20/kg). It is most likely that he
never had surfactant deficiency and quite possible that surfactant treatment was
harmful in his case.
Given the poor agreement between estimates of Crs made by junior doctors and those
of their colleagues and between estimates of Crs made by junior doctors and
measured Crs that were demonstrated in chapter 2 it is not surprising that there were
cases where Crs measurements appeared to be clinically important. These are only
individual cases however and it is possible that there were other occasions when the
compliance data were rightly ignored as potentially misleading, although these were
not obvious. This collection of cases may reflect artificially well on the potential
usefulness of compliance measurements. Nevertheless they are persuasive and in
combination with the data presented in the preceding chapters are supportive of the
basic hypothesis that some form of lung function monitoring may have a place in
clinical care.
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Chapter 7: Summary and General
Discussion.
During the last decade neonatal intensive care has moved a long way forward in its
efforts to conquer the respiratory consequences of premature birth. The widespread
use of antenatal steroids means that far fewer infants than before develop respiratory
distress syndrome. Replacement surfactant dramatically improves the outlook for
those who do. Yet despite the improvements in equipment and expertise many infants
still die of respiratory disease and we still face the challenge of chronic lung disease.
The infants who are developing chronic lung disease are now considerably smaller
and less mature than those originally described by Northway 257 but our success in
keeping them alive means that this problem is increasing rather than decreasing10-21.
The annual cost of caring for infants with chronic lung disease in the United States
has been estimated at $2.4 billion 258.
It may be that not all of the increase in chronic lung disease can be attributed to
increased survival alone 259. There is certainly substantial variation between treatment
centres in its frequency. Avery et al260 compared the incidence of CLD between large
treatment centres in the United States. One centre had considerably less CLD than the
others. The only important difference that was identified in management style
between the units was that the successful centre had a policy of a gentler and more
permissive approach to mechanical ventilation with early institution of nasal
continuous positive airway pressure soon after birth.
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A recent retrospective analysis of the risk factors for the development of CLD in a
group of infants randomised into a multicentre surfactant study found a five times
higher risk of CLD to be associated with a low arterial carbon dioxide tension in early
life after controlling for known potential confounders 261. The interpretation of this
finding was that for a ventilated preterm infant with a diagnosis of RDS to have a low
carbon dioxide tension in early life, the recruited alveoli must be being over
ventilated and placed at higher risk of lung injury. Chronic lung disease is
undoubtedly multi-factorial in origin 258,262 but few wouici contest the central role of
mechanical ventilation. If as suggested lung injury caused by ventilation can be
decreased by more effective ventilator management this must be seen as a very
important goal.
The mechanical ventilation of newborn infants is a constantly evolving process. The
basic time cycled, pressure controlled continuous flow ventilators of the 1970's and
1980's are being joined by a new generation of ventilators that offer ever more modes
of support. As well as having to pick up the basic principles of respiratory physiology
and time cycled pressure controlled ventilation, the newcomer to neonatology may
now have to pick up the concepts of patient triggered ventilation (both assist control
and synchronised intermittent mandatory ventilation with various methods of
triggering), high frequency oscillatory ventilation, high frequency jet ventilation,
pressure support and volume controlled ventilation, as well as combinations of these.
Some of these newer ventilators are also beginning to incorporate varying degrees of
inbuilt respiratory function monitoring. Junior doctors are unlikely to develop real
expertise on so wide a front given the shortening of their training. Many of these
innovations are evolutions that grew up as imaginative solutions to perceived
shortcomings in the existing technology and as such they should be greeted with
enthusiasm.
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However none of them has yet emerged from rigorous real life evaluation with clear
evidence based on clinical outcomes to document their superiority over earlier
techniques. Medicine is already crowded with "established treatments": of uncertain
worth. There is a responsibility to prevent their number increasing. More and more,
"evidence based medicine" is seen as the standard of care of the future 263.
The objective of these studies was to evaluate the potential for regular measurements
of the static compliance of the respiratory system using the single breath technique to
improve the care and outcomes of mechanically ventilated newborn infants. There are
still no published studies demonstrating that any form of lung mechanics monitoring
could achieve this aim. There are already commercial systems obtainable for
measuring the lung mechanics using either dynamic or static techniques and many
small studies providing persuasive evidence that their introduction has the potential to
improve clinical care. The single breath technique was selected for these studies
because in comparison to dynamic techniques it appeared less complicated with
problems of inteipretation.
In the present studies the single breath technique was found to be safe in this
population of infants with over a thousand episodes of measurement being tolerated
without significant complications. No scientific study of the physiological effects of
the measurements was performed, but Simbruner et al264 found no significant effects
on heart rate, respiratory rate and oxygenation when they applied a similar technique
to a series of 12 newborn infants. Measurements of Crs in ventilated infants should
ideally be performed reasonably close to endotracheal suction to avoid any distortion
of the results by secretions so if the adoption of this technique required very frequent
measurements it would result in more episodes of suction and that might be harmful.
151
The technique has been described as "readily learned"63. The mechanics of operating
the apparatus and obtaining data recordings were not difficult but a large body of
knowledge has been amassed concerning every aspect of the methodology and its
pitfalls which the user needs to be familiar with. This would complicate its more
widespread introduction. Because of the problems of active infants, air leaks around
the endotracheal tubes, and lungs whose behaviour could not be described by a single
compartment model there were many occasions where measurements were not
successful. Other authors of studies using the single breath technique in ventilated
infants have acknowledged the failure of the technique in some infants but not
reported the failure rate. Fletcher et al138 were unable to record satisfactory Crs data
using the single breath technique in 5 of 16 older infants. Their infants were not
intubated. This failure rate is a serious disadvantage in comparison with on-line
dynamic techniques which will give at least some information all the time. The
success rate of individual studies could be improved by sedating or paralysing the
infants but if the technique is to be promoted for regular non-invasive monitoring
throughout the duration of mechanical ventilation this would not be practicable or
desirable.
In chapter 2 it was found that junior doctors estimates of Crs agreed poorly both with
one another and with an objective measurement. This should come as no surprise.
Other studies considering the clinical skills of doctors have been similarly
unimpressive 58. That they should adopt opposite poles on several occasions was
rather worrying. It is a concern of the Medical Educational Bodies that curricula are
becoming too heavily fact-laden with a consequent loss of available time for clinical
skill acquisition 265. With the shortening of post-graduate training, clinical skill levels
are unlikely to improve.
152
Clinical decision support systems are likely to develop increasing popularity provided
that they stand up to scrutiny. It would have been interesting to examine more
rigorously whether the judgements made by consultants were any better than those of
their juniors but this was not possible at the time of these studies.
In chapter 3 the principal finding of the randomised controlled trial was that the single
breath technique used routinely as an aid to management in 123 ventilated infants had
no effect on their outcomes in comparison to 122 control infants. The numbers of
adverse outcomes experienced by the two groups were very similar which makes it
difficult to entertain the possibility that this finding might represent a type I statistical
error. The finding of a significantly reduced duration of ventilation in survivors
accompanied by a similar but smaller (non-significant) reduction in the duration of
ventilation in the experimental group over the study as a whole suggests the
possibility of a type II error over this outcome. A larger multicentre study could be
planned to test this hypothesis. Were the hypothesis proven the difference in resource
usage between the two groups would certainly have the potential to result in
considerable cost savings nation-wide. It is doubtful whether such a study would be
attractive to other units. It would require a large investment of energy for a study that
would not be expected to improve the major outcomes of neonatology. There are
more pressing issues for collaborative study such as the use of nitric oxide, oscillatory
ventilation, pain management and corticosteroid treatment. It is possible that the study
design was not adequate to evaluate fully the potential of the technology. The results
of the measurements and their interpretation were simply written on the blood gas
sheets and it was left up to the clinicians to act according to their own judgement. A
more prescriptive approach might have worked differently. But if the technique were
ever to find its way into routine care it would be as a source of additional information
rather than as a prescriptive ventilation management system.
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Another potential confounder in the trial is that lessons learned from infants in the
experimental group may have been applied successfully to the infants in the control
group. Once several infants had been shown to improve greatly when their ventilator
settings were adjusted to avoid inadvertent PEEP, the clinicians became much more
wary of it and looked for it even in the absence of Crs data that suggested it.
In chapter 4 the reproducibility of the single breath technique was found to be
acceptable for clinical use and at least comparable to that of other techniques. This
was assessed in the two study investigators who had gained considerable experience
in the technique by this time. It remains to be seen whether any of the techniques
proposed for respiratory function monitoring in the sick newborn infant are as reliable
in the hands of a number of different members of the on-call staff who would by
necessity have less experience in their use. Ease of use would be an argument in
favour of automated on-line techniques.
In chapter 5 the finding that a value of Crs which predicted biochemical lung
immaturity in one study predicted the response to surfactant replacement in another
represented a biological validation of the objectivity of the technique. The finding of
improved Crs after Curosurf helps to explain the mechanism of action of surfactant
treatment in human infants with RDS. It is by no means the sole explanation however.
Just as the Exosurf treated infants showed some early clinical improvements a
number of infants showed good clinical response to Curosurf without showing
improved Crs. Possible explanations for this have already been discussed. The
difference in response between natural and artificial surfactant is likely to be
important. An increasing number of studies comparing natural and artificial surfactant
have been published. Considered alone they do not favour any one surfactant but
considered together the case for preferring naturally derived surfactant to artificial
surfactant is strengthening 266.
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The greater surface activity of natural surfactants appears to be attributable to the
presence of the apoproteins SP-B and SP-C. There is now interest in whether or not
the addition of the other apoproteins SP-A and SP-D will confer additional
benefits 267. Of 19 infants with initial Crs > 1.8 ml/cmH20 17 showed a fall in Crs
after surfactant treatment. This consistent finding promotes the hypothesis that there
may be a group of infants with a clinical diagnosis of RDS that can be identified
prospectively as being unlikely to benefit from treatment. They represent around 20%
of all infants currently treated. This finding requires prospective study. If pilot work
demonstrates that there is no obvious harm associated with non-treatment then a 20%
reduction in surfactant usage would be a worthwhile goal. Aside from the large cost
savings, surfactant administration is increasingly recognised as a significant stress to
the fragile infant at risk from intraventricular haemorrhage. This finding coupled to
the observations that clinical assessments of Crs tend to be poor suggests that this is
an area where some kind of lung function testing may have a real future. This is not
an issue if prophylactic treatment of RDS is the preferred approach but there is no
good evidence to suggest that prophylaxis is superior to very early selective rescue
treatment. The early changes in Crs after surfactant treatment were often quite large.
Certainly they were large enough to warrant alterations to the ventilator settings. It is
important to remember that these changes were undetectable using the on-line
dynamic techniques that are becoming popular, probably because of dynamic
pulmonary hyperinflation attributable to the positive end expiratory pressure being
applied 15.
What is the future for the clinical application of lung function testing in the neonatal
population? These studies would imply that there is unlikely to be a place outside the
research setting for the single breath technique as it currently stands. For research
purposes such as the evaluation of new treatments it has so far stood the test of time
as well as any other technique.
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Newer ventilators provide large amounts of information on tidal volume and minute
volumes and on pressure, flow and volume and their relationships with time. The
manufacturers are less quick to provide rigorous data on the accuracy of these
measurements over the ranges encountered or on their frequency responses and phase
relationships. There is a long way to go before it can be teased out just how much of
this information is useful and under what circumstances. This is an important research
priority as there is presently considerable information overload with these systems.
Given the increasing evidence that lung injury is caused by volume overdistension
there seems little doubt that measurements of volumes will find some place.
Interpretation of dynamic pressure-volume loops can provide useful information but
requires skill and experience. They may enable the detection of lung
overdistension111. There is a need for more data concerning their frequency
dependence. Flow-volume loops likewise may be helpful in determining changes in
resistance patterns and adequacy of the set expiration time. It is likely that such loop
appearances can be described mathematically and screened for by on-line computer
so that an appropriate warning message such as "over-inflation, consider reducing
inspiratory pressure" or "incomplete expiration, increase expiration time" can be
displayed and acted upon without the need for expertise in direct interpretation of the
loops. Work needs to be done on the sensitivity and specificity of algorithmic
analyses such as this before they can be introduced. The concern remains that these
approaches will not detect excessive end-expiratory pressure and that as a result even
"normal" tidal volumes may be seriously overinflating the lungs. It may be that more
readily applicable techniques for measuring FRC will enable this problem to be
overcome. Alternatively an integrated ventilator/monitoring system capable of
venting rapidly to atmospheric pressure would allow complete information about
expiratory volume to be obtained to complete the picture.
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Abstract
Static respiratory system compliance
(Crs) was measured by a single breath
passive expiratory flow technique in 73
newborn infants treated with exogenous
surfactant. The first 39 received Curosurf,
a natural porcine surfactant. The other 34
received Exosurf Neonatal, a synthetic
surfactant. All had a diagnosis of res¬
piratory distress syndrome with an
arterial/alveolar oxygen ratio <0-22.
Static Crs and arterial blood gases were
measured shortly before, and at three and
12 hours after the first dose of surfactant.
In 32 infants treated with Curosurf with
initial static Crs <1-8 ml/cm H20/m body
length, which is consistent with surfactant
deficiency, static Crs improved by 18% at
three hours and by 39% at 12 hours along
with a median reduction in fractional
inspired oxygen (Fio2) at three hours by
0-32. In 26 infants treated with Exosurf
with initial Crs <1-8 ml/cm H20/m, Crs
did not improve three and 12 hours after
treatment and oxygenation improved less
than after Curosurf, with a median reduc¬
tion in Fio, at three hours of 0-11. Fifteen
of the 73 (21%) infants had initial static
Crs of 3=1-8 ml/cm H20/m, not consistent
with surfactant deficiency. Thirteen of
these 15 infants showed a fall in static Crs
after surfactant" treatment, raising the"
question whether exogenous surfactant
did them more harm than good. Initial
static Crs and surfactant type both appear
to determine the early response to the first
dose of surfactant. Only a considerably
larger, randomised study can show which
surfactant is more effective in reducing
adverse clinical outcome.
(Arch Dis Child 1994; 70: F19-F24)
The early clinical response to exogenous sur¬
factant treatment is variable, but there is
usually a rapid improvement in oxygenation
and a reduction in requirements for ventilatory
support. Concurrent improvements in lung
mechanics have been demonstrated in
animals1"4 but most studies in ventilated
human infants have not shown consistent early
changes in lung mechanics after exogenous
surfactant.3"11 This inconsistency may reflect
differences both in methods ofmeasuring lung
mechanics in infants and between various sur¬
factants. Changes in dynamic compliarfte after
surfactant treatment are more susceptible to
distortion by ventilator management than
changes in static compliance measured con-
currendy in the same infants.12 Naturally
derived surfactants appear to have a more
rapid clinical effect than synthetic ones.4 We
report changes in lung mechanics in infants
treated with natural and synthetic surfactant,
using a single breath passive expiratory flow
technique to measure the static compliance of
.the respiratory system (Crs).
Patients and methods
SURFACTANT TREATMENT
Newborn infants admitted to the teaching
hospitals in Dundee and Edinburgh were
studied between August 1991 and August
1992 as part of a randomised controlled trial to
test the hypothesis that regular information
about respiratory mechanics improves clinical
outcome in mechanically ventilated neonates.
Infants from both centres were treated with
surfactant if between 2 and 72 hours of
age they required mechanical ventilation for
respiratory distress syndrome and had an
arterial/alveolar oxygen (a/A) ratio <0-22.
Between August 1991 and December 1991
infants were treated with Curosurf (Chiesi
Farmaceutici) according to the protocol of
Curosurf 4,13 a trial of alternative dose
"
regimens. From January 1992"to August 1992"
infants received ExosurfNeonatal (Wellcome).
Curosurf is a preparation of polar lipids,
isolated from minced pigs lungs. It contains
approximately 99% lipids, mainly phos¬
pholipids, and 1% low molecular weight
hydrophobic apoproteins SP-B and SP-C.14
Infants were randomly assigned to receive
either 1-25 or 2-5 ml/kg body weight (100 mg
or 200 mg/kg) with the aim of achieving rapid
distribution throughout the lung. Half*was
delivered into each main bronchus by position¬
ing the infant on one side before instilling
the surfactant intratracheally and continuing
mechanical ventilation in that position for one
minute. The procedure was then repeated on
the opposite side. Exosurf is a synthetic surfac¬
tant which contains 13-5 mg/ml of dipalmitoyl
phosphatidyl choline, 1-5 mg/ml cetyl alcohol,
1 mg/ml tyloxapol in 0-1 N sodium chloride
and no surfactant apoproteins.2 Over approxi¬
mately 20-30 minutes 5 ml/kg was adminis¬
tered into the proximal endotracheal tube. The
infants remained supine and mechanical venti¬
lation continued throughout. Exosurf was
F20 Stenson, Glover, Parry, Wilkie, Laing, Tamow-Mordi
administered more slowly than Curosurf to
reduce the risk of poorer tolerance of the larger
volume.
Oxygenation, ventilator efficiency index
(VEI), and static Crs were assessed in each
infant shortly before and as close as possible to
three and 12 hours after the first dose of sur¬
factant. Ail the infants were ventilated with
Sechrist IV 100b pressure limited, time cycled,
continuous flow ventilators. The investigators
were not responsible for the clinical care of the
infants. The study was accepted by the ethical
committees of both hospitals. Written
informed consent was obtained from one or
both parents before including their infant in
the study.
STATIC CRS MEASUREMENTS
Static Crs was measured using a computerised
passive expiratory flow technique as previously
described,15 using software developed at the
Children's Hospital, Toronto by Professor A C
Bryan, Dr M H Bryan, and Dr PNLe Souef.
To standardise for body size, Crs values were
corrected for body length because we had
found this slightly more accurate than correc¬
tion for weight in predicting both hospital
death and an immature lung phospholipid
profile.15 16 All Crs results were calculated as
the mean of 3-6 satisfactory breaths. Breaths
were only accepted if there was a clearly
defined pressure plateau (approximately 200
msec) after airway occlusion, if the linear
portion of the expiratory flow-volume curve
accounted for two thirds or more of the expira¬
tion, and if the correlation coefficient for the
slope of the asymptote to the flow-volume
curve was >0-996. Studies were only accepted
if they had a within-study coefficient of varia¬
tion between breaths of < 15% and no study
required exclusion on this criterion. In com¬
paring sequential studies on the same infant we
planned to conduct them all within a range of
expired volume of 5-10 fhl/kg body "weight!
Occasionally the expired volume was less than
this in infants with very stiff lungs. None of
these results was excluded, as subsequent
studies in these infants were conducted at
similar pressures or expired volumes.
Changes in Crs were expressed as percentage
differences of the pretreatment value. We
planned before analysis to subdivide the
infants according to whether or not their static
Crs before treatment was consistent with
surfactant deficiency (<1-8 ml/cm H20/m).16
OXYGENATION
Arterial oxygen tension (Pa02) was measured
intermittently by blood gas analysis.
Oxygenation was expressed as the fractional
inspired oxygen (Fio2) required at the time of
study to maintain the infants' arterial or con¬
tinuously monitored transcutaneous oxygen
tension between 6 and 10-3 kPa or their
oxygen saturation-between 90 and 94% by
continuous pulse oximetry. Transcutaneous
oxygen tension was calibrated against Pa02 by
intermittent arterial puncture.
VENTILATOR REQUIREMENTS
In order to adjust for variations in ventilator
settings between infants, we used the VEI
devised by Notter et al.17 This index estimates
alveolar ventilation in relation to ventilator set¬




where p is the inspiratory pressure minus the
expiratory pressure of the ventilator, f is the
ventilator rate in cycles per minute, and PaC02
is the arterial carbon dioxide tension in mm
Hg. VEI increases rapidly as ventilation
requirements become minimal. Therefore all
VEI values of > 1 were defined as 1 in the -
group comparisons.
STATISTICAL ANALYSIS
Results were analysed using SPSS-PC and
Minitab. Variables were compared three and
12 hours after treatment with their corres¬
ponding pretreatment value in paired group
analyses using the Wilcoxon matched pairs
signed ranks test. Distributions of each
variable were compared using the Mann-
Whitney U test. A two tailed probability
was accepted as statistically significant if
p<0-05.
Results
During the study period 111 infants were
treated with surfactant in the two centres. Of
these the 88 who were enrolled in this study
(table 1) did not differ significantly in import¬
ant prognostic characteristics. Pairs of Crs
measurements were made successfully in 73
of these 88 infants (83%). The reasons for
failure to obtain Crs data in the others were
(i) inability to obtain adequate pressure
plateaux after "airway occlusion "(either
because of air leaks around the endotracheal
tube or failure to induce a Hering-Breuer
reflex in active infants) or (ii) alinearity of the
flow-volume relationship. Of the 15 infants
without successful Crs measurements nine
received Curosurf and six Exosurf. There
were no statistically significant differences
between them and the babies in whom Crs
was measured successfully in birth weight,
gestational age, or oxygen requiremen? before
Table 1 Infants eligible for study, enrolled and successfidly
measured. Gender, gestation, birth weight, and length by




Gestation (weeks) 29 (23-37) 30 (23-38)
Birth weight (g) 1253 (580-3250) 1370 (600-4150)
Enrolled 48 40
M/F 31/17 26/14
Gestation (weeks) 29 (23-35) . 29 (25-38)
Birth weight (g) 1226 (580-2540) 1285 (607-4150)
Measured 39 34
M/F 26/13 21/13
Gestation (weeks) 29 (25-35) 29 (25-38)
Birth weight (g) 1253 (677-2540) 1285 (607-4150)
Length (cm) 38 (32-49) 40 (33-52)
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Symbols denote significant difference between groups (Mann-Whitney U).















treatment or in changes in oxygen require¬
ments and VEI after treatment with either
surfactant.
The mean (SD) within study coefficient of
variation in Crs between accepted breaths in
134 sequentially analysed studies was 6-7
(3-5)%. The mean (SD) difference between
the results of paired studies performed five
minutes apart by the same observer on 15
infants >12 hours after treatment with surfac¬
tant was 0-2 (10-5)%. The mean (SD) differ¬
ence between the results obtained by two
different observers analysing the same data,










Time (hours) Time (hours)
Figure 1 Changes after surfactant administration in infants toith initial Crs <1-8 ml/cm
HoO/m. Graphs show medians with 95% confidence intervals. Symbols denote significant
difference from value before treatment: *p<0-05, \p<0-0l, dp<0-005. %p—0-000l by
Wilcoxon signed rank test.
blind to the results obtained by the other in 71
randomly selected studies was 0-4 (7-4)%.
Of the 73 infants with valid Crs data, there
were no differences in the distributions of birth
weight, length, gestational age, oxygen require¬
ment, age at treatment, and static Crs before
treatment between those treated with Curosurf
and those treated with Exosurf (table 2). The
infants with initial values of static Crs suggest¬
ing surfactant deficiency (<1-8 ml/cm H20/m)
who received Exosurf had slightly greater ven¬
tilation requirements (VEI) before treatment
than those treated with Curosurf. There were
15 infants whose static Crs before treatment
was not consistent with surfactant deficiency
(5=1-8 ml/cm H20/m). They were significantly
heavier, longer, easier to ventilate, older at
time of treatment, and of later gestation than
those whose initial Crs was consistent with sur¬
factant deficiency.
The changes in Crs, oxygen requirements,
and VEI seen after treatment are shown in figs
1 and 2. Of the 58 infants with initial Crs
<1-8 ml/cm H20/m (fig 1) those treated with
Curosurf showed a median improvement in
Crs of 18% (p= 0-002) three hours after treat¬
ment increasing to 39% (p = 0-0001) at 12
hours. These changes were accompanied by
significant improvements in oxygenation and
VEI at both three and 12 hours. The infants
treated with Exosurf showed no statistically
-significant changes in Crs at three or—12
hours,- with median changes of -6-2%
(p= 0-24) at three hours and +5% (p = 0-28)
at 12 hours. Their oxygen requirements were
significantly lower at three hours than before
treatment but the VEI did not improve until
12 hours. The median reduction in oxygen
requirement was greater after Curosurf than
Exosurf both at three hours (change in Fio2
-0-32 compared with -0-11; p<0-001) and
at 12 hours (change in Fio2 -0-32 compared
with -0-13; p<0-005) after treatment. If the
Crs results for these infants are expressed in
absolute terms rather than as percentage
changes, the same pattern is observed with
median pretreatment Crs for the Curosurf
treated infants of 1-1 ml/cm H,0/m and
median change at three hours +0-2
(p= 0-0037), and median pretreatment Crs
for the Exosurf treated infants 1-1 ml/cm
H20/m and median change at three hours
-0-1 (p = 0-156). At each time point in fig 1
the medians and 95% confidence intervals for
each of the three variables were calculated
from the same infants except that there was
F22 Stenson, Glover, Parry, Wilkie, Laing, Tamow-Mordi
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Figure 2 Changes after surfactant administration in infants with initial Crs^l-8 ml/cm
H2O/m. Lines represent individual infants.
one missing data point for the VEI in an
infant treated with Exosurf.
Of the 15 infants with initial Crs 3=1-8
ml/cm H20/m (fig 2), all eight treated with
Exosurf and five out of seven treated with
Curosurf showed a fall in Crs after treatment.
The infants treated with Curosurf showed an
overall reduction in their oxygen requirements
while those treated with Exosurf did not.
There was no consistent pattern to the changes
in the VEI.
Discussion
In this study infants diagnosed as respiratory
distress syndrome with a/A ratio <0-22 showed
rapid improvements in static Crs, oxygenation,
and ventilation requirements after porcine
surfactant if their initial static Crs was consis¬
tent with surfactant deficiency. A similar group
of infants showed no improvement in static
compliance, a smaller improvement in oxy¬
genation, and no significant reduction'in venti¬
lation requirements over the same time after
synthetic surfactant. It should be stressed that
these two groups were not randomly assigned
to natural or . synthetic surfactant, so this
comparison should be interpreted with cation.
However, the results are consistent with
individual studies of naturally derived12 and
synthetic surfactants1:1 using the same methods
in human infants and with randomised studies
in animals.4 Improved pulmonary pressure-
volume characteristics are therefore likely to be
an important factor in the rapid clinical
improvements seen after natural surfactant.
Several clinical studies on ventilated human
infants have failed to show rapid improvements
in lung mechanics that would explain the
immediate improvements in gas exchange seen
after surfactant treatment.'-11 Some of these
studies involved infants treated with synthetic
surfactant,3 6711 which may have slower effects
on lung mechanics than natural surfactant.
Three considered infants treated with natural
surfactants, who showed rapid improvements
in oxygenation but no concurrent improve¬
ments in dynamic compliance during ventila¬
tion.8-10 The improvements in gas exchange
have been attributed to documented improve¬
ments in functional residual capacity (FRC).
■ These'observations and conclusions may partly
reflect the limitations inherent in measuring
dynamic compliance. When positive end ex¬
piratory pressure is being applied to compliant
lungs, they may remain sufficiently distended
at end expiration to cause the lungs to operate
higher up on the flatter part of the pressure
volume curve during ventilator breaths. Under
these circumstances there might be no net
improvement in dynamic compliance but a
large improvement in FRC and hence oxygena¬
tion. The passive expiratory flow technique for
measuring static compliance avoids this
problem by measuring expired volume from
peak inflation to zero (atmospheric) pressure.
This has recently been elegandy demonstrated
by Kelly et al who measured compliance by
both methods in a population of infants treated
with a naturally derived surfactant and demon¬
strated significant improvements in static com-
—ptiance "without-' improvements "in dynamic "
compliance.12 If the lungs are operating on the
flat upper portion of the pressure volume curve
because of excessive peak inflation pressure,
however, this would lead to underestimation of
changes in both dynamic and static compli¬
ance. Indeed Kelly et al reported improvements
in both static and dynamic compliance when
peak inflation pressure was reduced after
surfactant treatment.12
Infants in this study are unlikely to have
been ventilated with excessive peak inflation
pressure as their expired volumes, extrapolated
to zero flow and atmospheric pressure, were
5—10 ml/kg body weight or less. Although
static Crs in respiratory distress syndrome
improved after treatment and oxygen require¬
ments often decreased substantially in this
study the infants still required to be ventilated,
often vigorously, and their respiratory compli¬
ance did not reach the levels seen in infants
without lung disease. Surfactant therefore
alleviated but did not cure their respiratory
distress syndrome.12
Part of the difference in the speed of
response that we observed between the two
surfactants in our study may reflect differences
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Figure 3 Crs corrected to weight (kg) in relation to Crs
corrected to length (m).
in the methods of surfactant administration.
Nevertheless, rapid response to a surfactant
may not lead to improvements in adverse
clinical outcome. In the Curosurf 4 trial for
example, oxygenation and ventilation require¬
ments improved faster in infants given an
initial dose of 200 mg/kg of surfactant than in
those given 100 mg/kg but there was no clear
difference in mortality or major morbidity
between them.13
The observations that in 15/73 (21%) of the
infants static Crs was consistent with mature
lungs (3*1-8 ml/cm H20/m16) before surfactant
treatment and that in 13 of them static Crs fell
after treatment raise important questions.
Should they have received surfactant? Did it do
more harm than good? Are clinicians being
tempted to overdiagnose respiratory distress
syndrome now that an effective treatment is
available?18-20 These 15 infants may have had
respiratory problems other than respiratory
distress syndrome, which can be difficult to
discriminate on an early chest radiograph. If
so, the apparently poorer lung mechanics and
gas exchange of the eight 'mature' infants after
Exosurf may have reflected the adverse effects
of the greater volume of fluid instilled into their
lungs. The seven mature infants treated with
Curosurf still showed a reduction in their
oxygen requirements, which might reflect
more rapid clearance of administered fluid and
continuing improvement in their underlying
condition. Larger numbers are required to
validate these observations.
Should static Crs be corrected for length or
for weight? The lack of improvement in static
Crs after surfactant treatment in 13 infants
classified as mature (with static Crs >1-8
ml/cm H20/m) seems consistent with the
behaviour of mature lungs. However, had we
instead corrected static Crs for weight using a
predefined cut off for lung maturity of 3=0-54
ml/cm H20/kg based on previous work,16 only
five infants would have been identified as
having mature lungs (fig 3). Furthermore, six
out of the eight infants treated with Exosurf
whose lung mechanics and gas exchange did
not improve would have been identified as
immature, which seems inconsistent with their
lack of response to surfactant.
This supports the suggestion that correction
of static Crs for weight may slightly over¬
estimate the disease severity of larger infants
relative to smaller ones.lD In this and two;
other studies therefore,15 15 correction of
static Crs for length appears to have been
more informative than correction for weight.
This may be important in planning future
studies. Nevertheless until reliable data from
randomised trials are available, we would urge
caution in giving or withholding surfactant on
the basis of a single lung function test.
-In summary, this study describes early
responses to treatment with two surfactants.
The results do not provide definitive evidence
in favour of either. There may be moderate but
important differences in major clinical out¬
comes between natural and synthetic surfac¬
tants, but to demonstrate them reliably would
require international collaboration. For
example, a sample of 4000 would be needed to
detect a reduction in the risk of death or
bronchopulmonary dysplasia in high risk
infants from 67% to 62% with 90% power at
2p=0-05.21 Respiratory distress syndrome
remains a common and disabling condition.
Detecting differences of this magnitude is
logical and feasible18 and poses a worthwhile
challenge to the international community.
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Crs technique is available from WOT-M at cost price.
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LIFE-THREATENING INADVERTENT
POSITIVE END-EXPIRATORY PRESSURE
Ben J. Stenson, M.R.C.P., Rebecca M. Glover, M.R.A.C.P,
Rosalie A. Wilkie, F.R.C.P.E., Ian A. Laing F.R.C.P.E.,
and William 0. Tarnow-Mordi, M.R.C.P.
ABSTRACT
Inadvertent positive end-expiratory pressure (PEEP) is a potential cause of lung
overdistension and impaired gas exchange in ventilated infants. It can be extremely
difficult to diagnose clinically and if unrecognized can be life-threatening. Measurement
of lung function can lead to the recognition of inadvertent PEEP, allowing appropriate
ventilator adjustment with immediate substantial improvement in clinical state. Lung
function measurements can help to optimize ventilation and may improve clinical
outcome.
Keywords: Positive end-expiratory pressure; gas exchange; lung distension; ventilation
During mechanical ventilation, when lung inflation
occurs before the preceding deflation is completed, gas is
trapped in the lungs. The trapped gas increases the lung
volume and exerts a positive pressure within the airspaces,
which is not apparent clinically. The phenomenon is called
inadvertent positive end-expiratorv pressure (PEEP).1'2
Respiratory dead space increases, impairing gas exchange.
Tidal volume decreases because the effective difference
between the inspiratory and expiratory pressures is re¬
duced. Cardiac output may be impaired by the increase in
intrathoracic pressure.3
Passive expiration occurs exponentially and the time
required is determined bv the expiratory time constant.4
This is the mathematical product of the compliance and
resistance of the respiratory system. The time constant de¬
scribes the time taken for 63% of the lung volume above
functional residual capacity to be passively exhaled. After
three time constants, expiration is 95% complete and clini¬
cally important gas trapping is unlikely. Increases in compli¬
ance or resistance lengthen the time constant and thereby
prolong the time required for efficient expiration. Long
expiration times are especially likely to be required where
compliance is not severely impaired but airway resistance is
high, as may be the case in chronic lung disease.
Lung function can be measured in ventilated infants
using the single breath passive expiratory flow technique.5'6
An airway occlusion during inspiration is used to induce a
Hering-Breuer reflex. This briefly inhibits the respiratory
muscles and during the pause in respiratory activity the
infant is allowed to exhale passively to atmospheric pres¬
sure. The characteristics of the relaxed expiration are used
to calculate the compliance, resistance, and time constant
of the respiratory system.
Inadvertent PEEP can be extremely difficult to diag¬
nose clinically. We report on three infants in whom it was
life-threatening. Lung function testing aided its recogni¬




A male infant was delivered at 25 weeks' gestation with
birthweightof890g. He required ventilation and remained
ventilator dependent. On day 26, his respiratory function
deteriorated. The chest radiograph showed bilateral hazy
opacification and he was treated with antibiotics. By day 32,
his ventilator settings had gradually increased to 50 breaths
per minute, with inspired oxygen concentration 60%, and
he was started on dexamethasone. Over the next 3 days, he
deteriorated further. His oxygen requirements rose to 90%
and the ventilator rate was increased to 60 breaths per
minute with pressures 24/5 cm H20 and inspiration time
was 0.45 seconds. The infant was critically ill and hypoxic.
He was reintubated without improvement. Lung4unction
measurements were obtained (Fig. 1). Respiratory system
compliance was 3.2 rnL/cm H„0/m body length (1.0
mL/cm LLO/kg) which is within the normal range. The
time constant was 0.26 seconds, giving a time for 95%
exhalation of 0.78 seconds (3 time constants). The ventila-
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chanics could not be calculated because the flow volume
trace was very irregular (Fig. 1), but the expiratory flow-
time trace (Fig. 2) showed extremely prolonged expiration.
The expired volume was 23 mL/kg, indicating marked
overinflation. The infant was paralyzed and the ventilator
set at 20 breaths per minute, pressures 25/4 cm H,0,
inspiration time 0.6 seconds. His condition stabilized im¬
mediately. It was now easy to see the prolonged expiratory
phase and an obvious wheeze was audible that had not been
detectable earlier. Four hours later, the arterial PCO, had
fallen to 23 mm Hg and the inspired oxygen concentration
was 52%. The presumed cause of deterioration was infec¬
tion, but this was not proven. The infant remained on low
rate ventilation with low oxygen requirements and was ex-







Figure 1. Passive expiratory flow-volume curves. The
slope of the straight line extrapolated to the axes in case 1 is
equal to the time constant of the respiratory system.
Case 3
A male infant was delivered at 27 weeks' gestation with
birthweight 750 g. He had no early lung disease and was
extubated on day 1. On day 5, his respiratory function
deteriorated. The chest radiograph showed bilateral hazy
opacification. He was treated with antibiotics and was venti¬
lated with low rate pressures and oxygen concentration. By
day 10, the chest radiograph showed a honeycomb appear¬
ance bilaterally. He continued to deteriorate and on day 14
dexamethasone was started. There was no significant im¬
provement and from days 14 to 19 he required more than
90% oxygen. By this time, the ventilator settings had in¬
creased to 55 breaths per minute, pressures 24/4 cm H,0,
inspiration time 0.5 seconds, and 100% oxygen. Reintuba-
tion made no difference. Arterial blood gases showed pH
7.39; PCO.,, 38 mm Fig; and PO„ 55 mm Hg. There was no
clinical improvement with nebulized ipratropium bromide.
tor settings allowed 0.55 seconds. The expired volume was
14.4mL/kg body weight (normal tidal volume is 7 to 9 mL/
kg7). These findings indicated gas trapping and inadver¬
tent PEEP. The ventilator rate was reduced to 40 breaths
per minute and the pressures to 16/4 cm H,0 with inspira¬
tion time of 0.45 seconds. The infant's oxygen require¬
ments fell immediately to 50% with no increase in arterial
partial carbon dioxide pressure (PCO,) and over the-next
18 hours continued to fall to 25%. The infant was extubated
into head-box oxygen 3 days later.
Case 2
A male infant was delivered at 27 weeks' gestation with
birthweight of 1089 g. He received surfactant for respira¬
tory distress syndrome and was extubated on day 10. On clay
30, he deteriorated with recurrent apnea and increasing
oxygen requirements. The chest radiograph showed bilat¬
eral patchy consolidation. He was ventilated and stabilized
on ventilator settings of 20 breaths/min, pressures 22/4 cm
H20, and 30% oxygen. The next day he became increas¬
ingly difficult to ventilate. Neither fast nor slow rate ap¬
proaches prevented him from deteriorating and requiring
manual ventilation.
.Arterial blood gases showed pH 6.9; PCO,, 138 mm
Hg; partial oxygen pressure (PO,) 59 mm Hg; base excess,
— 8.2 mmol/L. He was reintubated without improvement.
Later that day, it was only possible to maintain gas exchange
by manual ventilation with 100% oxygen and he was hand-










(c) Infant in recovery phase of RDS
time (s)
Figure 2. Airway pressure- and expiratory flow-time.
Cases 2 and 3 with tracing from an infant recovering from
RDS for comparison. — Proximal airway pressure during
ventilation. Recording stops when ventilation is interrupted
to sample passive expiratory flow. Passive expiratory
flow from peak inflation to atmospheric pressure.
\
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Because of his respiratory efforts, lung- function measure¬
ments were impossible until he was paralyzed.
The expiratory flow-time trace showed markedly pro¬
longed expiration (Fig. 2) and the volume expired to atmo¬
spheric pressure was 17.5 mL/kg, indicating gas trapping.
The infant was ventilated at 25 breaths per minute with
pressures 24/4 cm H20 and inspiration time of 0.6 seconds.
His oxygen requirements fell rapidly and were 30% 5 hours
later, with a minimal increase in arterial PCO,. Pancuro¬
nium was discontinued after 3 days and the infant was
extubated on day 37.
DISCUSSION
Inadvertent PEEP is often detectable in ventilated in¬
fants if measurements are made,2 but the degree of clinical
importance attached to it is variable.8 Such severe clinical
problems in relation to it have not been reported in the
newborn. The airway obstruction common in chronic lung
disease makes inadvertent PEEP especially likely to occur
but any cause of increased airway resistance such as a
kinked or blocked endotracheal tube or reactive airways
can lengthen the time required for expiration and poten¬
tially result in inadvertent PEEP. In the three cases de¬
scribed the problems evolved gradually and the ventilator
rates had been increased slowly in response to respiratory
acidosis, which developed at lower rates. Chest hyperinfla¬
tion was not apparent clinically or radiologically. Chest
movement with the ventilator was poor and expiration did
not appear prolonged. This may have been because gas
trapping can force tidal volume exchange to occur further
up the lung pressure-volume curve in its flatter portion
where compliance is reduced and resistance may also be
lower.2-9 This would tend to make the early part of expira¬
tion appear rapid. Under these circumstances, expiration
during the time allowed by the ventilator settings may not
appear prolonged and this may only become apparent if
ventilation is interrupted to allow complete expiration.
Even then, the infant's own respiratory efforts may still
confuse the issue. In case 2, low rates were tried without
improvement and it was only when they were imposed by
the addition of pancuronium that success was achieved. It is
possible that in cases 2 and 3 asynchronous ventilation was
contributing to the problem. Both infants were given pan¬
curonium. However, lung function testing indicated lung
overdistension and a prolonged expiratory phase and gas
exchange improved markedly when the ventilator rate was
slowed.
Simbruner2 demonstrated improved respiratory sys¬
tem compliance using a fixed tidal volume when inadver¬
tent PEEP was decreased. He measured the compliance at
the lung volume immediately above that generated by the
inadvertent PEEP. He concluded that reducing the over¬
distension had allowed the lung to operate in a more effi¬
cient region of the pressure-volume relationship. This find¬
ing would not be demonstrable using the single breath
technique as it allows complete exhalation to atmospheric
pressure and therefore the trapped gas that is generating
the inadvertent PEEP is also exhaled.
The single breath passive expiratory flow technique
may allow measurement of the time constant-and- facilitate
adjustment of the expiration time to avoid inadvertent
PEEP, but it is often not applicable in infants with severe
chronic lung disease. The technique requires the passive
expiratory flow-volume trace to be linear over the expired
volume range. In cases 2 and 3 this was not so. The trace in
case 1 (Fig. 1) was predominantly but not completely linear.
There is no clear consensus as to exactly what proportion of
the trace needs to be linear for this technique to be used.
In addition, the placement of a straight line over the flow-
volume trace is subjective and allows some small variation in
the values obtained.
Despite the difficulty of applying the single breath
technique in full in two of these infants, the apparatus
supplied important information that allowed effective ven¬
tilator adjustments that were followed by marked clinical
improvements. Our experiences suggest that potentially
life-threatening inadvertent PEEP may frequently remain
unrecognized. Crib-side measurements of lung function
may improve the management of ventilated infants.
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Abstract Objective: To assess the
reliability of estimates of static re¬
spiratory system compliance (Crs)
made by junior hospital doctors
caring for ventilated newborn in¬
fants.
Design: A prospective comparison
of junior doctors' estimates of Crs
to the Crs measured immediately
afterwards.
Setting: A regional neonatal inten¬
sive care nursery in Edinburgh,
Scotland.
Patients: 46 ventilated newborn in¬
fants.
Measurements and results: Crs was
estimated by three grades of junior
doctor (Senior House Officer, Reg¬
istrar and Research Fellow) using
two different methods, (i) based on
visual assessment of tidal volume in
relation to inflation pressure (opti¬
cal Crs) and (ii) directly using a vi¬
sual analogue scale, (analogue Crs).
The Crs was then measured imme¬
diately afterwards using the single
breath passive expiratory flow tech¬
nique. The differences between the
estimates and the measurements
were calculated for each grade of
observer and plotted against the
corresponding measurements. The
relationship between estimates and
measurements was also expressed in
terms of the coefficients of deter¬
mination r2 calculated by least
squares regression. With both meth¬
ods of estimation observers tended
to overestimate the Crs of infants
with lower measured Crs and un¬
derestimate that of infants with
higher measured Crs with many es¬
timates differing from the measure¬
ments by more than 50%. Values of
r2 ranged from 0.086 to 0.481 indi¬
cating a weak relationship between
the estimates and the measure¬
ments.
Conclusions: Junior doctors' esti¬
mates of Crs were unreliable and
did not represent a useful method
of assessing respiratory function.
The clinical use. of compliance-meat
surements merits wider evaluation.
Key words Pulmonary function
testing • Lung compliance
Introduction
Whenever an infant is mechanically ventilated the person
adjusting the ventilator makes an informal appraisal of
the lung mechanics by visually estimating the chest infla¬
tion. Estimates of static respiratory system compliance
(Crs) based on clinical assessment of chest inflation have
been proposed as a useful aid to ventilator management
in neonatal intensive care [1, 2], The reliability of clinical
judgements is likely to vary with clinical experience and
estimates made by the junior doctors who provide much
of the care to ventilated infants may be less reliable than
those of their seniors. It can be difficult to make an accu¬
rate diagnosis from a chest radiograph [3], Blood gas
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tings rather than what they might ideally be and over-ven¬
tilation can. substantially worsen gas exchange [4], Given
the subjective nature of the clinical information available,
objective lung function data such as Crs measurements
might help to optimise ventilation strategy. But if junior
doctors could reliably judge Crs then the additional in¬
fant handling and equipment costs associated with the
measurements however minimal would be hard to justify.
This study was designed to determine whether the junior
doctors in a regional neonatal intensive care unit can
make reliable clinical estimates of static respiratory sys¬
tem compliance.
[t 1}. The optical estimates and measurements were compared to
one another using their actual values. For the purposes of compari¬
son to- the analogue scale all measured Crs values that were greater
than 2.5 ml/cmFhO/m were called 2.5. Each observer was blind to
the estimates made by the others.
Crs measurements
Immediately following the estimates, Crs was measured by the re¬
search fellow (BJS) using the single breath passive expiratory flow
technique as previously described [4-6, 12]. This was then divided
by the infant's crown-heel length measured with a tape measure
(±1.5 cm) or birth weight in kg for comparison to the estimates.
Materials and methods
A total of 46 ventilated newborn infants were studied prospectively
in the Simpson Memorial Maternity Pavilion, Edinburgh between
September 1992 and June 1993. Infants were eligible for inclusion
if on the first day of life the Senior House Officer (SHO), Registrar
and Research Fellow were simultaneously available to estimate Crs
and no preceding Crs measurements had been made. Written paren¬
tal consent was obtained in all cases. The study was conducted
according to the principles established in Helsinki and with the
approval of the local ethics committee. Crs was estimated using two
methods and the estimates were compared to the measured Crs ob¬
tained immediately afterwards.
Crs estimates
The methods of estimation were: (a) optical Crs, and (b) analogue
Crs. Optical Crs is based on assessment of tidal volume [1, 2]. The
examiner placed the chest inflation observed with each ventilator
breath into one of three categories: less than normal and barely visi¬
ble, approximately normal, or greater than normal and distinctly
visible (normal being that observed in a healthy newborn infant
breathing spontaneously). A tidal volume of 5, 7.5, or 10 ml/kg
body weight was assigned accordingly. The values obtained were
divided by the inflation pressure (peak inspiratory pressure minus
positive end-expiratory_pressure)_jo_give the opticaLcompliance
funits ml/cmH20/kg body weight). Analogue compliance was esti¬
mated by marking a point on a linear scale corresponding to what
the observer thought the Crs would be (Fig. 1). The scale described
Crs values ranging from 0.4 (severely abnormal) to 2.5 ml/
cmH20/m body length (functionally normal). Crs values were ex¬
pressed on the analogue scale in relation to body length as Crs is
routinely corrected for length in our unit [4-6], In our experience
infants recovering from lung disease can usually be extubated and
are often breathing air by the time their Crs has reached 2.5 ml/
cmHjO/m but newborn infants with entirely normal lungs have a
Crs of around 5-8 ml/cmH,0/m [7-10] or 1 - 1.6ml/cmH20/kg
Statistical methods
The difference between each Crs measurement and the correspond¬
ing Crs estimate was calculated (measurement minus estimate) and
plotted against the measurement. In addition, the relationship be¬
tween the estimates and measurements was assessed by the coeffi¬
cients of determination (r2) calculated from least squares regres¬
sion. Statistical calculations were made by computer using Statview
II.
Results
Complete data were obtained from 46 infants. Their char¬
acteristics are described in Table 1.
Figures 2 and 3 show the differences between each
measurement and the corresponding estimates plotted
against the measurements. The observations of all 3
grades of examiner are combined in each plot as the pat¬
terns were similar between observers. Both methods of es¬
timation produced a similar distribution of observations
with a tendency for examiners to overestimate the compli¬
ance of the infants with the lowest measured compliance
and underestimate the compliance of the infants with the
highest measured-compliance. -The estimates- often dif¬
fered by considerably more than 50% of the measured
compliance. Table 2 shows the coefficients of determina¬
tion (r~) of the relationships between the measurements
and estimates for each grade of examiner and each meth¬
od of estimation. In all cases the measurements and esti¬
mates were only weakly related with r2 values ranging
from 0.086-0.481. Of the 46 infants, 6 (13%) had mea¬
sured Crs values > 2.5 ml/cmFUO/m. The values were
2.6, 2.8, 3.3, 3.5, 5.4, and 7.9.
0.6 Or less* 1.8 Or more §
(very stiff lungs) (minimal or no lung stiffness)
Fig. 1 Analogue scale for estimating Crs. *Crs<0.6ml/
cmHjO/m means high risk of death from lung disease [4],
§ Crs> 1.8 ml/cmH-,0/m implies normal lung phospholipid profile
[5]
Table 1 Patient characteristics expressed as median (range)
n 46
Gestational age (weeks) 31 (25-41)
Birth weight (kg) 1.496 (0.533 — 4.050)
Length (cm) 40 (29 - 57)
Crs (ml/cmH20) 0.518 (0.191 - 3.782)
Crs (ml/cmH20/kg) 0.358 (0.188 — 1.15)
Crs (ml/cmH,0/m) 1.3 (0.5-7.9)
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Fig. 2 Difference between measured and optical Crs. Dotted diag¬
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Fig. 3 Difference between measured and analogue Crs. Dotted
diagonal lines denote±50% of the measured Crs
Table 2 Relationship between optical or analogue estimates and
measurements of static respiratory system compliance. The coeffi¬
cients of determination (rl) from least squares regression analysis
are shown
Observer Measured and optical Measured and analogue
Crs Crs
SHO r2 = 0.086 r2 = 0.400
Registrar r2 = 0.184 r2 = 0.194
Research fellow r2 = 0.254 r2 = 0.481
In this study-junior doctors^ estimates©! static respirato¬
ry system compliance were unreliable. Neither method of
estimating Crs performed within sufficient limits of accu¬
racy to represent a realistic alternative to direct measure¬
ment.
The single breath passive expiratory flow technique for
measuring Crs has been used in ventilated infants by
many investigators and the Crs values in this study fell
within the published ranges of diseased and normal in¬
fants. Although the scatter plots suggest that neither
method for estimating Crs was clearly superior the r2
values favoured the analogue estimates. This may be
largely attributable to the upper limit of the analogue
scale being at a Crs of 2.5 ml/cmH20/m. By assigning a
value of 2.5 to the six measured Crs values above 2.5, in¬
accuracies that may have occurred over a wider range
were avoided. If the results are reanalysed excluding these
6 datapoints the r2 values are much closer to those of the
optical estimates (SHO r1 = 0.342, Registrar r2 = 0.081,
Research Fellow r = 0.267).
The two other studies in the literature examining the
abilities of doctors to estimate compliance [1, 2] conclud¬
ed that estimates of optical compliance were closely cor¬
related with measured compliance and may therefore be
clinically useful. Both studies used correlation coeffi¬
cients to describe the relationship between the measure¬
ments and estimates and neither expressed the Crs values
in relation to the size of the infants. The second study
also used the mean difference between the estimates and
measurements plus or minus one standard deviation as a
measure of agreement. Of the 45 data points in that study
15 fell outside those limits (as would be expected). Of the
differences between the estimates and measurements 95%
should lie between the mean difference±2 standard devi¬
ations. These limits would have been approximately
-55% to +41%. The estimates were made by a senior
neonatologist and the limits of agreement were consider-
~ably~narrower than those achieved by the junior doctors
in this study but they are still quite wide.
Expression of compliance values in relation to infant
size is important for two reasons. Firstly, in normal indi¬
viduals compliance is proportional to lung and body size
so large infants have a higher compliance than small in¬
fants. Only by expressing the compliance values in rela¬
tion to infant size do they truly become a comparative
measure of disease severity. Many investigators correct
compliance measurements to body weight. We have foun$
in other studies in this age group that correction to body
length may be of marginally greater predictive value
[4-6], hence the development of the analogue scale cor¬
rected for length. Secondly the correlation coefficient be¬
tween two variables will improve as the range of observa¬
tions widens [13]. Compliance values are spread over a
much wider range if they are not expressed in relation to
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body size. If the optical estimates and measurements in
this study were considered without correcting them for
body weight the range of observations would have been
more than 3 times as broad and the r2 values would have
been 0.491 (SHO), 0.587 (Registrar) and 0.572 (Research
Fellow). The ranges of observations for the Crs measure¬
ments corrected to body length (0.5-2.5, i.e. five fold)
and weight (0.188-1.15, i.e. six fold) were similar.
The trend for the compliance of the sickest infants to
be overestimated and of the healthiest infants to be un¬
derestimated by both methods is a reflection of the ten¬
dency of the observers to select values in the middle of the
range in the majority of infants. 105/138 (76%) of the
optical estimates were for the middle tidal volume option
and the standard deviation of the analogue estimates was
considerably narrower than that of the compliance mea¬
surements. This was also the finding of Aufricht et al. in
an inexperienced observer [2]. If the poor reliability of the
estimates is due to lack of clinical expertise or confidence
it is difficult to speculate on ways of improving the meth¬
ods of estimation to overcome this.
The measured Crs may not be the gold standard. The
more important question is what gives the best indication
of disease severity and is most useful in clinical practice.
It should be stressed that there is as yet no data which
clearly demonstrates that Crs measurements can improve
the outcome of neonatal intensive care. In 1982 Crs mea¬
surements were found to measure reliably disease severity
and predict outcome [14]. Another study has confirmed
these findings although the Crs value associated with" a'
high risk of death has lowered with time. This study also
suggested that Crs may be a better measure of disease se¬
verity in ventilated infants than oxygen requirements [4],
Crs measurements can identify biochemical lung immatu¬
rity [5] and measure the response to surfactant treatment
[6, 15]. They have been used to measure the effects of
bronchodilators [16] and may identify infants suitable for
extubation [17]. Automated systems for measuring pul¬
monary function are becoming increasingly available. If
Crs measurement is to become more widely used to assist
clinical management then substantial evidence that it can
improve clinical outcome is required. This should be
properly assessed in the context of a randomised con¬
trolled trial.
Acknowledgement The Authors would like to thank Dr. R. Elton
for his assistance with the statistical presentation of the data.
References
1. Aufricht C, Kohlhauser C, Simbruner
G (1990) Comparison of bedside meth¬
ods to assess lung mechanics in ventilat¬
ed neonates: inflation pressure, amount
of ventilation and optical compliance
versus measured compliance. Wien Klin
Wochenschr 102:307-309
2. Aufricht C, Huemer C, Frenzel C, Sim¬
bruner G (1993) Respiratory compli¬
ance-assessed from chest expansion ancf
inflation pressure in ventilated neo¬
nates. Am J Perinatol 10:139-142
3. Morrison SC (1988) Radiologic find¬
ings of newborn respiratory diseases.
In: Carlo WA, Chatburn RL (eds) Neo¬
natal Respiratory Care, 2nd ed. Year
Book Medical Publishers, Chicago, pp
289-319
4. Tarnovv-Mordi W, Wilkie R, Reid E
(1994) Static respiratory compliance in
the newborn I: A clinical and prognos¬
tic index for mechanically ventilated in¬
fants. Arch Dis Child 70:F 11 — F 15
5. Wilkie RA, Bryan MH, Tarnow-Mordi
WO (1994) Static respiratory compli¬
ance in the newborn II: its potential for
improving the selection of infants for
early surfactant therapy. Arch Dis
Child 70:F 16 —F18
6. Stenson BJ, Glover R, Parry G, Wilkie
RA, Laing IA, Tarnow-Mordi WO
(1994) Static respiratory compliance in
the newborn III: early changes follow¬
ing surfactant therapy. Arch Dis Child
70:F 19—F24
7. Thomson AH, Beardsmore CS, Silver¬
man M (1985) The total compliance of
the respiratory system during the first
year of life/ BuirEur"~Physiopathol
Respir 21:411-416
8. Haouzi P, Marchal F, Crance JP,
Monin P, Vert P (1991) Respiratory me¬
chanics in spontaneously breathing
term and preterm neonates. Biol Neo¬
nate 60:350-360
9. Olinsky A, Bryan AC, Bryan MH
(1976) A simple method of measuring
total respiratory system compliance in
newborn infants. S Afr Med J
50:128- 130
10. Gappa M, Rabbette PS, Costeloe KL,
Stocks J (1993) Assessment of passive
respiratory compliance in healthy
preterm infants: a critical evaluation.
Pediatr Pulmonol 15:304-311
11. American Thoracic Society, European
Respiratory Society (1993) Respiratory
mechanics in infants: physiologic evalu¬
ation in health and disease. Am Rev
Respir Dis 147:474 - 496
12. LeSouef PN, England SJ, Bryan AC
(1984) Passive respiratory mechanics in
newborns and children. Am Rev Respir
Dis 129:552-556
13. Bland JM, Altman DJ (1986) Statistical
methods for assessing agreement be¬
tween two methods of clinical measure¬
ment. Lancet 1:307-310
14. Simbruner G, Coradello H, Lubec G,
Pollak A, Salzer H (1982) Respiratory
compliance of newborns after birth and
its prognostic value for the course and
outcome of respiratory disease. Respi¬
ration 43:414-423
15. Kelly E, Bryan H, Possmayer F,
Frndova H, Bryan C (1993) Compli¬
ance of the respiratory system in new¬
born infants pre- and postsurfactant re¬
placement therapy. Pediatr Pulmonol
15:225-230
16. Wilkie RA, Bryan MH (1987>Effect of
bronchodilators on airway resistance in
ventilator-dependent neonates with
chronic lung disease. J Pediatr 111:
278-282
17. Balsan MJ, Jones JG, Watchko JF,
Guthrie RD (1990) Measurements of
pulmonary mechanics prior to the elec¬
tive extubation of neonates. Pediatr
Pulmonol 9:238 — 243
